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As their diversity of structures suggests, lipids have a wide range of functions 
from storing energy to participant signal transduction. Over the last decade, mass 
spectrometry has emerged as a powerful analytical tool for identification and quantitation 
of lipids. While tandem mass spectrometry affords a higher level of structural 
characterization than intact mass measurements alone, conventional ion activation 
methods often fail to elucidate subtle yet critical structural features. The research 
presented in this dissertation explores the utility of 193 nm ultraviolet photodissociation 
(UVPD), a fast and high-energy alternative ion activation method, for structural 
characterization of phosphatidylcholines and lipooligosaccharides. 
 Phosphatidylcholines are the most abundant glycerophospholipid in mammalian 
cell membranes and therefore represent an important analytical target. Low-energy 
collision-based activation methods generate head group and acyl chain fragment ions that 
permit determination of the lipid class and acyl chain composition, respectively. 
Photodissociation at 193 nm UVPD similarly produced head group and acyl chain 
fragment ions, in addition to diagnostic pairs of fragment ions that afforded localization 
of double bonds within acyl chains. Implementation of UVPD in a shotgun lipidomic 
 viii 
workflow enabled identification of double bond positional isomers in complex 
glycerophospholipid extracts that otherwise would have gone undetected with low-energy 
collision-based activation methods. Coupling of the UVPD method to a mass 
spectrometry imaging workflow further facilitated detection of double bond positional 
isomers in situ. Changes in the relative abundances of double bond positional isomers 
were correlated to specific tissue features. 
 Lipooligosaccharides (LOS) are saccharolipids that are the main component of the 
outer membrane of Gram-negative bacteria. Determination of unknown 
lipooligosaccharides structures and modifications is crucial considering the relationship 
between LOS structures and the development of antibiotic resistance. A mass 
spectrometry method utilizing the MS
n
 capabilities of linear ion trap mass analyzer, 193 
nm UVPD, and high resolution scanning in the Orbitrap mass analyzer facilitated detailed 
structural characterization of intact LOS structures in both shotgun and chromatographic 
workflows. The methods permitted both localization of non-stoichiometric modification 
and determination of unknown core oligosaccharide structures.  
 ix 
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Chapter 1:  Introduction 
1.1 INTRODUCTION 
Identification and quantitation of lipids, a subset of metabolites, is essential to 
achieve a full understanding of complex biological networks.  Lipids not only provide 
insight in to changes in metabolic processes that can result from environmental stimuli, 
but can be used as biomarkers to identify disease states. While studies during the end of 
the 20
th
 century and beginning of the 21
st 
century focused largely on DNA and proteins,  
advances in mass spectrometry technology have greatly advanced our ability to obtain 
lipidomic data that is complementary to genomic and proteomic data.
1
 However, further 
developments are required to address challenges associated with lipid structural 
characterization. Alternative ion activation methods, including ultraviolet 
photodissociation, have proven to be particularly useful for obtaining additional structural 
information not obtained with low-energy collision-based activation methods. The work 
presented herein focuses on structural characterization of phosphatidylcholines and 
lipooligosaccharides, subclasses of glycerophospholipids and saccharolipids, 
respectively, with an emphasis on coupling novel tandem mass spectrometry methods to 
shotgun, chromatographic and imaging workflows.   
1.2 MASS SPECTROMETRY-BASED LIPIDOMICS  
Lipids are a structurally diverse class of biomolecules that influence cell 
membrane structure, act as energy storage reservoirs, and participate in signal 
transduction.
2
 Lipids are divided in to eight categories: fatty acyls, glycerolipids, 
glycerophospholipids, sphingolipids, sterol lipids, prenol lipids and saccharolipids 
(Figure 1.1).  
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Figure 1.1 Representative structures from each of the eight categories of the lipids 
The spatial distributions of lipids in cells is tightly regulated yet highly dynamic, with 
differences in lipid composition occurring not only across different types of cells, but also 
between the leaflets of lipid bilayers and laterally across membranes.
2–7
 Alterations in 
lipid composition have pronounced biological effects in both eukaryotic and prokaryotic 
cells. While controlled changes permit cells to respond to environmental stimuli, 
unregulated alterations can result in pathological states. For example, lipid modification 
in Gram-negative bacteria can provide resistance to antibiotics, whereas aberrant lipid 
metabolism in eukaryotic cells has been linked to diseases including cancer, diabetes, and 
Alzheimer’s.8,9 Lipid characterization is therefore critical for a full understanding of 
biological processes and provides a measure of phenotypic status of a system. 
Lipidomics, the field of study that aims to profile and structurally characterize all the 
lipids within a biological system, has largely been driven by advances in mass 
spectrometry technology including the development of soft ionization techniques and 
new mass analyzers.
1,10–16
 Various sample preparation and mass spectrometric 
approaches have been developed to acquire specific types of information and to address 












 Direct infusion of lipids, a strategy termed “shotgun lipidomics”, 
provides a molecular fingerprint and permits a rapid assessment of complex mixtures.
19–23
 
However, simultaneous introduction of all lipids without separation can result in signal 
suppression of lower abundance lipids owing to division of signal across all the 
components of the mixture. Online chromatographic workflows can be used to alleviate 
signal suppression associated with shotgun methods.
24,25
 Neither shotgun nor 
chromatographic workflows provide any information regarding the spatial distribution of 
lipids in a sample. Mass spectrometry imaging, a technique that samples directly from 
surfaces, provides lipid spatial information by performing a shotgun-style experiment in 
situ at each point on a sample surface. Two-dimensional plots of m/z intensities provide 
images that display the relative abundances of ions in space. The most commonly used 
ionization techniques for MSI are desorption electrospray ionization (DESI) and matrix-
assisted laser desorption ionization (MALDI).
26
 Ion mobility spectrometry, a gas-phase 
electrophoretic technique that separates ions based on their charge, shape and size, can 
also be coupled to shotgun, chromatographic and imaging workflows to provide another 
dimension of separation.
27
 Considering complexity of spectra generated during shotgun 




With shotgun, chromatographic, and imaging workflows, differing levels of lipid 





spectra provide an intact mass measurement of detected lipids.  For methods that rely on 
intact mass measurements from MS
1
 spectra the most informative experiments are ones 
performed on high resolving power mass spectrometers that can, in some cases, enable 
molecular formula determination. High resolving power mass spectrometers also permit 
isobar differentiation, which is particularly beneficial for shotgun and imaging workflows 
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that often generate complex spectra.
30
 For a higher level of characterization, methods 
utilizing tandem mass spectrometry, are employed. Tandem mass spectrometry (MS/MS 
or MS
n
) entails gas-phase fragmentation of a mass selected ions. The resulting fragment 
ions provide a higher level of structural characterization and can therefore provide more 
detail regarding the overall lipidomic profile.  
1.3 GLYCEROPHOSPHOLIPIDS 
Glycerophospholipids, the main component of cell membranes, are composed of a 
glycerol backbone with acyl/alkyl chains at the sn-1 and sn-2 positions, and a phosphate-





Figure 1.2 General structure of a glycerophospholipid 
Combinations of structural features (head group, acyl chain length and unsaturation, sn- 
stereochemistry, unsaturation position, and unsaturation stereochemistry) lead to 
hundreds of thousands of possible glycerophospholipid structures, with subtle alterations 
in structure having large biological implications.
1,6,29,32–34
 For example, changes in the 
positions of double bonds have been shown to influence membrane fluidity.
33
 
Glycerophospholipid headgroups generally dictate the polarity (negative versus positive 
ionization modes) in which mass spectrometry experiments are performed, with 
phosphatidylcholines (PC) and phosphatidylethanolamines (PE) analyzed in positive 
Location of unsaturation






mode and phosphatidic acids (PA), phosphotidylserines (PS) and phosphatidylinositols 
(PI) analyzed in negative mode.
31
 Various complexation and derivatization methods have 
been devised to influence the ionization preference and increase sensitivity for 
glycerophospholipids.
35
 For example, McLuckey and coworker have used gas-phase ion-
ion reactions between a dianionic reagent and lipid cations to achieve high signal 




Depending on the mass spectrometric workflow, varying levels of structural 
characterization can be attained. Top-down high-resolution accurate-mass (HRAM) 
experiments enable determination of the “sum composition” level of structural 
characterization, as defined by Ekroos), with just an intact mass measurement; this level 
of characterization includes the head group, total number of carbons in the acyl/alkyl 
chains, and the number of unsaturations.
30,39–41
 For additional structural information, 
tandem mass spectrometry is required. Early lipidomics studies performed on ion trap 
and triple quadrupole instruments utilized tandem mass spectrometry and were critical for 
establishing the field of lipidomics.
39
 While the most common low-energy collision-
based ion activation methods provide more information than an intact mass measurement 
alone, they often fail at elucidating some of the more subtle structural features. Various 





1.4 TANDEM MASS SPECTROMETRY OF GLYCEROPHOSPHOLIPIDS 
1.4.1 Low-Energy Collisional-Induced Dissociation (CID) and Infrared Multiphoton 
Dissociation (IRMPD) 
Low-energy collision-induce dissociation (CID) is the most commonly used ion 
activation method for fragmentation of glycerophospholipids and has been characterized 
in detail.
31,43,44
 Low-energy CID causes fragmentation via conversion of kinetic energy of 
an ion to internal energy through low-energy collisions with an inert gas, typically helium 
or nitrogen. Ions with low kinetic energies (<100 eV) require multiple collisions to 
induce fragmentation and result in cleavage of the most labile bonds. Low-energy CID 
has been incorporated into modern mass spectrometers either through resonant-excitation 
of ions in ion traps by application of an auxiliary waveform at the ion secular frequency, 
or beam-type activation through acceleration of ions in to a collision cell. Beam-type 
activation is the cornerstone of tandem mass spectrometry on triple-quadrupole mass 
spectrometers with the second quadrupole (Q2) functioning as a collision cell. [Note: 
Beam-type activation has been termed higher-energy collision-dissociation (HCD) on 
Thermo Orbitrap platforms where collisional activation occurs in a dedicated collisional 
cell, and should not be confused with true high-energy keV CID.)] In positive mode, low-
energy CID of glycerophospholipids results in abundant product ion or neutral loss 
fragments corresponding to head group loss, in addition to very low abundance neutral 
loss ions corresponding to loss of acyl chains either as fatty acids or ketenes.
43
 Both 
charge-driven and charge remote processes play a role in the observed fragmentation.
43
 
Activation of glycerophospholipids cations by infrared multiphoton dissociation 
(IRMPD), an activation method that uses infrared photons from a CO2 laser to 
vibrationally excite ions, produces similar fragmentation patterns to low-energy CID.
45
 In 
negative mode, low-energy CID results in abundant fatty acid product ions and lower 
 7 
abundance neutral loss ions also corresponding to loss of acyl chains as fatty acids or 
ketenes. The fragment ions generated by low-energy CID can therefore confirm the 
glycerophospholipid subclass and acyl chain composition. In addition, the relative 
abundances of product and neutral loss ions originating from cleavage of acyl chains 
have previously been correlated to sn-position.
43
 However, even with calibration using 
isomerically pure standards, caution must be exercised when relying on fragment ion 
abundances to determine sn-position, as the type of mass analyzer, collision energy and 
glycerophospholipid structure can all influence the relative abundances of fragment ions; 
to unequivocally determine acyl chain sn-position, fragment ions unique to each sn-
position are necessary.
31
 Predictable head group and acyl chain fragment ions have led to 
the implementation of low-energy CID in both shotgun
44,46–48
 and LC-based lipidomic 
workflows. For example, a multidimensional mass spectrometry shotgun method for 
glycerophospholipid analysis that utilizes the different scanning modes of triple-
quadrupole mass spectrometers enables rapid characterization of many 
glycerophospholipid species present in a complex sample.
48
 Considering the structural 
information obtained from each polarity, charge-inversion methods have been developed 
to ensure that the glycerophospholipid precursor ion charge matches the desired analysis 
polarity.
36,49,50
 For instance, to obtain acyl chain information from fatty acid fragment 
anions for PCs that preferentially ionize in positive mode, PC cations were converted to 
anions through gas-phase charge-inversion via complexation with a dianion. Low-energy 
CID of the resulting electrostatic complex yielded characteristic fatty acid anions.  
Low-energy CID is by far the most utilized ion activation technique, yet critical 
structural features, including double bond position within acyl chains, remain unresolved. 




 to alter 
the observed fragmentation to address the shortcomings of low-energy CID. Using 
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lithium adduction in combination with MS
n
 activation in an ion trap, Hsu et al. were able 
to determine double bond positions within acyl chains through fragment ions generated 
by charge-remote fragmentation.
51
 While this method is also capable of determining acyl 
chain sn-position, it again relies on ion abundances rather than unique fragment ions. 
Derivatization methods used to localize unsaturations in acyl chains include, but are not 




, and oxidation 
reactions
63–65
. In general, derivatization methods chemically modify unsaturations such 
that they produce diagnostic pairs or sets of fragment ions upon low-energy CID. For 
example, collisional activation of Paternò-Büchi reaction products form diagnostic pairs 
of ions separated by 26 Da that enable localization of unsaturations within acyl chains. 
Workflows utilizing Paternò-Büchi reactions have revealed detectable differences in the 




While complexation and derivatization strategies enable manipulation of low-
energy CID fragmentation patterns, alternative ion activation methods are another means 
by which to obtain additional structural information. These included high-energy CID, 
ozone-induced dissociation (OzID), electron-based activation methods, charge-transfer 
dissociation (CTD), helium metastable atom-activated dissociation (He-MAD), radical-
directed dissociation (RDD) and ultraviolet photo dissociation (UVPD). These methods 
have also been used in conjunction with metal complexation and derivatization, and in 
tandem with low-energy CID. 
1.4.2 High-Energy CID 
High-energy CID, similar to low-energy CID, relies on conversion of kinetic 
energy to internal energy via collisions. However, in high-energy CID, ions are 
 9 
accelerated to kinetic energies in the keV range.
68,69
 Upon collision with an inert gas, ions 
can be electronically excited and decompose via charge-remote fragmentation. High-
energy CID was traditionally performed on tandem sector mass spectrometers that could 
accelerate ions to high translational energies. On such instruments, fragmentation along 
the length of C-C bonds of acyl chains could be used to localize double bonds.
70
 With the 
decline in popularity of sector instruments, high-energy CID became a less widely used 
activation method. In recent years, implementation of high-energy CID on MALDI-TOF-
TOF instruments has led to resurgence of interest in its application to biomolecule 
characterization owing to the informative spectra that are generated.
71–75
 In the context of 
glycerophospholipids, high-energy CID appears to be most successful for salt-adducted 
species.
74
 Activation of the [M+K]
+
 ion of PC 16:0_18:1 at m/z 798  resulted in fragment 
ions typically observed for low-energy CID, including head group and acyl chain neutral 
losses, in addition to a series of ions above m/z 500 corresponding to C-C bond 
cleavages, that enable localization of double bonds.
75
 Similarly informative spectra were 
also obtained for lipid anions. Unlike the spectra for low-energy CID of derivatized 
lipids, high-energy CID spectra do not contain a distinct set or pair of diagnostic ions, 
rather cleavage occurs along the entirety of each acyl chain. Therefore, spectra are often 
congested and can be challenging to interpret. Despite the additional structural 
information that can be obtained with high-energy CID, the short interaction time 
between ions and inert gas also results in low fragmentation efficiency and low 
sensitivity. 
1.4.3 Ozone-Induced Dissociation (OzID) 
Pioneered by Blanksby and coworkers, ozone-induced dissociation (OzID) is a 
gas-phase fragmentation technique in which ozone is reacted with ions under vacuum, 
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primarily at the locations of unsaturrations.
76
 In glycerophospholipids, OzID can be used 
to localize double bonds in acyl chains by forming a primary ozonide ring at the location 
of unsaturation which subsequently fragments to form diagnostic aldehyde and Criegee 
ions spaced 16 Da apart. In its first iteration, OzID was implemented on a linear ion trap 
mass spectrometer where ion-molecule reactions and ion detection occurred in the same 
region of the instrument. The limited allowable pressure of ozone that could be used 
without negatively impacting spectral resolution resulted in long activation times (~10 s) 
and low-intensity informative fragment ions.
76
 In its second iteration, a hybrid triple 
quadrupole-linear ion trap mass spectrometer was outfitted with OzID, where ion-
molecule reactions occurred in Q2 and mass analysis occurred in the linear ion trap 
(Q3).
77
 Increased ozone pressure was attained in Q2 without negatively affecting the 
spectral quality; separation of the reaction and analysis regions significantly diminished 
reaction times (~1s) and increased sensitivity. On both platforms, MS
n
 capabilities 
allowed OzID to be performed in tandem with low-energy CID. Activation of sodium-
adducted glycerophospholipids followed by OzID of the dioxolane-type fragment ion, 
generated fragments ions diagnostic of acyl chain sn-position.
78
 This tandem mass 
spectrometry method was the first to use unique ions to determine sn-position rather than 
rely on ion abundances as previous methods have done. Double bond positions with acyl 
chains could additionally be determined by a subsequent OzID activation step 
[CID/(OzID)
2
], enabling near complete characterization. Despite relatively long 
activation times (~1-10s), OzID and CID/OzID were successfully incorporated in to 
chromatographic and imaging workflows, yet coupling of OzID to UPLC separations, 
where chromatographic peak widths are narrow, required further reduction in ion-
molecule reaction times were required.
79–82
 As such, a hybrid quadrupole-TOF mass 
spectrometer with ion mobility separation capabilities was modified to utilize the ion 
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mobility cell as a high pressure OzID reaction chamber.
83
 The dramatic increase in 
allowable ozone pressure in the ion mobility cell further reduced reaction times to 20-200 
ms and enabled identification of UPLC-separated PC double-bond positional isomers.  
Use of the ion mobility cell as a high pressure reaction chamber precluded its use for gas-
phase ion mobility separations and inspired implementation of OzID on a quadrupole-
TOF mass spectrometer with ion mobility separation capabilities and a separate high 
pressure trapping ion funnel where ion-molecule reactions took place.
84
 While much 
progress has been made to increase OzID reaction efficiency, to date, OzID on all 
platforms occurs along the main ion path. Exposure of all ions to ozone currently limits 
the utility of OzID to workflows to those that do not require acquisition of MS
1
 and 
tandem mass spectra, i.e., data-dependent acquisition, in sequence. Incorporation of a 
dedicated reaction chamber orthogonal to the main ion path could further increase the 
utility of OzID. 
1.4.4 Electron-Based Activation Methods 
Electron-based activation methods promote fragmentation via gas-phase 
interaction of ions with either electrons, or radical anions or cations. The fundamental 
differences between the variety of electron-based activation methods lie in the electron 
energy and ion polarity. Electron capture dissociation (ECD) and electron transfer 
dissociation (ETD) induce fragmentation of cations by addition/transfer of electrons to 
cations via low-energy electrons (~0.1 eV) and radical anions, respectively. ECD and 
ETD have had much success in the realm of protein analysis, however these methods 
effectively neutralized singly charged lipid cations and are therefore of little utility for 
lipid analysis. While ETD and ECD were effectively performed on multiply charged 
metal-glycerophospholipid complexes, the observed fragmentation patterns yielded  
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comparable or less structural information than low-energy CID.
85,86
 Methods termed 
electron-induced dissociation (EID) or electron impact excitation of ions from organics 
(EIEIO), where ions are irradiated with a beam of higher energy electrons (>9 eV), have 
been shown to provide informative fragmentation spectra for glycerophospholipid 
cations.
87–90
 Higher energy electrons induced charge-remote fragmentation that provided 
cleavage of C-C bonds along the acyl chains acyl that enabled double bond localization. 
Fragment ion intensities were additional used to determine sn-position. In general, 
fragment ion intensities for EID/EIEIO are low and cleavage is not specific, resulting in 
complex spectra. To date, no negative mode electron-based activation methods have been 
used to analyze glycerophospholipids. 
1.4.5 He-Metastable Atom-Activated Dissociation (He-MAD) and Charge-Transfer 
Dissociation (CTD) 
Helium metastable atom-activated dissociation (He-MAD) and charge transfer 
dissociation (CTD) are fragmentation techniques in which a beam of high energy 
metastable helium atoms or helium cations, respectively, are directed at trapped ions.
91–93
 
The fragmentation patterns produced by He-MAD and CTD of phosphatidylcholine 
cations ions are very similar to each other and to other electron-based activation methods; 
spectra contain a series of fragment ions corresponding to cleavage of C-C bonds along 
the entire length of the acyl chains. He-MAD and CTD therefore also permit localization 
of double bonds within acyl chains. Unique to He-MAD and CTD are product ions with 
an increased charge state resulting from electron detachment. Also similar to electron-
based activation methods, He-MAD and CTD spectra are complex as a result of non-
specific cleavage.  
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1.4.6 Radical-Directed Dissociation (RDD) and Ultraviolet Photodissociation 
(UVPD) 
Activation of ions with UV photons is another means by which to access excited 
electronic states that can lead to fragmentation patterns that are complementary to those 
generated by low-energy CID.
94
 Ion-photon reactions are most common performed by 
directing the beam of a UV laser through an optical window in line with the ion-trapping 
region of a mass spectrometer. The observed product ions are dependent on the laser 
wavelength and the photon absorption properties of precursor ions. Radical-directed 
dissociation (RDD), which utilizes 266 nm photons generated by the fourth harmonic of a 
neodymium-doped yttrium aluminum garnet (Nd:YAG) laser, is a clever means by which 
to initiate radical fragmentation for singly charged glycerophospholipids ions.
95–97
 RDD 
requires two stages of activation: (1) photoactivation of isolated singly-charged ions 
covalently-modified or non-covalently complexed with molecules containing a 
“photocaged” radical and (2) low-energy CID of the resulting “uncaged” radical product 
ion. RDD spectra contain a series of product ions corresponding to cleavage along the 
acyl/alkyl chain with ions spaced 12 Da apart indicating the locations of unsaturations. 
Heiles and coworkers also coupled ultraviolet photodissociation (UVPD) at 266 nm with 
Paternò-Büchi reactions for localization of double bonds within acyl chains and further 




Excimer lasers at 193 nm have recently gained popularity for biomolecule 
fragmentation as innate structural features absorb at this wavelength.
94
 UVPD at 193 nm 
has been previously used for lipid structural characterization and has recently been 
utilized to localize double bonds within acyl chains of phosphatidylcholines without 
derivatization, as is detailed in Chapters 3 and 4.
100–104
 Fragmentation is mediated by 
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absorption of 193 nm photons at unsaturations, with the number of unsaturations 
influencing both the fragmentation efficiency and the production of even- and old-
electron fragment ions. UVPD at 193 nm was further extended to determine both double 
bond positions and acyl chain sn-positions using an MS
3
 method analogous to an MS
3 




Lipopolysaccharides (LPS) are structurally complex saccharolipids that occur 
exclusively in the outer leaflet of the outer membrane of Gram-negative bacteria (Figure 
1.3a).
106
 LPS is composed of three distinct regions: lipid A, core oligosaccharide and O-
antigen.  
 
Figure 1.3 a) Schematic of lipopolysaccharides on the surface of Gram-negative bacteria. 
The outer membrane, peptidoglycan, and inner membrane are labeled OM, 
PG, and IM, respectively. b) Structure of E. coli lipid A with labeled acyl 







































Lipid A is the hydrophobic membrane anchor consisting of a β(1-6)-linked 
diglucosamine backbone that is variably acylated and phosphorylated at the 2, 3, 2’ and 
3’ positions, and 1 and 4’ positions, respectively. Lipid A of LPS is a pathogen-
associated molecular pattern (PAMP) recognized by the mammalian innate immune 
system via the Toll-like receptor 4 (TLR4)/myeloid differentiation factor 2 (MD2) 
complex.
107–110
 While recognition of lipid A by the TLR4/MD2 complex is essential for 
infection clearance, over-stimulation can result in potentially fatal septic shock.
110
 Bis-
phosphorylated, hexa-acylated lipid A elicits the maximum stimulatory effect of the 
TLR4/MD2 complex (Figure 1.3b). Alterations in lipid A structure not only influence 
immune system recognition and potency of response, but also modulate bacterial 
susceptibility to antibiotics.
111
 For example, Helicobacter pylori, a Gram-negative 
bacteria that colonizes the gastrointestinal tract, produces a tetra-acylated lipid A with a 
single phosphoethanolamine modification at the 1 position of the proximal glucosamine 
(Figure 1.3c).
111–113
 The acyl chain composition and phosphate arrangement of H. pylori 
cause a weak response that enable innate immune system evasion. In addition, removal or 
modification of phosphate groups effectively neutralizes the anionic surface charge of the 
Gram-negative outer membrane and make cationic antimicrobial peptides (CAMPs) no 
longer effective. Lipid A modification is one mechanism by which Gram-negative 
bacteria have developed antibiotic resistance.  
The core oligosaccharide is composed of a series of saccharides glycosidically 
linked to lipid A through 3-deoxy-D-mano-oct-2-ulosonic acid (Kdo). (Kdo)2-lipid A is 
the minimal LPS structure required for viable Gram-negative bacteria. The core 
oligosaccharide can be divided in to an inner core and outer core (Figure 1.3a). The inner 
core is highly conserved among a species and, similar to lipid A, can be non-




 The outer core is generally much more variability in its 
saccharide structure. 
  Connected to the core oligosaccharide is the hydrophilic O-antigen, a variably 
repeating saccharide unit composed of two to eight saccharides.
117
 Not all bacterial 
species produce LPS with O-antigen. Those that do have the appearance of smooth 
colonies on agar plates and are therefore called smooth-type LOS (S-LPS), while those 
that do not have the appearance of rough colonies on agar plates and are therefore called 
rough-type LPS (R-LPS) or lipooligosaccharides (LOS).
118
 O-antigen can also be non-
stoichimetrically modified, making it the most variable and structurally complex region 
of LPS.
119
 Another mechanism by which Gram-negative bacteria can evade the immune 
system is to produce O-antigen structures that mimic of host surface antigens. For 
example, H. pylori presents an O-antigen with characteristics that mimic Lewis antigens 
present on the surface of red blood cells.
120
 
Structural characterization of the features of LPS/LOS that confer antibiotic 
resistance and prevent immune system detection are necessary to further our 
understanding of bacterial modification systems and provide a guide for novel antibiotic 
development. 
1.6 MASS SPECTROMETRY OF LPS/LOS 
Determination of structural features of LPS/LOS by mass spectrometry is most 
commonly done by decomposing LPS/LOS and performing analysis on its constituent 
lipid A and polysaccharide portions, often with separation by liquid chromatography 
(LC) or capillary electrophoresis (CE).
100,121–130
 Of the lipid A characterization methods 
that employ online separations, the highest quality separations to date have used 




 Other lipid A and oligosaccharide online separation techniques 
have generally produce modest results. Tandem mass spectrometry has been used heavily 
for structural characterization of the lipid A moiety. Low-energy CID, IRMPD, UVPD, 
and activated-electron photodetachment (a-EPD) have all been used to obtained detailed 
structural characterization of lipid A.
100,121,127,128,132,133
 Low-energy CID cleaves the most 
labile bonds in lipid A structures, which results in abundant fragments corresponding to 
acyl chain neutral losses from the 3 and 3’ positions, fatty acid anions and small molecule 
neutral losses, i.e. H2O, H3PO4. While IRMPD produces similar fragmentation patterns to 
CID, comparison of CID and IRMPD spectra allow rapid identification of phosphate 
containing fragment ions owing to the fact that P-O bonds are strong IR chromophores, 
resulting in rapid and preferential annihilation of phosphorylated products.
100
 In 
particular, Madsen et al. used CID and IRMPD to confirm phospho-containing product 
ions of lipid A.
100
 Both UVPD and a-EPD cleave C-O and C-N bonds in addition to 
cross-ring cleavages that assist with localization of acyl chains on the glucosamine ring 
structures, and therefore produce more structurally informative spectra.
100,127
 A number 
of lipid A characterization methods have utilized the sequential MS
n
 capabilities of ion 
traps to assign structures.
128,134,135
 Owing to the amphipathic nature of intact LPS/LOS 
and the heterogeneity of native LPS/LOS samples, far fewer analytical methods have 
been developed for intact species, many of them shotgun methods.
136–140
 A number of 
methods have used collisional activation to bisect the lipid A and saccharide portions in 
the gas phase, some of which have utilized ion mobility spectrometry to further identify 
lipid A and oligosaccharide portions.
139,140
 Of the methods that have incorporated online 





1.6 OVERVIEW OF CHAPTERS 
Considering the complexity and variety of lipid structures, analytical methods are 
generally tailored to the specific challenges associated with each lipid category. The 
research presented in this dissertation aims to improve structural characterization of 
phosphatidylcholines and lipopolysaccharides/lipooligosaccharides, through the use of 
UVPD at 193 nm, within the context of the shotgun, chromatographic and imaging 
workflows. 
In Chapter 3, 193 nm UVPD was evaluated as an ion activation method for 
structural characterization of phosphatidylcholines. Photoirradiation resulted in 
diagnostic pairs of fragment ions with a 24 Da difference that facilitated localization of 
double bonds within acyl chains. To assess the influence of specific structural features on 
the observed fragmentation patterns, UVPD spectra were collected for a series of 
phosphatidylcholine standards with varying structural features, including double bond 
positions, acyl chain sn-positions, and number of double bonds. The developed UVPD 
method was then applied to a shotgun infusion experiment whereby double bond 
positional isomers were identified in a complex lipid extract. 
In Chapter 4, the UVPD method developed in Chapter 3, was applied to direct 
analysis of tissue sections using desorption electrospray ionization (DESI). In all 
experiments, UVPD was performed on surface-desorbed ions isolated in the mass 
spectrometer. DESI profiling experiments confirmed successful coupling to UVPD and 
verified changes in the relative abundances of double bond isomers across tissue types. 
DESI-UVPD imaging experiments enabled correlation of changes in the spatial 
distribution of phosphatidylcholine double bond isomers to specific tissue features. 
Saccharolipids represent one of the more structurally complex categories of lipids. 
Traditional workflows to structurally characterize LPS/LOS rely on chemical 
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decomposition to constituent lipid A and core oligosaccharide components.   However, 
decomposition has the potential to remove biologically relevant labile modifications and 
precludes determination of combinations of lipid A and oligosaccharide structures 
present. In Chapter 5, an MS
3
 method was developed to structurally characterize the lipid 
A and core oligosaccharide components of intact lipooligosaccharides. Low-energy CID 
of intact lipooligosaccharides resulted cleavage of the glycosidic bond between the lipid 
A and core oligosaccharides portions. Subsequent activation of the lipid A and core 
oligosaccharide fragment ions by UVPD enabled a high level of characterization, 
including localization of phosphate and pyrophorylethanolamine modifications, and 
differentiation of lipooligosaccharides isomers. 
The data presented in Chapter 5 make obvious the heterogeneity of 
lipooligosaccharides samples and reveals the pitfalls of relying on direct shotgun 
analysis. In Chapter 6, the MS
3
 method developed in Chapter 5 is coupled to online 
chromatographic separations with MS
3
 analysis performed in a targeted manner. After 
assessing separation characteristics of the LC method and the capabilities of UVPD on a 
standard mutant E. coli sample, unknown LOS structures from clinically relevant strains 
of Acinetobacter baumannii were determined. 
In Chapter 7, 193 nm UVPD was evaluated for structural characterization of 
glycosaminoglycan (GAG) saccharides. GAGs are highly acidic, variably sulfated linear 
polysaccharides whose modifications and structural variants modulate specific 
interactions with proteins. Low-energy collisional activation of heavily sulfated native 
GAGs results predominantly in sulfate decomposition which prevents acquisition of 
saccharide sequence information and sulfate localization. 193 nm UVPD enabled both 
saccharide sequencing and sulfate localization with results similar to NETD and electron-
detachment dissociation (EDD). 
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Chapter 2: Experimental Methods 
2.1 IONIZATION 
2.1.1 Electrospray Ionization 
Critical to mass spectrometry is the production of gas-phase ions. Early ionization 
techniques produce spectra containing abundant molecular ion decomposition products. 
The invention of electrospray ionization (ESI) in 1989 revolutionized the field of mass 
spectrometry by enabling facile production of gas-phase molecular ions from solution 
under ambient conditions.
1
 During ESI, a high voltage (±2.5-6 kV) is applied to stream of 
solution flowing through a capillary or emitter to generate a plume of charged droplets. 
As solvent evaporates, droplet charge density increases until charge repulsion overcomes 
the droplet surface tension, i. e. the Rayleigh stability limit, and desolvated ions are 
expelled from droplets.
2
 The process of droplet charge accumulation and solvent 
evaporation continues until completely desolvated ions enter the mass spectrometer inlet.  
Nebulizing gas can be used to further facilitate the desolvation process. NanoESI is 
another iteration of ESI whereby a lower voltage (0.5-2 kV) is applied to a capillary or 
emitter with a significantly smaller orifice (1-3 µm).
3
 A smaller initial droplet size 
permits tolerance of high salt concentration and increased analyte sensitivity. 
For the work presented in this dissertation, all LC-MS experiments were 
performed with an ESI source and all shotgun infusion experiments were performed 
using a static nanoESI source where the applied voltage drove solution through the pulled 
capillary. NanoESI required no nebulizing gas. 
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2.1.2 Desorption Electrospray Ionization 
Invented in 2004, desorption electrospray ionization (DESI) is a surface sampling 
technique in which an electrospray plume is directed at a surface, and desorbed ions are 
detected by a mass spectrometer.
4
 DESI requires little sample preparation and has been 
used to obtain chemical profiles directly from tissue surfaces and tissue sections.
5
 DESI 
has therefore contributed significantly to field of mass spectrometry imaging (MSI). 
During DESI-MSI experiments, an electrospray plume is rastered over a tissue section in 
the x and y directions, and the abundances of specific m/z values are mapped in two 
dimensions to permit visualization of the spatial distribution of biochemicals. DESI-MSI 
enables differentiation of normal and diseased regions of tissue based on distinct 
chemical profiles.  
2.2 LIQUID CHROMATOGRAPHY 
For separations of lipids, various types of liquid chromatography are employed to 
influence lipid elution order. All of the chromatographic separations performed in this 
work were reversed-phase. Therefore, all lipids were eluted based on hydrophobicity. A 
Dionex Ultimate 3000 microflow liquid chromatography system (Sunnyvale, CA) was 
used for all chromatographic separations performed in this work. 
2.3 MASS SPECTROMETRY 
All experiments were performed on hybrid quadrupole-Orbitrap-linear ion trap 
mass spectrometer (Thermo Fisher Orbitrap Fusion or Orbitrap Fusion Lumos; San Jose, 
CA). A quadrupole mass filter is composed of two pairs of cylindrical or hydrobolic 
electrodes that are radially-equidistant with one pair orthogonal to the other. A radio 
frequency (RF) voltage is applied to all electrodes with pairs of electrodes 180 degrees 
out of phase. A quadrupole can function as a RF only ion guide during MS
1
 analysis or an 
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m/z filter with narrow isolation widths depending on the application of appropriate DC 
offset voltages to each pair of electrodes. The linear ion trap functions as both an ion 
activation region and a low resolution mass analyzer. A linear ion trap is also composed 
of two pairs of orthogonal, radially-equidistant hydrobolic electrodes with RF voltage 
applied to all electrodes; again, the voltage each pair of electrodes 180 degrees out of 
phase. Each electrode is segmented in to three sections with DC offset voltage applied to 
the front and back sections to permit ion trapping in the center section.
6
 An RF voltage 
amplitude ramp allows ions to be mass-selectively ejected from the ion trap through slits 
in the center electrodes. Collisional activation and ion detection occur in the high and low 
pressure regions of the dual linear ion trap, respectively. High resolution and high mass 
accuracy detection occurs in the Orbitrap mass analyzer. Ions injected in to the Orbitrap 
simultaneously orbit radially and oscillate axially around an inner spindle-shaped 
electrode at high voltage while image current is detect by two outer electrically grounded 
barrel-shaped electrodes.
7
 The combination of the quadrupole mass filter, the linear ion 
trap mass analyzer and the Orbitrap mass analyzer allows sophisticated ion manipulations 
and confident assignment of both precursor and fragment ions. 
2.3 ION ACTIVATION 
2.3.1 Collisional Activation 
On the Orbitrap Fusion and Orbitrap Fusion Lumos platforms, low-energy 
collision-induced dissociation (CID), where ions are accelerated at m/z specific secular 
frequencies and undergo collisions with helium, occurs in the high-pressure trap of the 
dual linear ion trap. During higher-energy collisional dissociation (HCD), ions are 
accelerated in to the ion routing multipole (IRM) region of the instrument which is 
pressurized with 2-8 mTorr nitrogen. HCD is a non-resonant beam-type collisional 
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activation method and is therefore more likely to produce fragment ions that are the result 
of secondary fragmentation.  
2.3.2 193 nm Ultraviolet Photodissociation 
On the Orbitrap Fusion and Orbitrap Fusion Lumos platforms, the dual linear ion 
trap is an ideal region to perform photodissocation. The beam of a Coherent Excistar 
excimer laser at 193 nm was directed through a fused silica optical window in the back 
panel of the vacuum chamber using a set of optical mirrors. The excimer laser, with a 
repetition rate of 500 Hz and 5 ns pulse width, can be pulsed every 2 ms. 
Photodissociation can be performed in either the high-pressure or low-pressure traps of 
the dual linear ion trap. In the present work, photodissocation was performed in either the 
low-pressure or high pressure trap with ion activation periods of 10 to 40 ms 
(corresponding to 5 to 20 pulses and total irradiation times of 25 to 100 nsec). 
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Chapter 3:  Structural Characterization of Phosphatidylcholines Using 
193 nm Ultraviolet Photodissociation Mass Spectrometry* 
3.1 OVERVIEW 
Advances in mass spectrometry have made it a preferred tool for structural 
characterization of glycerophospholipids. Collisional activation methods commonly 
implemented on commercial instruments do not provide fragmentation patterns that allow 
elucidation of certain structural features, including acyl chain positions on the glycerol 
backbone and double bond positions within acyl chains. In the present work, 193 nm 
ultraviolet photodissociation (UVPD) implemented on an Orbitrap mass spectrometer is 
used to localize double bond positions within phosphatidylcholine (PC) acyl chains. 
Cleavage of the carbon-carbon bonds adjacent to the double bond provides a diagnostic 
mass difference of 24 Da and enables differentiation of double-bond positional isomers. 
The UVPD method was extended to the characterization of PCs in a bovine liver extract 
via a shotgun strategy.  Positive mode higher-energy collisional dissociation (HCD) and 
UVPD, and negative mode HCD were undertaken in a complementary manner to identify 
species as PCs and to localize double bonds, respectively. 
  
                                                 
*Klein, D. R.; Brodbelt, J. S. Structural Characterization of Phosphatidylcholine Using 193 nm Ultraviolet 
Photodissociation Mass Spectrometry. Anal. Chem. 2017, 89, 1516-1522. 
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3.2 INTRODUCTION 
Glycerophospholipids, a diverse subclass of lipids and the main component of cell 
membranes, have been the focus of many targeted lipidomics studies. In addition to 
heavily influencing cell membrane dynamics, they also participate in cellular signaling 
and can influence the organization and structure of proteins within the membrane.
 1–5
 
Despite their relatively low molecular weights compared to other biomolecules, 
glycerophospholipids are highly complex as a result of the various combinations of 
substituents that can occur at each of the three positions of the glycerol backbone.
6–8
 
Consequently, glycerophospholipid isomers are commonplace, with subtle differences 
potentially having large implications for biological function.
1,3,9–12
 Considering the 
impact of specific structural features on membrane dynamics, a detailed characterization 
of glycerophospholipids is necessary to achieve a full understanding of cellular behavior.  
Two general ex vivo mass spectrometric approaches to analyze lipids have been 
developed: one employing separations with either liquid chromatographic (LC) mass 
spectrometry
13
 or ion mobility methods
14–16
, and the other based on direct infusion of 
lipids extracts, the latter termed “shotgun lipidomics”.
17–23
 With each of these approaches, 
various levels of structural characterization can be obtained depending on the type of 
mass spectrometric data collected.
1,23
 High resolution MS
1
 data can be used to accurately 
determine lipid molecular formulas, yet MS/MS spectra are required to identify a specific 
lipid or class of lipids. 
Collection of MS
1
 spectra alone for glycerophospholipid analysis, using either LC 
or a shotgun approach, is high throughput, gives a global profile of lipid composition, and 
can differentiate isobars at high resolution, yet it provides no structural information and 
therefore does not permit differentiation of isomers.
22
 Advances in tandem mass 
spectrometry have allowed significant inroads into the structural analysis of 
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glycerophospholipids. The most commonly employed and well-studied method of 
fragmentation for bottom-up lipid analysis is low-energy collision induced dissociation 
(CID). Fragmentation patterns in positive and negative mode produce predominant 
fragments corresponding to the head group and acyl chains, respectively.
17,24
 The 
different ionization efficiencies of glycerophospholipid subspecies can often dictate the 
mode of analysis. In an attempt to improve ionization efficiencies, methods involving 
chemical modification of glycerophospholipid head groups have been developed. 
Specifically, Wasslen et al. and Canez et al. trimethylated the glycerophospholipid amino 




Methods that utilize polarity 
switching have also been developed.
22
 However, the mode in which ionization is optimal 
may not produce MS/MS spectra containing the desired structural information. Ion-ion 
reactions and ion adduction have thus been used to overcome these obstacles.
27–29
 
Stutzman et al. reacted phosphatidylcholine cations with doubly deprotonated 1,4-
phenylenedipropionic acid in the gas phase to produce phosphatidylcholine anions that, 
upon CID fragmentation, produced informative fragmentation patterns with enhanced 
signal-to-noise.
27
  In addition, Ho et al. found that CID of glycerophospholipid-metal 
cation complexes gave more informative spectra.
29
 
Conventional CID methods provide structural information regarding the acyl 
chain lengths, number of unsaturated C-C bonds, and head groups; however, often CID 
does not reveal some of the more subtle structural characteristics of 
glycerophospholipids, including acyl chain position and double bond position. Therefore, 
the development of new analytical tools to completely characterize glycerophospholipid 
structures and quantify their abundances remains an active area of interest. For example, 
Hsu and Turk used lithium adduction and an MS
n
 approach to determine double bond 
position.
30
 Xia and coworkers recently reported a selective reaction/CID strategy to 
 41 
elucidate the position of double bonds in the acyl chains and quantify the relative 
abundances of mixtures of double bond isomers.
31–33
 The key step exploited the well-
known Paternò-Büchi reaction which causes photochemical formation of an oxetane ring 
from a ketone/aldehyde and double bonds within the acyl chains.
31–33
 Yang et al. 
employed a strategy in which the variation in abundances of neutral loss products were 
monitored as a function of double bond position to both identify both the double bond 
position and quantify relative amounts of fatty acid isomers.
34
 Additional methods have 
focused on novel ion activation techniques including radical-directed dissociation (RDD) 
via 266 nm photodissociation followed by CID
35–37
, ozone-induced dissociation 
(OzID)
38–40





 and electron-transfer dissociation (ETD)
44
. In 
parallel studies Pham et al. explored non-covalent complexation of  4-iodobenzoic acid 
or 4-iodoaniline to glycerophospholipids and reactions of 4-iodobenzyl alcohol with  
fatty acids.
35,36
 Irradiation with 266 nm photons resulted in radical species that allowed 
assignment of double bond position upon CID. OzID involves the gas-phase reaction of 
isolated glycerophospholipid cations with ozone in an ion trap
39,40
; CID subsequently 
provided information regarding double bond positions and sn-position. While EIEIO, 
MAD and ETD are each initiated by reactions of ions with electrons, metastable helium 
or argon atoms, or radical anions, respectively, these methods appear to induce similar 
radical-based fragmentation pathways. 
Another ion activation method that produces rich fragmentation spectra for 
various biomolecules, including lipids, is 193 nm ultraviolet photodissociation 
(UVPD).
45–51
 Absorption of a 193 nm photon results in deposition of ~6.4 eV of internal 
energy, and the photoactivation process occurs in a 5 nsec laser pulse period.  This high 
energy excitation affords access to fragmentation pathways not observed by collision 
 42 





 as well as other types of 
biological molecules.
45
 In the present study, 193 nm UVPD is shown to produce 
fragmentation patterns that allow double-bond isomer differentiation and is used for 
detailed structural characterization of mixtures of phosphatidylcholines (PC), a subclass 




All PC samples as well as the polar bovine liver extract were purchased from 
Avanti Polar Lipids (Alabaster, Alabama) and were used without further purification.  
The structures and molecular weights of all PCs included in the study are shown in Table 
3.1. Lipid shorthand notation used is in accordance with previously established 
notation.
53
 In brief, acyl chain compositions are indicated by the number of carbons 
atoms in the acyl chain followed by a colon and the number double bonds. For PCs with 
known acyl chain orientation, the acyl chain compositions of sn-1 and sn-2 are separated 
by “/” with sn-1 followed by sn-2. For unknown acyl chain orientation, acyl chain 
compositions are separated by “_”. For known double bond positions, positions are 
indicated in parenthesis after the acyl chain composition by the carbon number and Z, E 
or ∆ to indicate the bond orientation as cis, trans or unknown, respectively. For example, 
PC 16:0/18:1(9Z) represents a phosphatidylcholine with palmitate (16 carbon chain) at 
the sn-1 position and oleate (18 carbon chain with 1 unsaturation) at the sn-2 position 
with a cis double bond at carbon number 9.  Methanol (MeOH), acetonitrile (ACN, and 
water (H2O) were purchased from EMD Millipore (Billerica, MA); HPLC grade 
chloroform (CHCl3) and LC-MS grade ammonium formate were purchased from Sigma 
Aldrich (St. Louis, MO). All samples were diluted in 50:50 ACN:H2O with 30 mM 
 43 
ammonium formate to 10 µM for PC standards and 10 µg/mL for polar bovine liver 
extract.  
Table 3.1 Names, structures and molecular weights of all standard PCs 
 
Approximately 10 µL of sample were loaded into a silver-coated pulled tip glass capillary 
(1.2 mm OD) and sprayed using a Proxeon offline nano-electrospray set-up (Thermo 
Scientific, San Jose, CA). The spray voltage was set to 1.1 kV. All positive mode spectra 
were collected on either a Thermo Scientific Orbitrap Fusion Lumos mass spectrometer 
or (San Jose, CA) or an Orbitrap Elite mass spectrometer (Bremen, Germany) each 
modified with a 193 nm Coherent Existar excimer laser (Santa Cruz, CA) to perform 
UVPD as previously described.
51,52
 On the Orbitrap Elite mass spectrometer, UVPD was 
performed in the HCD cell with 8 laser pulses at 5 mJ per pulse, and on the Orbitrap 








































Fusion Lumos mass spectrometer, UVPD was performed in the low pressure trap of the 
dual linear ion trap by applying 10 laser pulses at 6 mJ per pulse. In each case, the laser 
was operated at 500 Hz, resulting in an activation period of 16 to 20 ms per scan. For 
UVPD/CID MS
3 
spectra collected on the Orbitrap Fusion Lumos mass spectrometer, 
UVPD activation was first performed in the high pressure trap of the dual linear ion trap 
with 10 laser pulses at 6 mJ per pulse followed by CID with a normalized collision 
energy (NCE) of 30. All negative ion mode spectra were collected on the Thermo 
Scientific Orbitrap Fusion Lumos mass spectrometer. Data were collected with an AGC 
target between 5 x 10
4
 and 1 x 10
5
 at a resolution of 60,000. To maximize the quality of 
the benchmark MS/MS spectra, 100 scans were averaged with 2 µscans per scan, 
corresponding to approximately one minute per spectrum. MS/MS spectra could be 
collected with as few as one scan per spectrum, as shown in Figure 3.1.  All HCD data 
were collected with an NCE of 25. On the Orbitrap Fusion Lumos mass spectrometer an 
isolation width of 1 Da was used and on the Orbitrap Elite mass spectrometer an isolation 
width of 2 was used. Default activation times were used for HCD. All data were analyzed 
in XCalibur Qual Browser and manually interpreted. 
 45 
 
Figure 3.1 HCD mass spectra acquired for the ion of m/z 760.58 from polar bovine liver 
extract with a) 1, b) 2, c) 5, d) 10 and e) 20 scans averaged. UVPD spectra 
acquired for the ion of m/z 760.58 from polar bovine liver extract with f) 1, 
g) 2, h) 5, i) 10 and j) 20 scans averaged. Each scan contains 2 µscans. 
3.4 RESULTS AND DISCUSSION 
For this study, a series of PCs were characterized by HCD and UVPD in order to 
compare the types of fragment ions produced by each activation and evaluate the 
capability for localization of double bonds and isomer/isobar differentiation. Infusion of 
each PC in positive mode yielded abundant protonated ([M+H]
+
) and less abundant 
sodium cationized ([M+Na]
+
) ions (Figure 3.2).  


































































 spectra of a) PC 16:0/18:1(9Z), b) PC 18:1(9Z)/18:1(9Z), c) PC 
18:1(6Z)/18:1(6Z), d) PC 18:0/18:0, e) PC 18:0/18:1(9Z), f) PC 
18:0/18:2(9Z,12Z), and g) PC18:1(9Z)/16:0. 




























































Examples of the HCD and UVPD mass spectra are shown in Figures 3.3 and 3.4. As an 
example, HCD of protonated PC 16:0/18:1(9Z) produced an abundant product ion of m/z 
184.07, corresponding to the phosphocholine head group, and less abundant ions of m/z 
478.33, 496.34, 504.35 and 522.35 corresponding to acyl chain neutral losses (Figure 
3.3a). All ions observed upon HCD are consistent with results previously reported for 




Figure 3.3 a) HCD (NCE 25) and b) UVPD (10 pulses, 6 mJ) spectra of protonated PC 
16:0/18:1(9Z) ([M+H]
+
, m/z 760.59). 
UVPD produced the same acyl chain neutral loss ions as well as highly informative ions 
corresponding to C-C cleavages along the acyl chain (Figure 3.3b). The UVPD mass 
spectrum lacks the predominant head group ion of m/z 184.07 as a result of the default 
622.45
646.45





















































ion trap q-value when performing UVPD on the Orbitrap Fusion Lumos mass 
spectrometer; with the current software, the ion trap q-value cannot be decreased below a 
default value of 0.25. To confirm that the head group ion is in fact generated upon 
UVPD, HCD and UVPD spectra were collected on an Orbitrap Elite mass spectrometer 
also equipped with a 193 nm excimer laser, with UVPD performed in the HCD cell 
(Figure 3.5). The UVPD mass spectrum collected on the Orbitrap Elite mass 
spectrometer confirms that the head group ion of m/z 184.07 is generated. 
 49 
 
Figure 3.4 a) HCD (NCE 25) and b) UVPD (10 pulses, 6 mJ) spectra of protonated PC 
18:1(9Z)/18:1(9Z) ([M+H]
+
, m/z 786.60). c) HCD (NCE 25) and UVPD (10 













































































































Figure 3.5 a) HCD (NCE 25) and b) UVPD (10 pulses, 6 mJ) of PC 16:0/18:1(9Z) 
([M+H]
+
, m/z 760.59) collected on the Orbitrap Fusion Lumos mass 
spectrometer. c) HCD (NCE 25) and b) UVPD (8 pulses, 5 mJ) of PC 
16:0/18:1(9Z) collected on the Orbitrap Elite mass spectrometer. (Data 
presented in parts a) and b) is the same as data in Figure 3.3) 
The most abundant of the C-C acyl chain cleavage products (m/z 622.45 and m/z 646.45) 
in the spectrum in Figure 3.3b correspond to cleavage of either one of the carbon-carbon 









































































of this diagnostic pair of ions.  Putative structures of the two marker ions are shown in 
Figure 3.6.  
 
Figure 3.6 Putative structures of the two diagnostic ions (m/z 622.44 and 646.44) 
generated from UVPD of PC 16:0/18:1(9Z) ([M+H]
+
, m/z 760.59) 
This pair of key diagnostic ions is also generated upon UVPD of the corresponding 
sodium-cationized PC, as illustrated in Figure 3.7. HCD of sodium-cationized PC 
16:0/18:1(9Z) results predominantly in neutral losses of choline and phosphocholine 
(yielding the products of m/z 723.49 and m/z 599.50, respectively), again providing 
characteristic head group information. Additionally, acyl chain neutral losses consistent 
with retention or loss of sodium are also observed. In the corresponding UVPD mass 
spectrum, fragment ions produced by cleavage of the C-C bond on either side of the 
double bond are again observed (m/z 644.43 and 668.43). Both of these ions retain 








double bond positional information as noted for the protonated PC.  For the remainder of 
the study, the analysis will focus on the protonated PCs. 
 
Figure 3.7 a) HCD (NCE 25) and b) UVPD (10 pulses, 6 mJ) of sodium adducted PC 
16:0/18:1(9Z) ([M+Na]
+
, m/z 782.57). The subscript “Na” in the labels of 
the fragment ion map indicates ions that retain the sodium adduct. 
HCD and UVPD spectra of the isomeric lipids PC 18:1(9Z)/18:1(9Z) and PC 


























































group (m/z 184.07) and diagnostic acyl chain (m/z 504.34 and 522.36) ions, but the HCD 
spectra for these isomeric PCs are indistinguishable. In contrast, the fragmentation 
patterns generated by UVPD exhibit ions that allow differentiation of the double bond 
positional isomers based on the unique C-C cleavage products that differ by 24 Da. The 
most abundant C-C cleavage fragments for PC 18:1(9Z)/18:1(9Z) are m/z 648.46 and 
672.46, and for PC 18:1(6Z)/18:1(6Z) they are m/z 606.41 and 630.41.  In addition, the 
UVPD spectra of PC 16:0/18:1(9Z), PC 18:1(9Z):18:1(9Z), PC 18:1(6Z)/18:1(6Z) and all 
other PCs with double bonds exhibit the loss of a hydrogen atom from the precursor, 
resulting in products of m/z 759.57, m/z 785.57 and m/z 785.57, respectively, and also 
display other odd-electron fragment ions that are suggestive of radical-directed 
fragmentation processes. The hydrogen atom losses from the precursor ions upon UVPD 




Figure 3.8 Fragmentation spectra expanded  on precursor ions during HCD isolation, 
HCD (NCE 25), UVPD isolation and UVPD (10 pulses, 6 mJ) for PC 
16:0/18:1(9Z), PC 18:1(9Z)/18:1(9Z), PC 18:1(6Z)/18:1(6Z), PC 18:0/18:0, 
PC 18:0/18:1(9Z), PC 18:0/18:2(9Z,12Z) and PC18:1(9Z)/16:0. 
To further investigate the nature of the hydrogen atom loss product, UVPD/CID 
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Figure 3.9 a) UVPD (10 pulses, 6 mJ) of PC 16:0/18:1(9Z) and b) UVPD/CID (10 
pulses, 6 mJ/NCE 30) of PC 16:0/18:1(9Z). UVPD/CID is an MS
3
 event 
where UVPD is first performed on m/z 760.59 and then CID is subsequently 
performed on the atomic hydrogen loss species at m/z 759.58. 
UVPD was used to generate the hydrogen loss product (m/z 759.57) which was 




































































































fragment ion abundances between the UVPD and UVPD/CID spectra (Figure 3.9a 
versus 3.9b), in general, many of the ions present in the UVPD spectrum are also present 
in the UVPD/CID spectrum. However, there exist fragment ions unique to UVPD, 
namely the product ion of m/z 622.45 which is one of the key diagnostic fragment ions 
used to determine double bond position.  In the UVPD/CID, there is an alternate product 
ion of m/z 620.43 which is 26 Da lower in mass, not 24 Da lower in mass, than the 
companion ion of m/z 646.45.  
The production of diagnostic product ions that differ by 24 Da upon UVPD is 
consistent for a number of PCs containing acyl chains with a single unsaturation, and 
interestingly it is 2 Da less than the difference between allylic cleavages observed by 
Pham et al. for a radical-directed dissociation (RDD) process
35
 and for the products in the 
UVPD/CID spectra (Figure 3.9).  Beyond the presence of diagnostic C-C cleavage 
products in the spectra of PC 18:1(9Z)/18:1(9Z) and PC 18:1(6Z)/18:1(6Z), there are 
differences in the abundances of these ions for each of the two isomers (Figure 3.4b and 
3.4d) suggesting that the specific double bond position influences the fragmentation 
processes. 
To further probe the influence of specific structural features on the observed 
UVPD spectra, HCD and UVPD spectra for a series of PCs were compared. Figure 3.10 
shows the UVPD spectra for PC 18:0/18:0, PC 18:0/18:1(9Z) and PC 18:0/18:2(9Z, 12Z); 
the only variable feature is the number of double bonds. Figure 3.11 shows the 
corresponding HCD mass spectra. The UVPD spectrum for PC 18:0/18:1(9Z) (Figure 
3.10b), as expected, contains a diagnostic ion pair of m/z 650.47 and m/z 674.47. The 
UVPD spectrum for PC 18:0/18:2 (9Z, 12Z) (Figure 3.10c) contains two sets of 
diagnostic ions of m/z 650.47 and m/z 674.47, and m/z 690.50 and m/z 714.50, indicating 
that the positions of multiple unsaturations within an acyl chain can be localized.  
 57 
 
Figure 3.10 UVPD spectra (10 pulses, 6 mJ) of a) PC 18:0/18:0 ([M+H]
+
, m/z 790.63), b) 
PC 18:0/18:1(9Z) ([M+H]
+
, m/z 788.61), and PC 18:0/18:2(9Z,12Z) 
([M+H]
+
, m/z 786.60). d) Bar graph comparing the impact of the number of 
double bonds on HCD and UVPD as a function of precursor depletion 






























































































































































Figure 3.11 HCD (NCE 25) spectra of a) PC 18:0/18:0 ([M+H]
+
, m/z 790.63), b) PC 
18:0/18:1(9Z) ([M+H]
+


















































































































However, in contrast to UVPD spectra of PCs with a single unsaturation in an acyl chain, 
the UVPD spectrum for PC 18:0/18:2(9Z,12Z) contains additional ions of m/z 675.47, 
m/z 676.48, m/z 688.49 and m/z 689.50, shown in the inset of Figure 3.10c. These 
fragments appear to correspond to odd electron fragments originating from homolytic 
cleavage of C-C bonds (m/z 675.48 and m/z 689.50) or fragments derived from radical-
directed processes (m/z 676.49 and m/z 688.49).  The expanded regions of the UVPD 
mass spectra in Figure 3.8 confirm an increased abundance of the hydrogen atom loss 
product for PC 18:0/18:2(9Z,12Z) (see m/z 785.59) compared to isomeric PC 
18:1(9Z)/18:1(9Z) and PC 18:1(6Z)/18:1(6Z). Figure 3.10d additionally shows how the 
number of double bonds influences HCD and UVPD efficiency as a function of precursor 
depletion. Precursor depletion is calculated as percentage of the surviving precursor ion 
after activation by HCD (NCE 25) or UVPD (10 pulses, 6 mJ).  In general, the number of 
double bonds has little influence on the precursor depletion during HCD, whereas the 
number of double bonds significantly increases the depletion of the precursor upon 
UVPD. Increased precursor depletion may be related to an increase in UV 
photoabsorption cross-section and possibly more facile radical-mediated processes, both 
which scale with the number of double bonds.  
For the acyl chain positional isomers PC 16:0/18:1(9Z) and PC 18:1(9Z)/16:0, 
HCD leads to preferential loss of acyl chains at the sn-2 position as ketenes (Figure 
3.12). This preferential loss results in the product ions of m/z 496.34 for PC 
16:0/18:1(9Z) and m/z 522.36 for PC 18:1(9Z)/16:0. Although the abundances of acyl 
chain neutral loss ions may be skewed by the presence of contaminating isomers inherent 
to the sample, as has been previously reported,
15,41
 the same overall trend holds between 
the positional isomers.  
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Figure 3.12 a) HCD (NCE 25) and b) UVPD (10 pulses, 6 mJ) of PC 16:0/18:1(9Z) 
([M+H]
+
, m/z 760.58). c) HCD (NCE 25) and d) UVPD (10 pulses, 6 mJ) of 
PC 18:1(9Z)/16:0 ([M+H]
+
, m/z 760.58). 
In the UVPD spectra of the positional isomers, there appears to be preferential 
losses of the unsaturated acyl chains leading to more abundant ions at m/z 478.33 and m/z 



























































































496.34. Again, this preference suggests that fragmentation is modulated by the presence 
of the double bond. However, there is no significant difference in the abundances of the 
fragment ions corresponding to cleavage of either carbon-carbon bond adjacent to the 
double bond. While it is difficult to determine whether specific fragments are generated 
via a charge-driven or charge-remote processes without performing experiments with 
specific deuterium-labeled PCs, it is likely that multiple fragmentation mechanisms 
contribute to the observed UVPD mass spectra.  Moreover, the double bond positions, 
number of double bonds and acyl chain position may influence which fragmentation 
pathways are preferentially accessed. 
While complete structural characterization of lipids is challenging, detection and 
differentiation of isomeric lipids in complex biological extracts is crucial for correlation 
of molecular structure with biological function. For analysis of PCs in biological samples, 
application of the developed UVPD method is well suited for a shotgun approach for two 
reasons: 1) as UVPD of PCs suffers from rather low fragmentation efficiency, a shotgun 
approach offers the ability to average multiple spectra for optimal signal to noise, and 2) 
while co-isolation and fragmentation of isobaric and isomeric lipids can create 
convoluted MS/MS spectra that can be challenging to interpret, the high resolution 
capabilities of the Orbitrap mass spectrometer enable identification of fragment ions with 
high confidence despite the presence of convoluting species. To demonstrate the UVPD 
strategy, a bovine liver extract was analyzed owing to its high PC content. Figure 3.13 
shows the positive mode and negative mode shotgun MS
1
 mass spectra. The positive 





Figure 3.13 a) Positive mode and b) negative mode MS
1
 spectra of 10 µg/mL bovine 
liver extract in 50:50 ACN:H2O with 30 mM ammonium formate.  
High resolution and high mass accuracy allow empirical formulae to be determined from 
the MS
1
 spectra. For structural characterization of PC, ions throughout the mass spectrum 
were manually selected for subsequent MS/MS analysis. HCD was first performed to 
identify an ion as a PC species using the characteristic head group product ion of m/z 
184.07.  Negative mode HCD spectra of the formate adduct ([M+COOH]
-
) were also 
collected to verify the acyl chain composition.  If a precursor ion was identified as a PC, 
then the same precursor was subsequently isolated and subjected to UVPD in the positive 


























































mode. For example, HCD was performed on the ion of m/z 760.58 (observed in Figure 
3.14a). The resulting HCD spectrum displayed an abundant fragment of m/z 184.07 
indicative of a PC (Figure 3.14b). UVPD was then performed on the ion of m/z 760.58, 
and fragment ions with a difference of 24 Da were used to determine double bond 
positions (Figure 3.14c).  
 
Figure 3.14 Positive mode a) HCD (NCE 25) and b) UVPD spectra (10 pulses, 6 mJ) of 
m/z 760.58, ([M+H]
+
) and c) negative mode HCD spectrum of m/z 804.67, 
([M+COOH]
-
) with corresponding fragment ion maps. 
Two sets of ions with a difference of 24 Da were observed in the UVPD spectrum:  m/z 
622.44 and 646.44 corresponding to PC 16:0_18:1(9∆) and m/z 650.47 and 674.47 





































































































species in negative mode (m/z 804.57, seen in Figure 3.13) to further confirm the acyl 
chain composition. Ions at m/z 255.23 and m/z 281.25 confirm palmitate (16 carbon 
chain) and oleate (18 carbon chain with 1 unsaturation) acyl chains. This strategy allows 
differentiation of isomeric PCs in biological samples. Table 3.2 contains a list of 
seventeen PCs identified in the bovine liver extract with localized double bonds and the 
corresponding diagnostics ions. Figures 3.18-3.27 show the corresponding positive mode 
HCD and UVPD spectra and negative mode HCD spectra for the identified PCs (Chapter 
3, Supporting Information). 
Table 3.2 List of identified PCs from polar liver extract  
 
Substantial differences in the relative abundances of the diagnostic ions in the 
UVPD spectrum are apparent in Figure 3.14b. Comparison of the variations in relative 
abundances of diagnostics ions between samples affords insight into changes in the 
isomer profiles. In fact, changes in the relative abundances of isomeric lipids have 
previously been correlated to disease states.
33
 To assess the ability of the shotgun UVPD 








Acyl chain fragment ions (m/z)
- ion mode
Figure
PC 14:0_18:1(9∆) 732.55 594.41, 618.41 776.54 227.20, 281.25 3.18
PC 16:0_16:1(9∆) 732.55 622.44, 646.44 776.54 253.22, 255.23 3.18
PC 16:0_18:1(9∆) 760.58 622.44, 646.44 804.57 255.23, 281.25 3.19
PC 16:0_18:1(11∆) 760.58 674.47, 650.47 804.56 255.23, 281.25 3.19
PC 16:0_18:2(9∆,12∆) 758.57 622.44, 646.44, 662.47, 686.47 802.56 255.23, 279.23 3.20
PC 16:0_20:3(8∆,11∆,14∆) 784.58 608.43, 632.43, 648.46, 672.46, 688.49 828.57 255.23, 305.23 3.23
PC 16:0_22:4(7∆,10∆,13∆,16∆) 810.60 594.41, 618.41, 634.33, 658.44, 698.47, 714.50 854.59 255.23, 331.26 3.25
PC 18:0_18:1(9∆) 788.61 650.47, 674.47 832.60 281.25, 283.25 3.21
PC 18:0_18:1(11∆) 788.61 678.50, 702.51 832.60 281.25, 283.25 3.21
PC 18:0_18:2(9∆,12∆) 786.60 650.47, 674.47, 690.50, 714.51 830.59 279.23, 283.26 3.22
PC 18:0_18:3(6∆,9∆,12∆) 784.58 608.43, 632.43, 648.46, 672.46, 688.49 828.57 277.22, 283.26 3.23
PC 18:0_20:3(8∆,11∆,14∆) 812.61 636.46, 660.46, 676.49, 700.49 856.60 283.26, 305.25 3.24
PC 18:0_20:4(5∆,8∆,11∆,14∆) 810.60 594.41, 618.41, 634.33, 658.44, 698.47, 714.50 854.59 283.26, 303.23 3.25
PC 18:0_22:4(7∆,10∆,13∆,16∆) 838.63 622.44, 646.44, 662.47, 686.47, 702.50, 726.51, 742.53 882.62 283.26, 331.26 3.26
PC 18:0_22:5(7∆,10∆,13∆,16∆,19∆) 836.61 622.44, 646.44, 662.47, 686.47, 726.50, 766.54 880.61 283.26, 329.25 3.27
PC 18:1(10∆)_18:1(10∆) 786.60 662.47, 686.48 830.59 281.25 3.22
PC 18:1(9∆)_18:2(9∆,12∆) 784.58 646.43, 670.43, 648.46, 672.46, 688.49 828.57 279.23, 281.25 3.23
*All negative mode neutral loss fragments have also lost a head group methyl
 65 
various molar ratios of the isomers PC 18:1(6Z)/18:1(6Z) and PC 18:1(9Z)/18:1(9Z) 
(with a fixed total concentration of 10 µM) were analyzed (Figure 3.15, 3.16). 
 
Figure 3.15 MS1 spectra of solutions containing different molar ratios of PC 
18:1(9Z)/18:1(9Z) ([M+H]
+
,  m/z 786.60) and PC 18:1(6Z)/18:1(6Z) 
([M+H]
+
,  m/z 786.60). a) 9:1, b) 7:3, c) 6:4, d) 5:5, e) 4:6, f) 3:7, g) 1:9. 
The total PC concentration for each solution is 10 uM. These samples were 
constituted in 50:50 MeOH:CHCl3. 
[M+H]+
















































Figure 3.16 Expanded regions of the UVPD spectra for solutions containing various 
molar ratios of PC 18:1(9Z)/18:1(9Z) and PC 18:1(6Z)/18:1(6Z). Mass 
spectra correspond to the following ratios of PC 18:1(9Z)/18:1(9Z) to PC 
18:1(6Z)/18:1(6Z): a) 9:1, b) 7:3, c) 3:2, d) 1:1, e) 2:3, f) 3:7 and g) 1:9. 













































UVPD mass spectra were collected, and the abundances of the pair of diagnostic ions for 
PC 18:1(6Z)/18:1(6Z) were used to calculate the percentage of ion current attributed to 
PC 18:1(6Z)/18:1(6Z) relative to PC 18:1(9Z)/18:1(9Z)).  Figure 3.17 confirms there is a 
linear relationship in the percent abundance of diagnostic ions that correlates with the 
concentration of PC 18:1(6Z)/18:1(6Z), thus providing a means to evaluate the 
composition of mixtures. 
 
 
Figure 3.17 Plot confirming the linear relationship between the concentration of PC 
18:1(6Z)/18:1(6Z) (x-axis) and intensity percent of the summed diagnostics 
ions for PC 18:1(6Z)/18:1(6Z) (m/z 606 + m/z 630) relative to the total 
summed intensity for all diagnostic ions (m/z 606 + m/z 630 + m/z 648 + m/z 
672) (y-axis).  
3.5 CONCLUSION 
Although collisional activation of phospholipids provides head group and acyl 
chain information, isobaric/isomeric structures resulting from variations in double-bond 
position and acyl chain position often go undetermined. The presented results confirm 
that 193 nm UVPD allows PC double bond positional isomers to be discerned. 
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Comparison of the fragmentation patterns of a series of PCs gave insight into the 
underlying pathways promoted by UVPD. The series of collected spectra suggest that 
both the number of double bonds and their relative positions influence photoactivation 
and fragmentation. A shotgun method utilizing HCD and UVPD in conjunction with the 
high resolution capabilities of the Orbitrap mass analyzer affords the ability to analyze 
complex mixtures of phospholipids. From a bovine polar liver extract seventeen PCs 
were identified, all with double bonds localized. Additionally, preliminary quantitative 
studies indicate that relative changes in isomer composition can be detected in biological 
samples. We are currently extending the UVPD method to other subclasses of 
phospholipids to gain a more detailed global profile of the phospholipids present in 
biological samples. Despite the advantages of the developed strategy, it is currently not a 
high throughput method. While automated peak selection and acquisition of MS
2
 spectra 
could easily be implemented into this method, identification of lipids from UVPD spectra 
remains a bioinformatics challenge. Most existing lipid identification software that use 
MS
2
 spectra for identification cater to collision-based fragmentation methods and do not 
assign peaks originating from cleavage of C-C bonds. Thus, the development of more 
sophisticated lipid analysis software is essential. In addition, while shotgun spectra are 
inherently complex, shotgun UVPD spectra are more so, which poses challenges for 
spectra interpretation and identification of lower abundance species. Coupling of a gas-
phase separation method, like differential mobility spectrometry, could allow for spectral 





3.6 SUPPORTING INFORMATION 
 
Figure 3.18 a) HCD and b) UVPD spectra of m/z 732.56 ([M+H]
+
) and c) HCD spectrum 
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Figure 3.19 a) HCD and b) UVPD spectra of m/z 760.58 ([M+H]+) and c) HCD spectrum 
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Figure 3.20 a) HCD and b) UVPD spectra of m/z 758.57 ([M+H]
+
) and c) HCD spectrum 























































































































Figure 3.21 a) HCD and b) UVPD spectra of m/z 788.61 ([M+H]
+
) and c) HCD spectrum 
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Figure 3.22 a) HCD and b) UVPD spectra of m/z 786.60 ([M+H]
+
) and c) HCD spectrum 











































































































































Figure 3.23 a) HCD and b) UVPD spectra of m/z 784.58 ([M+H]
+
) and c) HCD spectrum 
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Figure 3.24 a) HCD and b) UVPD spectra of m/z 812.61 ([M+H]
+
) and c) HCD spectrum 
of  m/z 856.60 ([M+COOH]
-
) 
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Figure 3.25 a) HCD and b) UVPD spectra of m/z 810.60 ([M+H]
+
) and c) HCD spectrum 
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Figure 3.26 a) HCD and b) UVPD spectra of m/z 838.63 ([M+H]
+
) and c) HCD spectrum 


























































































































Figure 3.27 a) HCD and b) UVPD spectra of m/z 836.61 ([M+H]
+
) and c) HCD spectrum 
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Chapter 4: Desorption Electrospray Ionization Couple with Ultraviolet 
Photodissociation for Characterization of Phospholipids Isomers in 
Tissue Sections* 
4.1 OVERVIEW 
Desorption electrospray ionization (DESI) mass spectrometry imaging has 
become a powerful strategy for analysis of tissue sections, enabling differentiation of 
normal and diseased tissue based on changes in the lipid profiles. The most common 
DESI workflow involves collection of MS
1
 spectra as the DESI spray is rastered over a 
tissue section. Relying on MS
1
 spectra inherently limits the ability to differentiate 
isobaric and isomeric species or evaluate variations in the relative abundances of key 
isomeric lipids, such as double-bond positional isomers which may distinguish normal 
and diseased tissues. Here 193 nm ultraviolet photodissociation (UVPD), a technique 
capable of differentiating double-bond positional isomers, is coupled with DESI to map 
differences in the double-bond isomer composition in tissue sections in a fast, high 
throughput manner compatible with imaging applications. 
  
                                                 
*Klein. D. R.; Feider, C. L.; Garza, K. Y.; Lin, J. Q.; Eberlin, L. S.; Brodbelt, J. S. Desorption Electrospray 
Ionization Coupled with Ultraviolet Photodissociation for Characterization of Phospholipid Isomers in 
Tissue Sections. Anal. Chem. 2018, 90, 10100-10104. 
 
CLF assisted with implementation of DESI on the Orbitrap Fusion Lumos. CLF and KYG participated in 
data collection, made DESI images and reviewed the manuscript prior to publication. CLF and KYG 
overall contributed equally. JQL wrote code to enable visualization of DESI-UVPD ratio images. JSB and 




Mass spectrometry imaging (MSI) has emerged as a formidable tool to obtain 
spatially-resolved chemical profiles from tissue sections, thus enhancing the diagnosis 
and prognosis of diseases like cancer.
1–4
 The most widely used ionization techniques for 
MSI include matrix-assisted laser desorption ionization (MALDI)
5,6
 and desorption 
electrospray ionization (DESI).
7–9
 MSI experiments are most commonly performed by 
collecting MS
1
 spectra as the ionization source is rastered over the tissue section with ion 
intensities subsequently plotted in two-dimensions. Direct sampling of tissue produces 
complex mass spectra with isobaric species often overlapping or interfering with the 
analytes of interest. Implementation of MSI on high performance mass spectrometers has 
alleviated the problem of isobaric interferences and exposed the complexity of 
biomolecular profiles within tissue sections.
10–13
 While high mass resolution and 
accuracy measurements facilitate analysis of congested spectra, collection of MS
1
 data 
provides little structural information on the detected species. Consequently, isomeric 
species remain indistinguishable by MS
1
 alone; however, structural characterization via 




Collisionally activated dissociation (CAD) is the most common MS/MS method 
used for structural characterization, particularly for lipids.
16
 However, a number of subtle 
features with significant biological implications, including double bond position, acyl 
chain sn-position and double bond stereochemistry, are frequently not confirmed by 
CAD.
17
 Differences in the spatial distribution of isomers arising from these features 
therefore go unresolved. In particular, double bond positions have been shown to greatly 
influence lipid membrane thickness and ordering,
18
  and play a substantial role in protein-
lipid binding.
19
 In addition, changes in the relative abundances of double-bond positional 
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isomers have shown promise for differentiation of normal and diseased tissues.
20
 
Advances in ion mobility spectrometry have enabled fast separation of lipid isomers in 
the gas phase,
21,22
 and tandem mass spectrometry is crucial for identification of the 
separated lipids. In–spray Paternò-Büchi reactions with subsequent collisional activation 
of reaction products have demonstrated success as a means to determine double bond 
positions.
21,22
 Alternatively, novel ion activation methods are another strategy to elucidate 







, electron impact excitation of ions 
from organics
29,30
, ozone-induced dissociation (OzID)
31–35
, and metastable atom-activated 
dissociation
36,37
. Ultraviolet photodissociation (UVPD) at 193 nm has also proven to be a 
compelling ion activation method for lipid characterization.
38–41
 For phosphatidylcholines 




Of the aforementioned methods, only a few have been used for profiling double 
bond positional isomers in situ.
22,23,32,35
 High-energy CID performed on a MALDI-TOF 
instrument allowed the detailed structural characterization of glycerophospholipids in 
mouse brain tissue.
23
 OzID has been integrated with a DESI platform for the detection of 
lipid sn-positional isomers in tissue sections
32
 and more recently to a MALDI-Orbitrap 
for MSI of lipid isomer spatial distribution
35
. Paternò-Büchi reactions have been coupled 
with a liquid microjunction surface sampling probe system for profiling and quantitation 
of double bond positional isomers in situ.
22
 In the present study, DESI is performed on an 
Orbitrap mass spectrometer equipped with 193 nm UVPD to map spatial distributions of 
double-bond isomers in situ. Our findings reveal that there are changes in the relative 
abundances of lipid isomers localized to specific tissue features, demonstrating for the 
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first time that ambient MSI integrated with UVPD-MS allows direct characterization of 
double bond isomers in tissue. 
4.3 EXPERIMENTAL 
4.3.1 Materials 
Acetonitrile (ACN) was purchased from EMD Millipore (Billerica, MA, USA). 
PC 18:1(9Z)/18:1(9Z) and PC 18:1(6Z)/18:1(6Z) standards were purchased from Avanti 
Polar Lipids (Alabaster, AB, USA). Hematoxylin stain was purchased from Ricca 
Chemical (Arlington, TX, USA) and eosin stain was purchased from Fisher Scientific 
(Waltham, MA, USA). Glass microscope slides and multi-spot glass microscope slides 
were purchased from Fisher Scientific (Waltham, MA, USA). 
4.3.2 Tissue Samples 
Mouse brain and kidney tissue samples were purchased from BioIVT (Hicksville, 
NY, USA). Pancreas, kidney, lung, fallopian and human tissues were acquired from 
Cooperative Human Tissue Network (CHTN). Ovarian tissue was acquired from MD 
Anderson Cancer Center Tissue Bank (Houston, TX, USA). Endometrial tissue was 
provided by Seton Medical Center (Austin, TX, USA). All tissues were analyzed in 
accordance with IRB and IBC protocols. Tissues were sectioned on a Cryostar NX50 
cryostat (Thermo Scientific, San Jose, CA, USA) at 16 µm each and stored at -80˚C prior 
to analysis. 
4.3.3 DESI-MS and DESI-UVPD Profiling and Imaging 
All experiments were performed in positive ion mode on an Thermo Scientific 
Orbitrap Fusion Lumos mass spectrometer (San Jose, CA, USA) modified with a 193 nm 




 All spectra were collected with the instrument operating in full profile mode. 
DESI was performed using a 2D Omnispray DESI stage and ion source adapter (Prosolia, 
Inc., Indianapolis, IN, USA) with a custom manufactured extended ion transfer tube for 
coupling to the Fusion Lumos interface (Figure 4.1). 
 
 
Figure 4.1 Picture of DESI stage set-up on an Orbitrap Fusion Lumos mass spectrometer 
with custom manufactured extended ion transfer tube. 
ACN was sprayed at rate of 5-8 µL/min through a lab built sprayer using a nitrogen 
pressure of 180 psi and a spray voltage of 5kV. Higher-energy collisional dissociation 
(HCD) spectra were collected at a normalized collision energy (NCE) of 30 and UVPD 
spectra were collected at 20 pulses with 6 mJ per pulse. UVPD was performed in the high 
pressure trap of the dual linear ion trap with the q-value set to 0.1. For DESI profiling 
experiments, MS
1
, HCD and UVPD spectra were collected with a maximum ion injection 
time of 500-1000 ms and an AGC target of 1E5-1E6. MS
1
 profiling spectra were 
collected with a mass range of m/z 300-1600 and are presented with a mass range of m/z 
700-1000. HCD and UVPD profiling spectra were collected with a mass range of m/z 
100-1000. All representative profiling spectra are a composite of 15 consecutive averaged 
spectra and all representative spectra from imaging data are a composite of 3 consecutive 
Adapter for Lumos
Custom ion transfer tube
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averaged spectra. DESI-MS images were collected at an instrument resolving power of 
240,000 at m/z 200 with the maximum ion injection time set to 50 ms and an ACG target 
of 1E6-2E6 to ensure consistent instrument scan times. DESI-UVPD images were 
collected by continuously activating the isolated m/z value of interest with the instrument 
operating at a resolving power of 120,000 at m/z 200, the maximum ion injection time set 
to 1400 ms, the ACG target set to 1E6-2E6 and a mass range of m/z 500-800. Mouse 
brain tissue section and human lymph node were imaged at a pixel size of 250 µm and 
human brain was imaged at a pixel size of 175 µm, respectively. 
4.3.4 2D Imaging Data Analysis 
Thermo RAW files were converted to mzml files using msConvert 
(ProteoWizard).
43
 Mzml files were subsequently imported into R using the mzR package 
from the Bioconductor repository. The peak intensity of an ion within a m/z window of 
.04 to .12 was taken. Ion intensities or ion ratio values were plotted as a heat map in R. 
4.3.5 Lipid Notation 
Lipid shorthand notation used is consistent with the notation previously described 
by Liebisch et al.
44
 In brief, a “/” is used between acyl chains of known orientation with 
sn-1 followed by sn-2, and “_” is used between acyl chains of unknown orientation. 
Double bond positions are indicated in parenthesis after the acyl chain composition as 
carbon number counted down the acyl chain starting at the carbonyl carbon followed by 
Z, E or Δ to indicate cis, trans or unknown double bond stereochemistry. 
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4.4 RESULTS AND DISCUSSION 
DESI was implemented on an Orbitrap Fusion Lumos mass spectrometer (Figure 
4.1). The lipid profile observed in the positive ion mode MS
1
 spectra of a mouse brain 




Figure 4.2 The observed positive ion mode MS
1
 spectrum of a mouse brain tissue section 
HCD and UVPD mass spectra for the prominent ion of m/z 798 with corresponding 
fragment ion maps are shown in Figure 4.3. Product and neutral loss ions in the HCD 
spectrum confirm the identity of this species as potassium-adducted phosphatidylcholine 
PC 16:0_18:1. The UVPD mass spectrum provides greater structural detail, confirming 
the occurrence of a least two double bond positional isomers, namely PC 16:0_18:1(9∆) 
and PC 16:0_18:1(11∆), through sets of diagnostic ions spaced apart by 24 Da. These 
pairs of fragment ions separated by 24 Da are signatures generated uniquely by UVPD 































Figure 4.3 a) HCD (NCE 30) and b) UVPD (20 pulses, 6 mJ) mass spectra of the ion of 
m/z 798 obtained from DESI profiling of a mouse brain tissue section  with 
c) corresponding fragment ion maps for detected isomers [PC 
16:0_18:1(9∆), PC 16:0_18:1(11∆)]. The subscript “K” in the labels of the 
fragment ion maps indicates ions that retain the potassium adduct. The 
prominent fragment ion at m/z 162 is characteristic of potassium-adducted 
PC corresponding to phosphate containing a potassium-adduct. 
 
 






















































































HCD and UVPD mass spectra for the sodium-adducted and protonated species of PC 
16:0_18:1 provide comparable information to the potassium-adducted ion, indicating that 
acyl chain composition and double bond information can be obtained regardless of 
adduction status (Figure 4.4-4.6). Despite the magnification of the key fragment ion 
region in some of the MS/MS spectra, S/N ratios of >100 were routinely obtained owing 
to the high sensitivity of the Orbitrap analyzer.  
 
Figure 4.4 HCD (NCE 30) mass spectra of ions of: a) m/z 760, b) m/z 782 and c) m/z 798 
from DESI profiling corresponding to the molecular ion, sodium-adducted 
ion, and potassium-adducted ion for PC 16:0_18:1, respectively. Fragment 










































































































Figure 4.5 UVPD (20 pulses, 6 mJ) mass spectra of ions of: a) m/z 760, b) m/z 782 and c) 
m/z 798 from DESI profiling corresponding to the molecular ion, sodium-
adducted ion, and potassium-adducted ion or PC 16:0_18:1, respectively. 
Fragment ion maps are shown in Figure 4.6. 






















































































































Figure 4.6 Fragment ion map for mass spectra in Supporting Information Figure 2 and 
Figure 3. Subscripts indicate the presence of a sodium (Na) or potassium (K) 
adduct. “X” represents either a proton, sodium cation or potassium cation.  
HCD and UVPD mass spectra were also collected for other ions of m/z 826 and m/z 820 
of high abundance in the lipid profile spectrum (Figure 4.7-4.8). The UVPD mass spectra 
for these other lipids reveal that they are each composed of at least two double bond 
positional isomers, PC 18:0_18:1(9∆) and PC 18:0_18:1(11∆) for m/z 826, and PC 
16:0_20:4(5∆,8∆,11∆,14∆) for m/z 820, based on the presence of paired fragment ions 
separated by 24 Da. This evidence confirms that UVPD is capable of localizing the 


























































Figure 4.7 a) HCD (NCE 30) and b) UVPD (20 pulses, 6 mJ) mass spectra of the ion of 
m/z 826 obtained from DESI profiling of a mouse brain tissue section with 
corresponding fragment ion maps for detected isomers [PC 18:0_18:1(9∆), 






















































































Figure 4.8 a) HCD (NCE 30) and b) UVPD (20 pulses, 6 mJ) mass spectra of the ion of 
m/z 820 obtained from DESI profiling of a mouse brain tissue section with 
corresponding fragment ion map. Subscripts indicate the presence of a 
potassium (K) adduct.  
DESI profiling experiments were performed on a number of human tissue types, 














































































Figure 4.9 MS1 spectra from DESI profiling of a) endometrial tissue, b) kidney tissue, 
c) lymph node tissue, d) ovarian tissue, e) pancreas tissue, and f) brain 























































































Figure 4.10 HCD (NCE 30) mass spectra from DESI profiling of a) endometrial tissue 
(m/z 782), b) kidney tissue (m/z 782), c) lymph node tissue (m/z 782), d) 
ovarian tissue (m/z 782), e) pancreas tissue (m/z 798), and f) brain tissue. All 
tissues were human. Magnification indicated at the top of the spectra applies 




















































































































Figure 4.11 UVPD (20 pulses, 6 mJ) mass spectra from DESI profiling of a) endometrial 
tissue (m/z 782), b) kidney tissue (m/z 782), c) lymph node tissue (m/z 782), 
d) ovarian tissue (m/z 782), e) pancreas tissue (m/z 798), and f) brain tissue 
(m/z 798). All tissues were human. Magnification indicated at the top of the 






















































































































Figure 4.12 Expansions of UVPD (20 pulses, 6 mJ) mass spectra from DESI profiling 
of a) endometrial tissue (m/z 782), b) kidney tissue (m/z 782), c) lymph node 
tissue (m/z 782), d) ovarian tissue (m/z 782), e) pancreas tissue (m/z 798), 
and f) brain tissue (m/z 798), showcasing the key diagnostic ions that 
differentiate two isomeric lipids [PC 16:0_18:1(9∆), PC 16:0_18:1(11∆)]. 
All tissues were human. The full m/z range HCD and UVPD mass spectra 
are shown in Supporting Information Figures 4.10 and 4.11. 
Figure 4.12 shows expanded regions of the UVPD mass spectra for sodium-adducted and 
potassium-adducted ions of m/z 782 or m/z 798, respectively, collected for each tissue 
type, focusing on the diagnostic fragment ions used to identify double bond isomers. 




























































based on the greater abundance of the m/z 644/668 or m/z 660/684 ion pair 
(corresponding to the 9∆ isomer) relative to the m/z 672/696 or m/z 688/712  ion pair 
(11∆ isomer), respectively, there is a notable change in the relative abundances of PC 
16:0_18:1(9∆) and PC 16:0_18:1(11∆) across all five tissue types. In some of the mass 
spectra, most notably Figure 2e, additional product ions are present corresponding to 
fragment ions from lipid species that are isobaric to the lipid of interest. The high 
resolving power and mass accuracy of the Orbitrap mass analyzer allows these product 
ions from isobaric species to be differentiated from specific diagnostic ions. Integration 
of the UVPD method on an imaging mass spectrometer also equipped with ion mobility 
separation capabilities is an intriguing idea that may enable acquisition of MS/MS spectra 
free from extraneous ion peaks. 
The profiling mode experiments described above confirmed the successful 
differentiation of isomeric lipids by UVPD, thus motivating the exploration of UVPD for 
tissue imaging experiments. To determine the ability of UVPD to discern spatially 
resolved differences in the relative abundances of phospholipid isomers during DESI-
MSI, a set of phospholipid isomer standards, PC 18:1(6Z)/18:1(6Z) and PC 
18:1(9Z)/18:1(9Z), in varying concentration ratios and with a summed concentration of 
10 µM, were spotted onto a glass slide and imaged (Figure 4.13). UVPD mass spectra of 
m/z 808, corresponding to a sodium-adducted ion, shown in Figure 4.14, provide 
structural confirmation of the isomers, with UVPD mass spectra containing diagnostic 
sets of ions of m/z 628 and m/z 652 for PC 18:1(6Z)/18:1(6Z), and m/z 670 and m/z 694 
for PC 18:1(9Z)/18:1(9Z). Changes in ion intensities in the DESI-UVPD images of each 
diagnostic ion correlate with variations in the lipid concentration ratios (Figure 4.13, 
Figure 4.15). Excellent agreement (R
2
 = 0.999) between the concentration ratio of PC 
18:1(6Z)/18:1(6Z) to PC 18:1(9Z)/18:1(9Z) (CPC 18:1(6Z)/18:1(6Z)/CPC 18:1(9Z)/18:1(9Z)) and the 
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ratio of summed diagnostic ion intensities (Im/z 628 + 652)/Im/z 670 + 694) was achieved (Figure 
4.13b).  The lowest concentration detectable based on the UVPD-MS method was 
estimated to be ~500 nM.  
 
Figure 4.13 a) DESI-UVPD ion images of two isomeric phospholipid standards, PC 
18:1(6Z)/18:1(6Z) and PC 18:1(9Z)/18:1(9Z), in varying concentration 
ratios. Each pair of product ions diagnostic for the double bond position are 
tracked. b) Plot of concentration ratio of PC 18:1(6Z)/18:1(6Z) to PC 
18:1(9Z)/18:1(9Z) (CPC 18:1(6Z)/18:1(6Z)/CPC 18:1(9Z)/18:1(9Z)) versus the ratio of the 
summed intensities of the diagnostic ions (I(m/z 628 + 652)/I(m/z 670 + 694)) 

























































Figure 4.14 a) HCD (NCE 30) and b) UVPD (20 pulses, 6 mJ) mass spectra from DESI 
profiling of PC 18:1(6Z)/18:1(6Z). c) HCD (NCE 30) and d) UVPD (20 
pulses, 6 mJ) mass spectra from DESI profiling of PC 18:1(9Z)/18:1(9Z). 
Subscripts indicate the presence of a sodium (Na) adduct.  




















































































































Figure 4.15 Representative expanded regions of UVPD (20 pulses, 6 mJ) mass spectra of 
isomeric phospholipid standards, PC 18:1(6Z)/18:1(6Z) and PC 
18:1(9Z)/18:1(9Z), in varying concentration ratios from DESI-UVPD ion 
imaging experiments. Mass spectra correspond to the following ratios of PC 
18:1(6Z)/18:1(6Z) to PC 18:1(9Z)/18:1(9Z): a) 1:19, b) 1:9, c) 1:4, d) 1:1, e) 
4:1, f) 9:1 and g) 19:1. 
These results confirm that the developed DESI-UVPD-MSI method can successfully 
detect changes in the relative abundances of phospholipid isomers in two dimensions 
indicating that differences detected in tissue should directly result from changes in isomer 
concentrations. 
DESI-UVPD-MSI experiments were performed in triplicate for coronal mouse 
brain tissue sections (Figure 4.16). H&E optical images for all tissues were collected 
























































Figure 4.16 DESI-UVPD ion imaging of a mouse brain tissue section. a, j, s) H&E 
image of a mouse brain tissue section; b, k, t) DESI-MS ion image of m/z 
798; c, l, u) DESI-UVPD ion image of m/z 660; d, m, v) DESI-UVPD ion 
image of m/z 684; e, n, w) DESI-UVPD ion image of m/z 688; f, o, x) DESI-
UVPD ion image of m/z 712; g, p, y) DESI-UVPD ion image of the summed 
intensity of m/z 660 and m/z 684 (Im/z 660 + 684); h, q, z) DESI-UVPD ion 
image of the summed intensity of m/z 660 and m/z 684 (Im/z 688 + 712); i, r, aa) 
DESI-UVPD ratio image of the ratio of the summed intensities of the UVPD 
double bond diagnostic ions (Im/z 660 + 684)/(Im/z 688 + 712). 
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The DESI ion image (Figure 4.16b, k, t) reveals a lower abundance of the lipid ion of 
m/z 798 (corresponding to PC 16:0_18:1) in the white matter compared to the gray 
matter. DESI-UVPD ion images for each of the diagnostic ions previously detected 
during DESI-UVPD profiling experiments are shown for each replicate (Im/z 660: Figure 
4.16c, l, u; Im/z 684: Figure 4.16d, m, v; Im/z 688: Figure 4.16e, n, w; Im/z 712: Figure 4.16f, o, 
x ), along with images of the summed intensities of the diagnostic ions (Im/z 660 + 684: 
Figure 4.16g, p, y; Im/z 688 + 712: Figure 4.16h, q, z). Ratio images of the ratio of the 
summed intensities of the diagnostic ions (Im/z 660 + 684/Im/z 688 + 712) demonstrate that there 
are, in fact, notable changes in the relative abundances of PC 16:0_18:1(9∆) and PC 
16:0_18:1(11∆) throughout the tissue corresponding to areas of gray matter and white 
matter (Figure 4.16i, r, aa). Key expanded regions of the representative UVPD mass 
spectra of gray and white matter are shown in Figure 4.17.  
 
 
Figure 4.17 Expanded regions of UVPD mass spectra of the white and gray matter of a 
mouse brain tissue section. The DESI-UVPD ratio image presented here is 
the same as that presented in Figure 4.16aa.  
While the overall abundance of m/z 798 appears to decrease in the white matter based on 
DESI-MSI data, the ratio of PC 16:0_18:1(9∆) to PC 16:0_18:1(11∆) increases in the 
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tissue (Figure 4.18) with branches of white matter in the human brain section observed in 
both the optical and DESI images. 
 
 
Figure 4.18 DESI-UVPD ion imaging of a human brain tissue section. a) H&E image of 
a mouse brain tissue section, b) DESI-MS ion image of m/z 798, c) DESI-
UVPD ion image of m/z 660, d) DESI-UVPD ion image of m/z 684, e) 
DESI-UVPD ion image of m/z 688, f) DESI-UVPD ion image of m/z 712, g) 
DESI-UVPD ion image of the summed intensity of m/z 660 and m/z 684 
(Im/z 660 + 684), h) DESI-UVPD ion image of the summed intensity of m/z 660 
and m/z 684 (Im/z 688 + 712), i) DESI-UVPD ratio image of the ratio of the 
summed intensities of the UVPD double bond diagnostic ions (Im/z 660 + 
684)/(Im/z 688 + 712), and j) expanded regions of UVPD mass spectra of the 
white and gray matter. 
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DESI-UVPD-MSI also offers the unique opportunity to investigate differences in 
the abundance of lipid isomers between normal and cancerous regions of tissue sections. 
DESI-UVPD-MSI was performed on a section of human lymph node tissue containing 





Figure 4.19 DESI-UVPD ion imaging of a lymph node tissue section with thyroid 
cancer metastasis. a) H&E image of a lymph node tissue section with 
thyroid cancer metastasis, b) DESI-MS ion image of m/z 798, c) DESI-
UVPD ion image of m/z 660, d) DESI-UVPD ion image of m/z 684, e) 
DESI-UVPD ion image of m/z 688, f) DESI-UVPD ion image of m/z 712, g) 
DESI-UVPD ion image of the summed intensity of m/z 660 and m/z 684 
(Im/z 660 + 684), h) DESI-UVPD ion image of the summed intensity of m/z 660 
and m/z 684 (Im/z 688 + 712), i) DESI-UVPD ratio image of the ratio of the 
summed intensities of the UVPD double bond diagnostic ions (Im/z 660 + 
684)/(Im/z 688 + 712), j) DESI-UVPD ratio image of m/z 684 to m/z 712, and k) 
expanded regions of UVPD mass spectra of the cancerous and normal 
regions of tissue. 
0 5e30 5e5 0 2.5e3 0 25
Ratio Image
(Im/z 660 + m/z 684)/(Im/z 688 + m/z 712)
Im/z 684/Im/z 712
H&E Optical Image
Im/z 798 (Precursor) Im/z 688 + m/z 712Im/z 688 Im/z 712
Im/z 660 Im/z 684 Im/z 660 + m/z 684
c) d) g)



























The presence of both PC 16:0_18:1(9∆) and PC 16:0_18:1(11∆) were confirmed by 
UVPD-MS based on the paired fragment ions. (Figure 4.20). One selected ion from each 
pair of diagnostic ions was used to create a ratio image that revealed a distinctive change 
in the relative abundance of the two lipid isomers between normal and diseased tissue 
(Figure 4.21). Although there appears to be a notable change in the relative abundances 
of the two isomers between the normal and cancerous portions of tissue, a larger sample 
set is required to establish the generality of this finding. 
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Figure 4.20 HCD profiling spectra of regions of a) cancerous and b) normal tissue from 
the lymph node tissue section with thyroid cancer metastasis and UVPD 
profiling spectra of regions of c) cancerous and d) normal tissue from the 
lymph node tissue section with thyroid cancer metastasis with corresponding 










































































































































Figure 4.21 Expanded UVPD spectra from regions of a) cancerous and b) normal tissue 
from Figure 4.20 showing an obstructing ion at m/z 688.411. The DESI-
UVPD ratio image was therefore made from division of m/z 688.430 and 
m/z 712.43 for avoid contributing signal form m/z 688.4. 
4.5 CONCLUSIONS 
This study represents the first coupling of ambient MSI with an ion activation 
technique capable of determining double bond positions in phospholipid acyl chains. 
DESI-UVPD not only differentiates phospholipid isomers but also unveils spatial 
changes in their relative abundances that are otherwise undetected during DESI-MSI 
experiments. The short activation period of UVPD enables fast acquisition of diagnostic 
MS/MS information. Considering the informative spectra generated by UVPD, 
application of this method to other types of lipids offers the potential to provide insights 
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Chapter 5:  Shotgun Analysis of Rough-Type Lipopolysaccharides 
Using Ultraviolet Photodissociation* 
5.1 OVERVIEW 
Detailed structural characterization of intact rough-type lipopolysaccharides (R-
LPS) was accomplished using an MS
3
 strategy consisting of low-energy collision-
induced dissociation (CID) followed by 193 nm ultraviolet photodissociation (UVPD) 
implemented on an Orbitrap Fusion mass spectrometer. Complex mixtures of R-LPS 
from either E. coli or S. enterica were directly infused into the mass spectrometer using 
static source nanoESI. An initial CID event performed on an R-LPS precursor produced 
spectra with abundant ions corresponding to the lipid A and core oligosaccharide (OS) 
substructures. Comparison of CID spectra of R-LPS ions with varying lipid A and core 
OS structures verify that lipid A and core OS ions are consistently produced in high 
abundance. The resulting lipid A and core OS ions were subsequently activated by CID, 
higher-energy collision-induced dissociation (HCD), or UVPD. For both the lipid A and 
core OS substructures, HCD and UVPD produced highly informative complementary 
spectra, with UVPD of the core OS producing an extensive array of cross-ring cleavage 
fragments. Successful discernment of E. coli R-LPS structures with isomeric core 
structures confirmed the degree to which subtle structural differences could be 
determined using this method. 
  
                                                 
*Klein, D. R.; Holden, D. D.; Brodbelt, J. S. Shotgun Analysis of Rough-Type Lipopolysaccharides Using 
Ultraviolet Photodissociation Mass Spectrometry. Anal. Chem. 2016, 88, 1044–1051. 
 
DDH largely contributed to the implementation of UVPD on the Orbitrap Fusion. JSB provided mentorship 
and reviewed the manuscript prior to publication. 
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5.2 INTRODUCTION 
Lipopolysaccharides (LPS), the main component of the outer membrane of most 
Gram-negative bacteria, are complex biomolecules responsible for immune system 
response to pathogen invasion.
1
 The generic structure of LPS includes three regions: lipid 
A, core oligosaccharide (OS) and O-antigen. LPS molecules with and without the O-
antigen are termed smooth-type (S-LPS) and rough-type (R-LPS) or lipooligosaccharides 
(LOS), respectively. Although there exist R-LPS mutant strains of bacteria that normally 
produce an O-antigen, some bacteria, including Neisseria and Haemophilus, have 
naturally evolved to produce R-LPS.
2
  Lipid A, the hydrophobic anchor that activates the 
Toll-like receptor 4 (TLR4), and the core OS, largely responsible for outer membrane 
stability, are essential for the viability of all Gram-negative bacteria.
3–7
 Variations in the 
acyl chain distribution, phosphorylation, and sugar orientation and distribution in both 
lipid A and the core oligosaccharide greatly impact the virulence of bacteria.
8–12
 For 
example, diphosphoryl hexa-acylated lipid A induces the strongest inflammatory 
response of the TLR4. Alteration of the acylation pattern or phosphorylation status can 
reduce the activity of lipid A by more than two orders of magnitude.
13
 Manipulation of 
lipid A structure to reduce toxicity, yet still initiate an immune response, is the basis for 
detoxified lipid A as a vaccine adjuvant.
14–17
 Additionally, phosphorylation of the core 
oligosaccharide has been shown to significantly contribute to outer membrane stability. 
Mutant strains of Escherichia coli (E. coli) modified to lack phosphorylations in the core 
region of the have shown increased susceptibility to antibiotics and detergents.
4
 
Considering the impact of subtle modifications to LPS, detailed structural 
characterization of LPS is necessary to further investigate the role of LPS in bacteria 
viability and to understand how LPS structure influences immune stimulation to facilitate 
development of bacterial vaccines.  
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Mass spectrometry has emerged as a powerful tool for characterization of LPS 
substructures. The amphiphilic nature of LPS causes micelle formation which can 
complicate mass spectrometric analysis. Consequently, a common approach for 
characterization of LPS involves hydrolysis of the glycosidic bond between lipid A and 
the core OS, and subsequent analysis of each substructure.
10,18,19
 Additionally, lipid A 
acyl chains can be removed by hydrolysis prior to analysis of the intact carbohydrate 
chain. Low-energy collisional induced dissociation (CID) is commonly used to obtain 




 substructures.  
However, CID does not always provide adequate fragmentation for elucidation of subtle 
structural differences. Limitations of CID have been the impetus for the development of 
alternative activation methods including infrared multiphoton photodissociation 
(IRMPD), negative-electron transfer dissociation (NETD), ultraviolet photodissociation 
(UVPD) and activated-electron photodetachment (a-EPD) which have been employed to 
produce either complementary or more informative fragmentation spectra.
27–29
 193 nm 
UVPD, a fast and high energy activation method that entails irradiation of ions with 193 
nm (6.4 eV) photons, has previously been shown to produce highly informative spectra 
for many biomolecules.
29
 When biological molecules are deliberately truncated or 
degraded prior to analysis (as is the case with “bottom up” approaches), some structural 
features or integrated patterns of features may be lost.  This is also the case with LPS 
analysis, for which attention has primarily focused on characterization of the lipid A sub-
structure rather than the core OS or O-antigen.  With approaches that evaluate hydrolyzed 
LPS substructures, not only are labile modifications potentially lost, but combinations of 
modifications occurring between lipid A and the core oligosaccharide are also not 
adequately reflected. Therefore, analysis of intact LPS molecules via a top-down 
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approach offers many advantages, albeit with concomitant challenges associated with the 
amphiphilic characteristics of LPS. 
Although there have been a few studies reported on the analysis of intact LPS, 
most have measured molecular weights and MS/MS spectra have not been commonly 
evaluated.
26,30,31
 Recently, we examined the  fragmentation patterns of intact R-LPS using 
a hybrid UVPD/HCD method.
32
 UVPD and hybrid UVPD/HCD produced very rich 
fragmentation patterns arising from a diverse array of C-O, C-N, and C-C cleavages from 
both the lipid and oligosaccharide portions of the LPS, as illustrated for endotoxin 
structures from E. coli.
32
 The structural complexity of LPS makes interpretation of the 
resulting MS/MS spectra challenging. Previous studies have shown that the glycosidic 
bond between the 3-deoxy-D-manno-octulosonic acid (Kdo) of the core OS and the 
glucosamine of lipid A is particularly weak and can be easily cleaved in the gas phase.
33
 





 structures and the ease with which this glycosidic bond can be cleaved, 
multi-stage tandem mass spectrometry can be implemented to interrogate intact LPS 
structures while at the same time simplifying data interpretation. The present study uses 
MS
3
 to cleave the glycosidic bonds between lipid A and the core OS of intact LPS 
transferred to the gas-phase by nano-electrospray ionization (nanoESI),  and subsequent 
UVPD of each substructure to gain detailed structural characterization of intact R-LPS 
with complete core.  
5.3 EXPERIMENTAL 
All R-LPS E. coli and Salmonella enterica sv. Minnesota (S. enterica) LPS 
samples were purchased from Glycobiotech (Research Center Borstel, Germany) and 
used without further purification.  As an example, the structure of S. enterica is shown in 
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Figure 5.1, along with a legend displaying a key to the color coded sub-units and 
common neutral losses observed in the MS/MS spectra.   
 
 
Figure 5.1 Structures of rough-type mutant strains of S. enterica (Ra-Re), saccharides 
symbols using the official Symbol Nomenclature for Glycans (SNFG), and 




Methanol (MeOH) and water (H2O) were purchased from EMD Millipore (Billerica, 
MA) and chloroform (CHCl3) was purchase from Sigma Aldrich (St. Louis, MO). All 
samples were diluted in 62:36:2 MeOH:H2O:CHCl3 to 100 µg/mL. Approximately 10 µL 







































using a Proxeon offline nano-electrospray set-up (Thermo Scientific, San Jose, CA). The 
spray voltage was set to 1.1 kV. All spectra were collected in negative mode on a Thermo 
Scientific Orbitrap Fusion mass spectrometer (San Jose, CA) modified with a 193 nm 
Coherent Existar excimer laser (Santa Cruz, CA) to perform UVPD in the high pressure 




Figure 5.2 Schematic of a Thermo Orbitrap Fusion modified with a 193 nm excimer 
laser  
UVPD was implemented by modifying the back end of the dual linear ion trap with a 
fused silica window to allow entrance of the laser beam into the high pressure trap of the 
instrument.  A periscope and appropriate mirrors were used to guide the laser beam to the 
center of the high pressure ion trap, and a pulse generator and customized instrument 
code were used to pulse the laser during the time of ion trapping. Data were collected 
with an AGC target between 5e4 and 2e5 at a resolution of 120,000. For CID and HCD 
193 nm excimer
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25 scans were averaged and for UVPD 100-200 scans were averaged with 2-3 µscans per 
scan. For CID activation at the MS
2
 level the NCE was set to 18. At the MS
3
 level CID, 
HCD and UVPD activation parameters were set to NCE 30, NCE 35 and five 2 mJ 
pulses, respectively. Default activation times were used CID and HCD. All data were 
analyzed in XCalibur Qual Browser and manually interpreted. For spectra that were 
deconvoluted to neutral forms, Xtract was used with a signal to noise threshold of 3. 
5.4 RESULTS AND DISCUSSION 
Due to the complex amphipathic nature of intact LPS, a universal workflow was 
developed to facilitate a streamlined approach for individual characterization of the two 
main sub-structures:  the lipid A sub-structure and the core Kdo/oligosaccharide sub-
structure. As shown below, conventional CID provided the optimal means to cleave LPS 
into the two constituent sub-structures, and then the capabilities of CID, HCD and UVPD 
were compared for the subsequent characterization of the two sub-structures. The first 
step of the workflow required a robust means to transfer intact LPS into the mass 
spectrometer. The most common mass spectrometry approaches to LPS structural 
analysis generally involve deliberate degradation of LPS prior to analysis, via hydrolysis 
of the glycosidic bond between Kdo and glucosamine, or partial or complete removal of 
acyl chains. To approach analysis of intact LPS, conditions that allow dissolution of the 
LPS for direct analysis by nanoESI were developed. Raetz et al. identified 
chromatographic conditions that allowed successful chromatographic separation and 
ionization of Kdo2-lipid A.
40
 Building on this earlier work, the starting gradient 
conditions employed in the Raetz study were used to successfully dissolve heterogeneous 
samples of R-LPS in the present study. LPS samples were dissolved in 62:36:2 
MeOH:H2O:CHCl3 to attain a concentration of approximately 100 µg/mL and sprayed 
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without chromatographic separation via a “shotgun” approach using a static nanoESI 
source. Due to the large number of lipids in each sample and the production of multiple 
charge states upon ESI, the resulting mass spectra were quite complex for three S. 
enterica and two E. coli samples (Figure 5.3, Figure 5.4a).  
 
 
Figure 5.3 a) nanoESI mass spectra (100 µg/mL) of a) S. enterica Rd1, b) S. enterica Rb, 
c) E. coli R2 and d) E. coli R3 infused without chromatographic separation 
into the mass spectrometer via static emitters. 
The charge-deconvoluted spectra confirm the high degree of heterogeneity in the samples 
(as exemplified in Figure 5.4b for S. Enterica Rc). Although some of this heterogeneity 
is likely a result of the method used to isolate the LPS, the resulting array of LPS species 
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Figure 5.4 a) nanoESI mass spectrum of S. enterica Rc (100 ug/mL) infused without 
chromatographic separation into the mass spectrometer via a static emitter, 
and b) deconvolved spectrum. 
Interpretation, assignment and labelling of the MS
3
 spectra of LPS poses its own 
set of challenges, especially in the context of displaying the results in a meaningful way 
to others. For the MS/MS spectra presented, LPS structures are depicted using the official 
Symbol Nomenclature for Glycans (SNFG).
38
 The complex MS/MS spectra shown in the 
present study are conveyed schematically as fragmentation maps, in which saccharide 
fragments are labeled using the nomenclature of Domon and Costello (Figure 5.5)
41
 and 
acyl chain cleavages are numbered. This same system is used to label the ions in the 
MS/MS spectra, and for products where acyl chains are cleaved, the numbers 
corresponding to those particular acyl chain are shown as losses from the LPS (which is 
designated as “M”). For instance, Figure 5.6a shows the CID mass spectrum of penta-
acylated S. enterica Rd1 (4-) and corresponding fragment ion map. 












































Figure 5.5 Domon and Costello carbohydrate fragmentation nomenclature
41
 
The ion of m/z 587.32 labeled as [Y2 - 2]
2-
 corresponds to the lipid A substructure 
generated upon cleavage of the Kdo-GlcN bond along with loss of the secondary 12-
carbon acyl chain (laurate) which is labeled as acyl chain 2. For products corresponding 
to the cleaved acyl chains, the number corresponding to the cleaved bond is used. For 
example, in Figure 5.6a, the ion of m/z 199.17 corresponds to the laurate moiety and is 





















Figure 5.6 CID (NCE 18) of the 4- charge state of a) tetra-acylated S. enterica Rd1 (m/z 
497.25) b) tetra-acylated S. enterica Rc (m/z 585.78) and c) tetra-acylated S. 
enterica Rb (m/z 765.56) (25 spectra averaged, LPS concentration 100 
µg/mL in 62:36:2 MeOH:H2O CHCl3). The acyl chains are numbered, and 
the loss of a particular acyl chain is denoted as M – N where M represents 












































































































































































Examples of the CID mass spectra obtained for three mutant glycoforms of 
tetraacylated S. enterica LPS and three lipoforms of S. enterica Rc are shown in Figures 
5.6 and 5.7, respectively. (Figure 5.1 shows the naming convention and structures for the 
different mutants of S. enterica.) In all cases, glycosidic bond cleavages lead to the most 
prominent products for each LPS.  For example, isolation and collisional activation of the 
tetra-acylated species from S. enterica Rc (MW = 2347.12 Da) shows predominant 
cleavage of the glycosidic bond between Kdo and glucosamine leading to product ions of 
m/z 679.41 (Y2
2-
) and m/z 492.14 (B4
2-
) corresponding to the lipid A and saccharide 
substructures, respectively (Figure 5.6b). The highly acidic nature of this glycosidic 
bond provides an explanation for its facile cleavage. This specific glycosidic cleavage is 
consistent with previous work from our group
31
 and is generally observed in matrix-
assisted laser desorption ionization (MALDI) spectra as well.
18,42
 Preferential cleavage of 
this glycosidic bond is particularly advantageous for two reasons. First, it allows general 
localization of structural modifications of LPS to either the lipid A or core OS 
substructures based on the masses of the two products relative to the intact LPS, 
especially for comparisons of series of LPS like the three shown in Figure 5.6 that 
possess the same lipid A sub-structure but with different oligosaccharides. Second, the 
preferential glycosidic cleavage results in two well-defined and abundant products that 
can be interrogated individually via MS
3
 to allow characterization of the two sub-units 
(e.g. lipid A and oligosaccharide). In essence, subsequent activation of each of these 
products reveals more detailed structural information.  
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Figure 5.7 CID (NCE 18) of the 4- charge state of a) tetra-acylated S. enterica Rc (m/z 
585.78) b) penta-acylated S. enterica Rc (m/z 642.33) and c) hexa-acylated 
S. enterica Rc (m/z 694.88) (25 spectra averaged, LPS concentration 100 
µg/mL in 62:36:2 MeOH:H2O CHCl3). The acyl chains are numbered, and 
the loss of a particular acyl chain is denoted as M – N where M represents 
the LPS and N represents the acyl chain that is lost. 




















































































































































































To optimize the formation of the two key sub-structure products in the initial MS/MS 
step, the collisional energy was varied over a range of values. One of the resulting 
energy-variable diagrams for penta-acylated S. enterica Rc was constructed to determine 
the optimal normalized collision energy (NCE) to achieve maximum signal abundance 
for the lipid A and saccharide substructures (Figure 5.8). An NCE of 18 proved to be the 
optimal collisional activation condition and was used throughout this study. 
 
 
Figure 5.8 CID energy-variable diagram of penta-acylated S. enterica Rc monitoring the 
precursor ion (m/z 642.57) and products ions corresponding to the 
saccharide substructure (m/z 492.14) and lipid A substructure (m/z 792.5) 
To verify that the lipid A and core OS ions would be consistently formed for an 
array of LPS, various R-LPS structures from mutant S. enterica were subjected to CID. 
The effect of core OS chain length was evaluated by comparing the CID patterns of tetra-
acylated S. enterica Rd1, tetra-acylated S. enterica Rc, and tetra-acylated S. enterica Rb, 
all with the same lipid A substructure but with variations in the core OS (Figure 5.6). 
Despite changes in the relative abundances of the lipid A and OS ions, these products are 
readily identified.  Additionally, significantly larger number of acyl chains fragments (i.e. 

























(Figure 5.6a) than for S. enterica Rc or S. enterica Rb. Similar to changes in 
fragmentation that occur in glycopeptides as a function of glycan structure and peptide 
length, the observed changes reflect changes in the size and complexity of the core OS, 
suggesting that acyl chain cleavages are less prominent when there are more 
opportunities for energetically favorable glycosidic cleavages.
43
 Regardless of this 
change in the distribution of products, the two key substructure ions are readily identified 
for all of the mutants. Similarly, the effect of lipid A structure was evaluated by 
comparing the fragmentation patterns of tetra-acylated S. enterica Rc, penta-acylated S. 
enterica Rc and hexa-acylated S. enterica Rc (Figure 5.7), three lipoforms which vary in 
the number of acyl chains of lipid A but all with the same OS substructure. In the CID 
spectrum of hexa-acylated S. enterica Rc (Figure 5.7c), although the lipid A and core OS 
substructure ions are readily identified (Y2
2-
 and B4), the predominant product is an ion of 
m/z 850.76 that corresponds to loss of the distal myristate secondary acyl chain (e.g. [M-
4]
3-
). Previous reports have shown  this acyl chain linkage at the 3’ position to be 
particularly labile.
28
 Although this alternative cleavage site diminishes the abundance of 
the targeted products corresponding to the full lipid A and core OS substructures, this ion 
can be used to confirm the presence of a secondary acyl chain at the 3’ position. 
After optimization of the conditions to enhance the formation of the two 
substructure products by CID, the products were subsequently isolated and subjected to 
CID, HCD, and UVPD (MS
3
) to complete the characterization of LPS.  Examples of the 
resulting MS
3
 spectra are shown in Figure 5.9 for tetra-acylated S. enterica Rb that 
contains a pyrophosphorylethanolamine modification with the spectra for the OS (m/z 
851.82, 2- charge state) on the left and the complementary spectra for the lipid A 




Figure 5.9 a) CID/CID (NCE 18/NCE 30), b) CID/HCD (NCE 18/NCE 35) and c) 
CID/UVPD (NCE 18/5 pulses, 2 mJ) of the core OS substructure of tetra-
acylated S. enterica Rb containing a pyrophosphorylethanolamine 
modification (m/z 851.81, charge state 2-). d) CID/CID (NCE 18/NCE 30), 
e) CID/HCD (NCE 18/NCE 35) and f) CID/UVPD (NCE 18/5 pulses, 2 mJ) 
of the lipid A substructure of S. enterica Rb modification (m/z 679.41, 
charges state 2-). A black star is used to indicate the precursor. Only select 
neutral losses are labeled on the spectra to avoid congestion. The acyl chains 
are numbered, and the loss of a particular acyl chain is denoted as M – N 
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All identified ions in the spectra in Figure 5.9 are listed in Table 5.1 (Chapter 5, 
Supporting Information). CID/CID of the core OS substructure results in predominant 
losses of Kdo (Y3β and Z3β) and Kdo2 (B1α and C1α), in addition to neutral losses of CO2 
and H2O (Figure 5.9a, Figure 5.10). 
 
 
Figure 5.10 CID/CID mass spectrum (NCE 18/NCE 30) of the core OS substructure of 
tetra-acylated S. enterica Rb containing a pyrophosphorylethanolamine 
modification (m/z 851.81). (Data also present in Figure 5.9a) The inset 
shows expansion of the range from m/z 600 to 900. ∆ = loss of 
phosphoethanolamine; * = loss of CO2; # = loss of H2O 
CID/HCD of the same OS (Figure 5.9b) yields a spectrum similar to the CID/CID 
spectrum. A notable ion of m/z 219.98 (labeled as ▼in Figure 5.9b) confirms the 
presence of the pyrophosphorylethanolamine modification on the core OS. The high 
resolution and high mass accuracy capabilities of the Orbitrap mass spectrometer allow 
this ion to be distinguished from the ion of m/z 219.05, which corresponds to the B1β ion. 
Additionally, fragment ions of m/z 967.25 and m/z 869.28 labeled as [C4α-Y5γ]
∆
 and B3α, 





















































respectively, that appear exclusively in the CID/HCD spectrum provide information 
regarding the saccharide branching pattern and localize the position of the 
pyrophosphoethanolamine modification. CID/UVPD of the ion of m/z 851.81 yields the 
richest mass spectrum with numerous fragments corresponding to cross-ring cleavages 
(X-type ions) that give saccharide linkage information (Figure 5.9c).  For example, the 
0,4
X4α ion (m/z 1422.37) confirms the linkage pattern of L-glycero-D-manno-heptose 
(heptose) (II) and glucose to heptose (I). By combining the information from the 
CID/HCD spectrum and the CID/UVPD spectrum, cleavages are observed between every 
glycosidic bond in the core OS.  This level of structural characterization is 
unprecedented.    
The MS
3
 spectra for the companion lipid A substructure (m/z 679.41, charge state 
2-) of S. enterica Rb are shown on the right side of Figure 4.  CID/CID and CID/HCD 
yield similar spectra (Figure 5.9d and 5.9e) that confirm the presence of laurate and 
myristate chains on the lipid A substructure based on m/z 199.19 and m/z 243.20, 
respectively, but do not localize their positions on the lipid A substructure. The 
CID/HCD spectrum displays an additional ion of m/z 242.21 that corresponds to cleavage 
of the proximal N-linked acyl chain. Again, high resolution and high mass accuracy 
allowed this ion to be distinguished from the ion of m/z 243.20 corresponding to the 
proximal O-linked acyl chain. CID/UVPD (Figure 5.9f) produces a richer array of 
fragment ions that assist in discerning the more subtle structural features of the lipid A 
substructure.  For example the 
1,5
X1 cross-ring cleavage (m/z 738.42) allows the 
distribution of acyl chains on the distal (containing 3’,2’ positions) and proximal  
(containing 3,2 positions) sides of the lipid A substructure to be determined.
27,28
 
Additional cross-ring and acyl chain cleavages allow acyl chain connectivity to be 
determined and hydroxyl modifications to be localized, respectively.  For example, the 
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product assigned as 
0,2
X1, in concert with 
1,5
X1, confirms that the secondary laurate acyl 
chain is connected to the distal N-linked myristate acyl chain.  For characterization of the 
lipid A substructure, integration of the information from CID/HCD and CID/UVPD 
together offer the most comprehensive elucidation of the lipid A moiety.   
Comparison of UVPD and CID/UVPD spectra of penta-acylated E. coli lipid A 
and penta-acylated S. enterica Rc, respectively, confirms that the integrity of the MS
3
 
spectra collected for the lipid A substructure is maintained after the initial CID activation 
event (Figure 5.11). All identified ions in the spectra in Figure 5.11 are listed in Table 
5.2 (Chapter 5, Supporting Information). The complexity of the resulting spectra 
reinforces the rationale for “separating” the characterization of the lipid A and core OS 
substructures based on the MS
3 
strategy. By first performing a CID event to cleave the 
bond between lipid A and core OS, the spectral complexity that acyl chain fragmentation 
would otherwise add to identification of glycosidic cleavages in core OS is eliminated, 
and manual interpretation of spectra becomes practical. 
Within E. coli LPS there are five naturally occurring core types: R1-R4 and K12. 
These core types are very similar, all containing heptose and Kdo in their inner core 
(various other non-stoichiometric modifications can occur in the inner core depending on 
the core type) and a series of hexose carbohydrates in the outer core.
44
 The nature, 
position and linkage of the hexoses in the outer core are dependent on the core type, with 
some of the variation being as subtle as a difference in the kind of linkage. To further 
confirm the detail to which core OS structures can be determined using this multi-stage 
mass spectrometry method, MS
3 
spectra were acquired for two isomeric R-LPS structures 
from E. coli R2 and E. coli R3. CID of was performed on the main LPS ion (MW = 





Figure 5.11 a) UVPD (5 pulses, 2 mJ) of penta-acylated from E. coli lipid A and b) 
CID/UVPD (NCE of the penta-acylated lipid A substructure from S. 
entrerica Rc. ■ = neutral loss of HPO3; A black star is used to indicate the 
precursor. The acyl chains are numbered, and the loss of a particular acyl 
chain is denoted as M – N where M represents the LPS and N represents the 
acyl chain that is lost. 
Other than small differences in ion abundances, the spectra are identical. The Y2
2-
 (lipid 
substructure, m/z 566.31) and B7
3-
 (OS substructure, m/z 674.84) are the two most 
prominent product ions in the CID spectra.  The CID/HCD and CID/UVPD spectra of the 
lipid A substructures (Y2
2-
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(Figure 5.13), confirming that the variation in the LPS structure must be a result of core 
OS structure and not lipid A structure.  
 
Figure 5.12 a) CID (NCE 18) of E. coli R2 (MW = 3162.16 Da, precursor m/z 631.43, 
charge state 5-) b) CID (NCE 18) of E. coli R3 (MW = 3162.16 Da, 
precursor m/z 631.43, charge state 5-); ■ = neutral loss of HPO3 
CID/HCD and CID/UVPD spectra of the core OS substructures (m/z 674.84, Figure 
5.14) are very similar; however, there exist fragment ions that allow the two isomeric 
structures to be distinguished from one another. All identified ions in the spectra in 
Figure 5.14 are listed in Table 5.3 (Chapter 5, Supporting Information). In the CID/HCD 
spectra, the B3α product in Figure 5.14a and B2α and C2α products in Figure 5.14b 









































































































































Figure 5.13 a) CID/HCD (NCE 18/NCE 30) of the lipid A substructure of E. coli R2 (m/z 
566.31, charge state 2-) b) CID/HCD (NCE 18/NCE 30) of the lipid A 
substructure of E. coli R3 (m/z 566.31, charge state 2-), c) CID/UVPD (NCE 
18/5 pulses, 2 mJ) of the lipid A substructure of E. coli R2 (m/z 566.31, 
charge state 2-) and d) CID/UVPD (NCE 18/5 pulses, 2 mJ) of the lipid A 
substructure of E. coli R3 (m/z 566.31, charge state 2-). ■ = neutral loss of 
HPO3, □ = neutral loss of H3PO4.  A bracket under a pair of ions indicates 
the presence of two resolved ions, but the mass difference is too small to 
allow inclusion of separate arrows. The acyl chains are numbered, and the 
loss of a particular acyl chain is denoted as M – N where M represents the 
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Figure 5.14 a) CID/HCD (NCE 18/NCE 30) of the core oligosaccharide substructure of 
E. coli R2 (m/z 674.84, charge state 3-) b) CID/HCD (NCE 18/NCE 30) of 
the core OS substructure of E. coli R3 (m/z 674.84, charge state 3-), c) 
CID/UVPD (NCE 18/5 pulses, 2 mJ) of the core OS substructure of E. coli 
R2 (m/z 674.84, charge state 3-) and d) CID/UVPD (NCE 18/5 pulses, 2 mJ) 
of the core oligosaccharide substructure of E. coli R3 (m/z 674.84, charge 
state, 3-). Unique ions that can be used to identify each isomer appear in red. 
■ = neutral loss of HPO3; the black star indicates the precursor ion in the 
spectrum. 






 ions in Figure 5.14c  




X6α ions in Figure 5.14d correspond to glycosidic and cross-
ring cleavages that uniquely identify the E. coli R2 and E. coli R3 cores, respectively. 


































































































200 400 600 800 1000 1200 1400 1600 1800 2000
0
100
































































































almost complete structural elucidation of core OS structures as reflected in the 




 strategy utilizing UVPD has been developed to enable the detailed 
structural characterization of intact R-LPS. An initial CID event produced lipid A and 
core OS ions that were subsequently activated in a second stage using CID, HCD or 
UVPD. Subsequent HCD produced ions from glycosidic cleavages that provide 
saccharide branching information, while UVPD produced ions from cross ring cleavages 
that revealed saccharide connectivity.  The complementary spectra produced by HCD and 
UVPD enabled confident re-construction of R-LPS structures. The high resolution and 
high mass accuracy of the Orbitrap analyzer allowed facile differentiation of informative 
but nearly isobaric fragment ions.  Despite the unprecedented characterization achieved 
in this study, the “shotgun” approach used here produces congested ESI mass spectra that 
can make isolation of a single LPS species challenging. Although mass isolation of a 
single R-LPS species was feasible in this study, smooth-type LPS has a significantly 
higher degree of heterogeneity as a result of the varying number of saccharide repeat 
units; isolation of single species is increasingly challenging.  To address this concern, we 
are developing appropriate offline and online separation methods to facilitate analysis of 
smooth-type LPS in a higher throughput manner. Additionally, both online and offline 
separations will alleviate signal suppression associated with direct infusion of a complex 
mixture and potentially allow sample consumption to be further diminished. 
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5.6 SUPPORTING INFORMATION 





Figure 5.9a Figure 5.9b Figure 5.9c Figure 5.9d Figure 5.9e Figure 5.9f
m/z Fragment m/z Fragment m/z Fragment m/z Fragment m/z Fragment m/z Fragment
1484.37 Y3β 1501.45 [M-▼]
- 1703.42 [M-H]•- 1279.85 [M-H]-■ 1279.85 [M-H]-■ 1358.81 [M-H]•-
1466.36 Z3β 1484.37 Y3β 1685.41 [M-H]
•-# 1261.84 [M-H]-□ 1261.84 [M-H]-□ 1298.79 0,4X1
1440.38 Y3β
* 1466.36 Z3β 1673.41 [M-CH3O]




•- 1115.61 [M-1]- 1115.61 [M-1]- 1175.80 2,5X1
1361.36 Y3β
∆ 1422.37 Z3β
* 1630.39 3,5X6α, 
3,5X6δ 1095.67 [M-4]
-■ 1095.67 [M-4]-■ 1174.63 [M-6]•-,[M-8]•-
1343.35 Z3β
∆ 1361.36 Y3β
∆ 1601.39 2,5X6α, 
2,5X6δ 1079.67 [M-3]
-■ 1079.67 [M-3]-■ 1159.81 0,2X1
1282.32 C4α 1343.35 Z3β
∆ 1570.37 1,5X6α, 
1,5X6δ 1035.65 [M-1]
-■, [M-2]-□, [M-5]-□ 1035.65 [M-1]-■, [M-2]-□, [M-5]-□ 1159.64 [M-3]-




∆ 1264.31 B4α 1525.37 Z6α, Z6δ 915.44 [M-1-3]
- 915.44 [M-1-3]- 920.42 1,2X1
1141.31 B4α
∆ 1159.32 C4α
∆ 1512.37 Y5γ 708.41 Y1 708.41 Y1 892.42
1,3X1
869.28 B3α 1141.31 B4α
∆ 1467.37 Z3β 670.40 Z2
2- 664.38 C6 874.41 [M-1-10]
-
842.71 [M-2H]2-# 1123.29 B4α
∆# 1422.37 Z3β
* 587.31 [M-4]2- 587.31 [M-4]2- 817.38 1,4A7
829.72 [M-2H]2-* 967.25 [C4α&Y5γ]
∆ 1282.32 C4β
• 579.32 [M-3]2- 579.32 [M-3]2- 738.42 1,5X1
820.71 [M-2H]2-#* 869.28 B3α 1263.31 B4β 566.31 [M-2]
2-, [M-5]2- 566.31 [M-2]2-, [M-5]2- 710.42 Y1
790.21 [M-2H]2-∆ 851.71 B5α 1246.27
1,5X5α 557.30 [M-1]
2- 557.30 [M-1]2- 692.41 Z1
754.69 B2γ
2- 842.71 [M-2H]2-# 1218.27 Y5α 466.22 [M-2-3]
2-, [M-1-4]2- 466.22 [M-2-3]2-, [M-1-4]2- 664.38 C6
741.68 Y3β
2- 829.72 [M-2H]2-* 1200.26 Z5α 457.21 [M-1-3]
2- 457.21 [M-1-3]2- 587.31 [M-4]2-
732.68 Z3β
2- 820.71 [M-2H]2-#* 862.15 1,5X4α 444.21 [M-1-5]
2- 448.21 [M-1-3]2-# 579.32 [M-3]2-
719.69 Y3β











































Table 5.2 List of identified ions in Figure 5.11 
  
Figure 5.11a Figure 5.11b
m/z Fragment m/z Fragment
1585.00 [M-H]•- 1585.00 [M-H]•-
1506.05 [M-H]•■- 1506.05 [M-H]•■-
1487.03 [M-H]•□- 1487.03 [M-H]•□-
1429.82 [M-7]•-, [M-10]•-, [M-13]•- 1429.82 [M-7]•-, [M-10]•-, [M-13]•-
1400.82 [M-6]•-, [M-8]•-, [M-9]•- 1400.82 [M-6]•-, [M-8]•-, [M-9]•-
1385.83 [M-5]- 1385.83 [M-5]-
1340.80 [M-1]•-, [M-3]•- 1340.80 [M-1]•-, [M-3]•-
1158.64 [M-14]•- 1158.64 [M-14]•-
890.58 C1 890.58 C1
738.42 1,5X1 738.42
1,5X1
710.43 Y1 710.43 Y1
692.42 [M-5]2- 692.42 [M-5]2-
679.41 [M-2]2-, [M-4]2-, [M-11]2- 679.41 [M-2]2-, [M-4]2-, [M-11]2-
243.20 1,3 243.20 1,3
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Table 5.3 List of identified ions in Figure 5.11 
 
  
Figure 5.14a Figure 5.14a Figure 5.14a Figure 5.14a
m/z Fragment m/z Fragment m/z Fragment m/z Fragment
1726.50 Y3β
■ 1726.50 Y3β
■ 1980.51 [M-H]-* 1980.51 [M-H]-*
1708.49 Z3β
■ 1708.49 Z3β
■ 1863.46 Y6δ 1788.45 Z3β
1524.45 C6α
■ 1524.45 C6α
■ 1823.44 Y8α 1702.42 Y7α
1506.44 B6α
■ 1506.44 B6α
■ 1788.45 Z3β 1684.41 Z7α
1412.35 [B6α-Y5γ]
- 1412.35 [B6α-Y5γ]
- 1661.39 Y7α 1604.42 C6α
1332.38 C5α 1332.38 C5α 1643.48 Z7α 1585.39 B6α
1314.37 B5α 1314.37 B5α 1604.42 C6α 1332.39 C5α
972.77 [M-2H]2-■ 972.77 [M-2H]2-■ 1585.39 B6α 1321.29 Z6α
902.73 Y3β
2- 902.73 Y3β























- 341.11 C2α 911.22 Y8α
2- 910.22 Y7δ
2-
424.15 2,4A3α 323.10 B2α 902.73 Z3β
2- 902.73 Z3β
2-
237.06 C1β 237.06 C1β 894.23 Y3β
2- 894.23 Y3β
2-










711.14 Y4α 237.06 C1β
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Chapter 6:  Top-Down Characterization of Lipooligosaccharides from 
Antibiotic-Resistance Bacteria 
6.1 OVERVIEW  
Modification of lipopolysaccharide (LPS) and lipooligosaccharide (LOS) 
structures represents one prevalent mechanism by which Gram-negative bacteria can 
become resistant to key antibiotics. While the structural characterization of LPS has 
largely focused on elucidation of lipid A substructures, analysis of intact LPS/LOS 
enables detection of core oligosaccharide modifications and gives insight into the 
heterogeneity that results from combinations of lipid A and oligosaccharide 
substructures. Top-down analysis of intact LPS/LOS also provides the opportunity to 
determine unknown oligosaccharide structures which is particularly advantageous in the 
context of glycoconjugate vaccine development. Advances in mass spectrometry 
technologies, including the development of MS
n
 capabilities and alternative ion 
activation techniques, have made it an indispensable tool for structural characterization of 
complex biomolecules. Here we combine a chromatographic method that uses a three-
part mobile phase with MS
3
 utilizing ultraviolet photodissociation (UVPD). This 
integrated approach was used to characterize LOS from Acinetobacter baumannii 5075 
and A. baumannii 1205. Notably, MS
3
 spectra for A. baumannii 1205, an antibiotic 
resistant strain, confirmed phosphoethanolamine and hexosamine modification of the 
lipid A substructure and further enabled derivation of a core oligosaccharide structure. 
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6.2 INTRODUCTION  
Multidrug- and pan-resistant bacteria pose one of the most serious public health 
threats to date.
1–5
 Gram-negative bacteria are intrinsically resistant to many antibiotics 
effective against Gram-positive bacteria owing to their unique dual membrane 
architecture, of which the outer leaflet of the outer membrane is comprised 
predominantly of lipopolysaccharides (LPS) that form a protective barrier.
5–8
 LPS is 
composed of three covalently linked regions: (1) lipid A, the most highly conserved 
portion of LPS responsible for immune system stimulation, (2) core oligosaccharide 
(OS), which serves to stabilize the membrane structure and (3) O-antigen, a key bacterial 
virulence factor.
9–11
 Various species of Gram-negative bacteria, including Campylobacter 
jejuni, Neisseria meningitis, Bordetella pertussis, and Acinetobacter baumannii naturally 
produce lipooligosaccharides (LOS), a rough-type LPS devoid of O-antigen.
12
 A growing 
global threat is the development of resistance acquired from genomic changes in a 
manner that defeats antibiotics previously effective against Gram-negative bacteria. One 
mechanism of acquired resistance involves modification of the antibiotic target.
5–7
 In the 
context of Gram-negative bacteria, alterations in the structure of LPS/LOS, including 
non-stoichiometric addition of phosphoethanolamine (pEtN), aminoarabinose (Ara4N), 
and galactosamine (GalN) to the lipid A and core OS, have been shown to promote 
immune system evasion and influence susceptibility to cationic antimicrobial peptides 
(CAMPs).
13–20
 The aforementioned modifications confer resistance by neutralizing 
anionic surface charge that promote CAMP affinity to the cell surface. An increasing 
number of Gram-negative species have been found to contain LPS/LOS modifications.
21–
28
 For example, several strains of multi-drug resistant A. baumannii, a pathogen that 
causes nosocomial infections commonly treated with the CAMP colistin, a “last-resort” 
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Comprehensive structural characterization of LPS/LOS is crucial considering the 
critical relationship between LPS/LOS structure and antibiotic resistance
3
 as well as the 
important role of LPS/LOS in the development of new therapeutics and vaccines.
30,31
 
Glycoconjugate vaccines that couple antigenic surface carbohydrates to immune-system-
stimulating carrier proteins have been successful for a number of bacterial species.
32,33
 
While bacterial surface carbohydrates appear to be ideal candidates for vaccine 
development, they cause a T-cell independent immune response which results in poor 
protective immunity.
32
 Conjugation of carbohydrate structures to proteins that elicit a T-
cell dependent response and impart protective immunity is the cornerstone of 
glycoconjugate vaccines. Development of new glycoconjugate vaccines relies on 
identification of surface targets, including LPS/LOS.
34
 Structural characterization of 
surface antigens that show promise for glycoconjugate construction is pivotal, especially 
in the context of antibiotic-resistant bacteria for which effective vaccines are critical.
35
 
Mass spectrometry (MS) has become a primary method for analysis of 
LPS/LOS.
36
 Challenges associated with LPS solubility and heterogeneity have led to the 
development of methods that decompose LPS/LOS and analyze its constituent lipid A 
and polysaccharide portions, often in conjunction with separation by liquid 
chromatography (LC) or capillary electrophoresis (CE).
36–44
 Decomposition of LPS/LOS 
simplifies its analysis but likely underrepresents the true heterogeneity that results from 
combinations of structures and modifications occurring on the lipid A and polysaccharide 
portions. Additionally, decomposition has the potential to remove biologically relevant 
labile modifications.
44
 Intact LPS/LOS analysis is therefore a more desirable analytical 
goal. Of the studies that have investigated intact LPS/LOS, most directly analyze 
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complex mixtures in a shotgun-type approach without separation.
44–54
 The shotgun mode 
can lead to signal suppression as well as generation of tandem mass spectra that are 
challenging to interpret owing to co-isolation of isobaric and isomeric species (the 
chimera spectra problem). Only a few studies have reported online electrophoretic or 
chromatographic separations of intact LPS/LOS.
45,46,55
 From these past reports, CE 
separations resulted in reduced sensitivity and peak broadening owing to the deleterious 
mixing of the make-up liquid with background electrolyte,
46
 and LC separations suffered 
from sub-par efficiency for intact LPS/LOS.
45
  
For structural characterization of intact LPS/LOS or its decomposition products 









 Low-energy collision-induced dissociation (CID), the most widely available 
ion activation method, has been utilized to disassemble LPS/LOS into lipid A and 
oligosaccharide sections that can be correlated to intact LPS/LOS structures.
52,53
  
However, owing to its low energy deposition that results in preferential cleavage of the 
most labile bonds, CID often produces tandem mass spectra lacking fragments necessary 
to determine subtle yet important structural features including saccharide branching 
patterns and the locations of non-stoichiometric modifications.
41
 Ultraviolet 
photodissociation (UVPD) at 193 nm, an alternative activation method that uses high 
energy photons to energize ions, has been shown to provide additional acyl chain, 
glycosidic, and cross-ring cleavages for both lipid A and intact LOS.
41–43,45,52,56
 
Implementation of UVPD on high resolution mass spectrometers has enabled acquisition 
of rich tandem mass spectra generated from a variety of complex biomolecules.
52,57 
A 
number of the UVPD methods developed for lipid A and LPS/LOS characterization use 
MS
n
 methods that are advantageous from the standpoint of spectral interpretation.
29,43,52
 
One such method entails collisional activation for bisection of intact LOS and subsequent 
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UVPD on the resulting lipid A and oligosaccharide portions.
52
 To further advance the 
characterization of LPS/LOS in increasingly complex samples, coupling MS
n
 methods 
that enable detailed structural characterization with online chromatography for separation 
of mixtures presents an attractive means to acquire high quality data in a high throughput 
manner, as detailed here.  
The present method provides unprecedented chromatographic separation of intact 
LOS and enables acquisition of high resolution MS
3
 data on an LC timescale. For each 
sample a data-dependent CID analysis is first performed to identify the lipid A and core 
OS portions of chromatographically-separated LOS. A second MS
3
 analysis targeting the 
identified lipid A and core OS portions allows detailed structural characterization. This 
strategy is highlighted for analysis of LOS isolated from various strains of A. baumannii, 
including a clinically relevant antibiotic-resistant strain. LOS structures are identified, 
and new oligosaccharide structures are deciphered. 
6.3 EXPERIMENTAL 
6.3.1 Materials and Reagents 
Escherichia coli R3 LOS was purchased from Glycobiotech (Research Center 
Borstel, Germany) and used without further purification. All A. baumannii LOS were 
isolated using a hot-phenol extraction described below.
58
 HPLC-grade methanol (MeOH) 
and water (H2O) were obtained from EMD Millipore (Billerica, MA), and chloroform 
(CHCl3) was obtained from Sigma-Aldrich (St. Louis, MO). LC/MS grade ammonium 
acetate was purchased from Fisher Scientific (Fairlawn, NJ). 
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6.3.2 LOS Isolation 
250 mL cultures of each strain were grown at 37
o
C to an OD ~ 1.0. Cells were 
pelleted at 5000xg, frozen, and lyophilized. Dried bacteria were resuspended in ddH2O to 
a concentration of 20 mg/mL and transferred to a 250 mL Teflon centrifuge tube. An 
equal volume of 80% w/v phenol was added to the sample, and incubated with shaking at 
65
o
C for 1 hour.
58
 The mixture was cooled on ice and centrifuged at 5000xg for 30 min at 
room temperature. The upper aqueous layer was transferred to a glass flask. The 
extraction was repeated once more via the addition of an equal volume of ddH2O to the 
residual organic phase. The combined aqueous phases were dialyzed against ddH2O for 
24 hours with a MWCO of 3500, with a minimum of 6 exchanges. To remove any 
insoluble material, the aqueous solution was centrifuged at 17k x g for 20 minutes at RT 
and the supernatant was lyophilized. The dried LPS sample was resuspended in 10 mL of 
10 mM Tris, pH 7.8 and transferred to a 50 mL Teflon centrifuge tube. RNase and DNase 
I were added to a final concentration of 25 µg/mL and 100 µg/mL respectively and 
incubated for 2 hours at 37
o
C. Proteinase K was added to a concentration of 100 µg/mL 
and incubated at 37
 o
C for 2 hours. The proteinase treatment was repeated once. After 
enzymatic treatments, 5 mL of water saturated phenol was added to the sample, vortexed, 
and the phases were separated via centrifugation at 5000 x g for 30 mins at RT. The 
upper aqueous phase was removed and dialyzed for 12 hours against ddH2O at 4
o
C with a 
MWCO of 3500 with a total of 5 exchanges. Dialyzed solution was centrifuged at 17k x g 
for 20 mins at RT to remove insoluble material prior to lyophilization. Final lyophilized 
product was resuspended to a concentration of ~ 10 mg/mL in endotoxin free ddH2O. 
 153 
6.3.3 Liquid Chromatography and Mass Spectrometry 
Separations were performed using a Dionex Ultimate 3000 microflow liquid 
chromatography system (Sunnyvale, CA) equipped with a Dikma Bio-Bond C8 column 
(2.1 mm X 150 mm, 3 µm particle size) (Lake Forest, CA) heated to 65˚C. Mobile phase 
A consisted of 62:36:2 MeOH:H2O:CHCl3, mobile phase B consisted of 80:20:2 
CHCl3:MeOH:H2O, and mobile phase C consisted of 62:36:2 MeOH:H2O:CHCl3 with 
100 mM ammonium acetate.
55
 Chromatographic runs were performed at flow rate of 400 
µL/min. From 0 to 2 minutes the solvent composition was held at 15% B, followed by a 
linear gradient over the next 18 minutes to a final composition of 30% B. The mobile 
phase composition was then held at 30% B for 10 minutes and then returned to 15% B for 
a 10 minute re-equilibration period. Mobile phase C was held at 2% during the entire 
chromatographic run to ensure a constant ammonium acetate concentration of 2 mM. 
Samples were diluted such that their final solvent composition was 62:36:2 
MeOH:H2O:CHCl3. For E. coli R3, 1 µg of sample was injected. For all A. baumannii 
samples, 20 µL of solution was injected. Chromatographic separations were coupled 
online to a Thermo Scientific Orbitrap Fusion Lumos mass spectrometer (San Jose, CA) 
modified with a 193 nm Coherent Existar excimer laser (Santa Clara, CA) via 
electrospray ionization as previously described.
52
 All experiments were performed in 
negative ion mode using Orbitrap detection with an electrospray voltage of 4.5 kV. The 
sheath gas and auxiliary gases were set to 50 and 25 arbitrary units, respectively, and the 
ion transfer tube temperature was set to 300˚C. For each sample, three chromatographic 
runs were performed: (1) a data-dependent CID survey analysis, (2) a targeted MS
3
 
CID/HCD analysis and (3) a targeted MS
3
 CID/UVPD analysis. For the data-dependent 
CID survey analysis, MS
1
 spectra were collected at a resolving power of 30,000 at m/z 
200 with a mass range of m/z 450-2000, and CID spectra were collected at a resolving 
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power of 15,000 with a normalized collision energy (NCE) of 25. For CID, precursor 
ions were accumulated in the ion trap using quadrupole isolation with an isolation width 
of m/z 3. For MS
1
 and CID spectra, AGC targets were set to 5E5 and 2E5, respectively. 
From the data-dependent CID survey analysis, a list of specific MS
3
 transitions was 
manually generated. Two MS
3
 transitions, a lipid A fragment ion and a core OS fragment 
ion, were targeted for each intact LOS ion, with transitions targeted at specific times 
during the chromatographic run. All MS
3
 data was collected at resolving power of 15,000 
at m/z 200. For CID/HCD spectra, HCD was performed with an NCE of 30. For 
CID/UVPD, UVPD was performed with 10 laser pulses at 2-4 mJ per pulse, 
corresponding to a 20 ms ion activation time. All spectra were collected with a maximum 
ion injection time of 300 ms and 2 µscans per scan. 
6.3.4 Data Analysis 
LOS structures are depicted using the official Symbol Nomenclature for Glycans 
(SNFG) (Figure 6.1).
59
 All spectra were manually interpreted. Identified fragment ions 
corresponding to glycosidic and cross-ring saccharide cleavages are mapped on to LOS 
structures using Domon and Costello nomenclature.
60
 Acyl cleavages are numbered on 
the lipid A substructure. Acyl chain neutral losses are labeled as [M-X]
-
 where X 
represents the numbered cleavages. Acyl chain fragment ions are just listed as numbers. 
In MS
2
 spectra, fragment ions with multiple cleavages are labeled with “-“ between 
different cleavages. For example, [B6-Y3β]
-
 indicates a fragment ion with two cleavage 
points. For MS
3
 spectra, fragment ions are labeled as though they originate from the 
intact LOS structure. It is implied that all MS
3
 fragment ions are generated from either a 
B or Y MS
2
 fragment ion; the MS
2
 cleavage is therefore not included in the labels of all 
MS
3




 spectra are averages of multiple scans and 
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are labeled with either m/z values or according to previously mentioned fragment ion 
nomenclature. 
 
Figure 6.1 Key of saccharide symbols used in the official Symbol Nomenclature for 
Glycans (SNFG). Hexa-acylated E. coli R3 LOS is provided as an example 
to show how LOS structures are depicted. Fragments are labeled on LOS 
structures using Domon and Costello nomenclature.
59,60
 
6.4 RESULTS AND DISCUSSION 
Analysis of intact LPS/LOS by tandem mass spectrometry gives insight into the 
structural heterogeneity that can result from combinations of lipid A and oligosaccharides 
structures. With such complexity, it is essential to perform chromatographic separations 
to alleviate the suppression of low abundance species that is inevitable during ESI of 









































confounds interpretation and thwarts assignment of structures. However, few methods 
have been developed that provide high quality separations given the limited solubility of 
LPS/LOS. The chromatographic method used throughout this work is an adaptation of 
the method developed by Raetz and co-workers for the evaluation of 3-deoxyl-D-manno-
octulosonic acid (Kdo)2-lipid A, the simplest LOS structure.
55
 This prior protocol used a 
two-part mobile phase; mobile phase A consisted of 62:36:2 MeOH:H2O:CHCl3 with 20 
mM ammonium acetate and mobile phase B consisted of 80:20:2 CHCl3:MeOH:H2O 
with 50 mM ammonium acetate.
55
 As detailed in the present work, the ammonium acetate 
was removed from mobile phases A and B, and a third mobile phase was added which 
consisted of 62:36:2 MeOH:H2O:CHCl3 with 100 mM ammonium acetate. Addition of 
mobile phase C enabled tunability of the ammonium acetate concentration to alleviate 
ESI signal suppression caused by excess salts.
61
 Mobile phase C was held at 2% of the 
mobile phase composition, thus maintaining a constant 2 mM concentration of 
ammonium acetate throughout the separation. The use of this three-part mobile phase 
afforded unparalleled separation efficiency. 
LOS from E. coli R3, an O-antigen-deficient mutant strain of E. coli containing 
the R3 core type, served as a benchmark mixture to allow assessment of the performance 
metrics of both the chromatographic and MS
n
 methods.  Figure 6.2 shows the base peak 
chromatogram of a data-dependent CID analysis of E. coli R3 with a series of extracted 
ion chromatograms. CID was previously determined as an effective means to bisect LOS, 
releasing lipid A and core oligosaccharide products which provide mass information 





 The masses of the CID fragment ions give insight into the degree of 
acylation and phosphorylation of the lipid A portion as well as the extent of modification 
of the core oligosaccharide portion.  
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Figure 6.2 Base peak chromatograms of LOS from E. coli R3 with intact mass extracted 
ion chromatograms colored according to a) the lipid A substructure and b) 
the core oligosaccharide substructure. The table to the right of the extracted 
ion chromatograms lists the intact LOS m/z detected from MS
1
 spectra and 
the m/z of each substructure detected from CID spectra. c) A color-coded 





 spectra appear in Figure 6.3. 
Previously published lipid A and core OS substructures of E. coli provide a guide for 
structural characterization of intact LOS of the R3 strain.
55,62
 Extracted ion 
chromatograms of each identified intact LOS species are color-coded in Figure 6.2a and 
Figure 6.2b according to the directory of lipid A and core oligosaccharide substructures 
in Figure 6.2c, respectively, and provide a visual representation of combinations of lipid 
























































































fragment ions from the LOS are summarized in the companion table (to the right of 
Figure 6.2a, b) with each species uniquely represented by two colored markers 
associated with the lipid A and core oligosaccharide structures in Figure 6.2c.  MS
1
 and 
CID spectra for all identified species are shown in Figure 6.3. Extracted ion 
chromatograms in Figure 6.2a occur in clusters and confirm a primary separation based 
on the lipid A substructure, with dramatic differences in retention times for increasingly 
acylated lipid A, in addition to separation based on more subtle lipid A structural features 
including degree of unsaturation. For example, CID of ions of m/z 1197.84, m/z 1238.85, 
m/z 1224.88, m/z 1198.52, m/z 1239.52, and m/z 1225.55 in the MS
1
 spectra result in 
production of fragment ions indicative of a penta-acylated lipid A substructure (Figure 
6.3). However, the product ion characteristic of the lipid A portion originating from LOS 
precursors of m/z 1197.85, m/z 1238.85, and m/z 1224.88 occurs at m/z 1568.00, whereas 
the lipid A portion evolving from CID of LOS precursors of m/z 1198.85, m/z 1239.52, 
and m/z 1225.55 appears at m/z 1570.01. The observed mass difference (~2 Da) between 
the lipid A substructure for each penta-acylated LOS corresponds to a single acyl chain 
unsaturation. The LOS structures with one unsaturated acyl chain elute earlier as a result 
of the overall decrease in hydrophobicity. This subtle structural feature that otherwise 
may be obscured using a shotgun method is resolved in the LC separation. Figure 6.2b 
confirms a secondary level of separation based on the variations in the core 
oligosaccharide structures. For example, structures with two core oligosaccharide 
phosphate modifications elute earlier than species with one phosphate modification and 
one pyrophosphorylethanolamine (P-pEtN) modification. As expected, a P-pEtN 







 and corresponding CID spectra for species detected in E. coli R3 LOS at 
the following chromatographic retention times in seconds: a) 3.73, b) 3.95, 
c) 4.27, d) 9.32, e) 9.52, f) 9.92, g) 15.20, h) 15.52, i) 15.74, j) 15.84, k) 




























































































































































For detailed structural characterization, the lipid A and core oligosaccharide substructures 
created by CID are subsequently activated using either higher-energy collisional 
dissociation (HCD) or UVPD. These two stage MS
3
 methods are designated as CID/HCD 
or CID/UVPD. These two stage MS
3
 methods are designated as CID/HCD or 
CID/UVPD.  As an example, analysis of an intact LOS species (m/z 1155.48) composed 
of penta-acylated lipid A and a mono-phosphorylated core OS provides an opportunity to 
showcase the critical impact of using the MS
3
 method for characterization of each 
substructure and localization of specific structural features (Figure 6.4).  Core OS and 
lipid A fragment ions identified during the data-dependent CID survey analysis of LOS 
were targeted for specific MS
3
 transitions. CID/HCD (Figure 6.4d, f) and CID/UVPD 
(Figure 6.4c, e) spectra were collected for the ions of m/z 1053.31 and 1359.81, 
corresponding to the lipid A and core OS moieties, respectively. HCD generally provides 
information on the presence of labile modifications via neutral loss fragments in addition 
to the saccharide linkage arrangement, whereas UVPD gives more detailed insight about 
saccharide branching and the positions of non-stoichiometric modifications. While acyl 
chain fragment ions in the spectra of the lipid A substructure (m/z 1359.81) confirm the 
acyl chain lengths (C12 and C14), other glycosidic and cross-ring cleavages confirm the 
acyl chain orientation, namely the presence of an O-linked acyl chain on the reducing end 
GlcN (Figure 6.4e, f). For the core oligosaccharide portion, both the intact mass of the 
core oligosaccharide ion in the CID spectrum (Figure 6.4b) and the resulting fragment 
ions in the companion CID/HCD (Figure 6.4d) and CID/UVPD (Figure 6.4c) spectra 
confirm that the ion of m/z 1053.31 corresponds to a core oligosaccharide containing a 
single phosphate modification and a GlcN modification. The fragment ion map in Figure 
2g depicts the MS
3




Figure 6.4 a) MS
1
 spectrum of m/z 1155.48
3-
 from chromatographic separation of LOS 
from E. coli R3; b) CID spectrum of m/z 1155.48
3-
; c) targeted MS
3
 CID 
/UVPD and d) CID/HCD spectra of m/z 1053.31
2-
 corresponding to a core 
oligosaccharide substructure with a single phosphorylation and a GlcN 
modification; e) targeted MS
3
 CID/UVPD and f) CID/HCD spectra of m/z 
1359.81 corresponding to a tetra-acylated lipid A substructure; e) Fragment 
ion map of the intact LOS structure mapping both CID/HCD and 























































































































































































































































There has been some debate as to whether HepIII is modified with GlcN or GlcNAc.
13
 
While a previous study of E. coli R3 reported modification of HepIII with GlcN, a 
deacylation method was used to treat lipid A, which consequently also removed acetyl 




 data of untreated intact LOS presented here 
unequivocally confirm modification of HepIII with GlcN. While non-stoichiometric 
modification of HepIII with GlcNAc may also occur, it happens at much lower non-
stoichiometric abundance. Regarding the phosphate modification, in the CID/HCD 





 ions, respectively, indicate phosphorylation of HepII. Alternatively, fragment 
ions of m/z 739.14, m/z 711.14 and m/z 695.14 produced exclusively in the CID/UVPD 
spectrum (Figure 6.4c) correspond to 
1,5
X4, Y4, and Z4 ions, respectively, indicating 
phosphorylation of HepI. Previous studies reported that phosphorylation of the core 
oligosaccharide occurred exclusively at HepI when HepIII was modified with GlcN, 




Figure 6.5 provides another example of the high level of structural 
characterization that is achieved with a targeted MS
3
 method. CID/HCD (Figure 6.5c) 
and CID/UVPD (Figure 6.5d) spectra of the ion of m/z 1796.21 are consistent with prior 
MS
2
 data acquired for hexa-acylated lipid A from E. coli.
41
 Both the intact mass of the 
core oligosaccharide fragment ion in the CID spectrum (Figure 6.3m) and fragment ions 
in the CID/HCD (Figure 6.5a) and CID/UVPD (Figure 6.5b) spectra confirm that m/z 
1012.76 corresponds to a core OS containing two phosphate modifications.  Fragment 
ions in both CID/HCD and CID/UVPD spectra of m/z 1314.38 and m/z 1332.38 




Figure 6.5 Targeted MS3 analysis of LOS from E. coli R3. a) CID/HCD and b) 
CID/UVPD (10 pulses, 4 mJ) spectra of m/z 1012.76
2-
 corresponding to a 
hexa-acylated lipid A substructure. c) CID/HCD and d) targeted MS
3
 
CID/UVPD (10 pulses, 4 mJ) spectra of m/z 1796.21 corresponding to a 
doubly phosphorylated core OS substructure. e) Fragment ion map of the 
intact LOS structure mapping both CID/HCD and CID/UVPD data. 
Fragment ion lists appear in Table 6.2. 
However, the product of m/z 705.67, which is observed exclusively in the CID/HCD 
spectrum (Figure S4a), suggests a doubly phosphorylated HepII may also be present. 














































































































































































































































X4, Y4, Z4 and 
1,5
X3 ions that occur exclusively in the CID/UVPD mass 
spectrum (Figure 6.5b) confirm phosphorylation of HepI and HepII. In conclusion, while 
CID/HCD provides complementary information to CID/UVPD regarding the saccharide 
composition, CID/UVPD provides fragmentation that uniquely allows confident 
localization of modifications. 
A. baumannii is an opportunistic pathogen that exclusively produces LOS and is 
among the list of “ESKAPE” pathogens that pose the greatest threat to public health.64 A. 
baumannii has developed antibiotic resistance via a number of mechanisms including 
LOS modification; infections caused by A. baumannii are therefore increasingly 
challenging to treat.
65
 A. baumannii 19606 is a strain for which the deacylated LOS 
structures, but not intact LOS, have been determined previously.
66
 Figure 6.6 shows a 
base peak chromatogram for LOS isolated from A. baumannii 19606. Four of the 
predominant intact LOS structures identified herein, shown through a series of extracted 
ion chromatograms (Figure 6.6a), are consistent with combinations of two 
oligosaccharide structures determined for A. baumannii 19606, and two hexa-acylated 
and hepta-acylated lipid A structures previously determined for A. baumannii 17978.
67,68
 
The m/z values of the intact LOS and CID product ions for all identified LOS species are 
shown in Figure 6.6 (right side). MS
1
 and CID spectra are shown in Figure 6.7. Figure 
6.6b shows fragment ion maps combining CID/HCD and CID/UVPD data for two intact 
LOS structures, ones corresponding to m/z 1191.23 (identified in Figure 6.7a and 
characterized in Figures 6.8a, e and 6.9a, e) and m/z 1049.89 (identified in Figure 6.7l 
and characterized in Figure 6.8d, h and 6.8d, h) that represent two combinations 
containing all four lipid A and core OS substructures. CID/HCD and CID/UVPD spectra 
confirmed that the lipid A and core OS substructures are consistent with the previous 




Figure 6.6 Structural characterization of LOS from A. baumannii 19606. a) Base 
peak chromatogram of A. baumannii 19606 LOS with intact mass extracted 
ion chromatograms. The table to the right of the extracted ion chromatogram 
lists the intact LOS m/z detected from MS
1
 spectra and the m/z of each 
substructure detected from CID spectra. b) Fragment ion maps for intact 
LOS structures mapping both CID/HCD and CID/UVPD (10 pulses, 4 mJ) 
data: decasaccharide core with hexa-acylated lipid A (left) and truncated 
core hexasaccharide core with hepta-acylated lipid A (right). MS
3
 spectra 
appear in Figure 6.8 and Figure 6.9. Fragment ion lists appear in Table 6.3 
and Table 6.4 (Supporting Information, Chapter 6). Colored markers in the 
table represent m/z values of intact LOS species and correspond to the 
colored extracted ion chromatograms in part a). 
  

















































































































































































































































































































































Figure 6.8 Targeted MS
3
 CID/HCD spectra of the core OS and lipid A substructure of 
four LOS structure from A. baumannii 19606. Fragment ion lists appear in 


































































































































































































































































Figure 6.9 Targeted MS
3
 CID/UVPD (10 pulses, 4 mJ) spectra of the core OS and lipid 
A substructure of four LOS structure from A. baumannii 19606. Fragment 
ion lists appear in Table 6.4 (Supporting Information, Chapter 6). 
MS
3
 spectra obtained for all four LOS structures are shown in Figure 6.8 (CID/HCD) 
and Figure 6.9 (CID/UVPD). Most importantly, this analysis of MS
3
 spectra makes 
obvious that information regarding the combinations of lipid A and core oligosaccharide 






























































































































































































































































methods that rely on separation of LOS and analysis of extracted lipid A and 
oligosaccharide sections are used. 
The newly developed MS
3
 method also provides the opportunity to investigate A. 
baumannii strains for which the core OS structures are unknown. Understanding the core 
OS structure of species that deviate from the most studied E. coli and S. enterica opens 
up doors for forward genetics to identify enzymes that help assemble the core OS. This 
knowledge assists in the development of potential new antibiotic targets and 
glycoconjugate vaccine platforms. To showcase the compelling analytical impact of the 
MS
3
 strategy, structural characterization of A. baumannii 5075 was undertaken. The LC 
trace obtained for A. baumannii 5075 is shown in Figure 6.10. For the initial data-
dependent CID survey analysis, many of the m/z values of the lipid A substructures 
match ions found in A. baumannii 19606, qualitatively suggesting a similar lipid A 
composition for A. baumannii 5075. Based on the m/z values observed in the MS
1
 spectra 
(Figure 6.10) and the corresponding lipid A fragment ions observed in the CID spectra 
(Figure 6.10), m/z values for the intact core OS fragment ion were determined. For 
example, the intact LOS species of m/z 1164.56 in the 3- charge state eluting at 17.66 min 
produces a CID spectrum with a lipid A fragment ion of m/z 1728.11 (Figure 6.10b). 
Therefore, the theoretical m/z of the core OS ion in the 2- charge state is calculated to be 
m/z 882.79 (corresponding to a net mass of 1767.59 Da). This theoretical m/z value 
matches the detected fragment ion of m/z 882.78 (Figure 6.10b). This core OS fragment 
ion was common in many of the CID mass spectra (Figure 6.10) and was selected as a 
target for MS
3






Figure 6.10 Base peak chromatogram, and MS
1
 and corresponding CID spectra for 
species detected in A. baumannii 5075 LOS at the following 
chromatographic retention times in seconds: a) 17.15, b) 17.66, c) 18.00, d) 
18.42, e) 18.52, f) 18.93, g) 21.26, h) 21.87, i) 22.18, j) 22.75, and k) 22.91. 
Based on the intact mass of the core OS fragment ion and manual de novo saccharide 
analysis of the CID/HCD (Figure 6.11a) and CID/UVPD (Figure 6.11b) spectra, a core 
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(Figure 6.11b) is dense with informative fragments including both glycosidic and cross-
ring cleavages that enable confident assignment of the saccharide arrangement. These 
results suggest a conserved inner core structure terminating with GlcANAc, and different 
outer core structures for each strain. 
 
 
Figure 6.11 Structural characterization of A. baumannii 5075 LOS. a) Targeted MS
3
 
CID/HCD spectrum of m/z 882.78
2-
, and b) targeted MS
3
 CID/UVPD (10 
pulses, 2 mJ) spectrum of m/z 882.78
2-
 corresponding to a core OS 
substructure of A. baumannii 5075. c) Fragment ion map of the intact LOS 
structure mapping both CID/HCD and CID/UVPD data. Fragment ion lists 
appear in Table 6.5 (Supporting Information, Chapter 6). 



































































































In contrast to the A. baumannii 19606 outer core structure which is composed of four 
linearly linked Glc saccharides, the A. baumannii 5075 outer core structure is composed 
of one Hex and two HexNAc saccharides. In addition, the CID spectra (Figure 6.10c, d, 
f, j) suggest that A. baumannii 5075 also produces LOS structures with truncated core 
oligosaccharides. Three of the identified species produce a core OS ion of m/z 439.11 
(Figure 6.10c, f, j), which corresponds to two Kdo saccharides, and one species produced 
a yet unidentified core OS ion of m/z 700.71 (Figure 6.10d). 
Structural characterization was performed in a similar manner for A. baumannii 
1205, an antibiotic-resistant strain containing modified lipid A (Figure 6.12). Based on 
CID (Figure 6.13), CID/HCD and CID/UVPD (Figures 6.14-6.19, Supporting 
Information, Chapter 6) spectra, all of the lipid A substructures were hexa- or hepta-
acylated and were found to contain either phosphoethanolamine or galactosamine 
modifications, as previously described for this strain.
27
 While intact core OS ions of m/z 
1725.54 and m/z 862.26 were detected, their abundances were not optimal for detailed 
MS
3
 analysis. Therefore, an ion of m/z 1285.43, corresponding to the core OS ion lacking 
two Kdo saccharides was selected for targeted MS
3
 analysis (Figure 6.12b, c). Again, the 
inner core structure is consistent with A. baumannii 19606, and the outer core structure is 
composed of two Hex and one HexNAc saccharides arranged linearly. While the MS
3
 
spectra for both A. baumannii 5075 and A. baumannii 1205 confirm linear connectivity of 
the outer core saccharides, the specific linkage positions or the types of hexoses could not 
be confirmed. For this reason, the outer core saccharides are not colored in the fragment 
ion maps in Figure 6.11c and Figure 6.12c. 
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Figure 6.12 Structural characterization of A. baumannii 1205 LOS. a) CID spectrum 
of m/z 1306.30
3-
, b) targeted MS
3
 CID/HCD and c) targeted MS
3
 
CID/UVPD (10 pulses, 2 mJ) data of m/z 1285.43 corresponding to a core 
OS substructure of A. baumannii 1205, d) fragment ion map of the core OS 
substructure mapping both CID/HCD and CID/UVPD data, and e) fragment 
ion maps lipid A substructures mapping both CID/HCD and CID/UVPD 
data. Fragment ion lists for part a) and b) appear in Table 6.6 (Supporting 
Information, Chapter 6). MS
3
 spectra and fragment ion lists for all lipid A 
substructures can be found in Figure 6.14-Figure 6.19 and Table 6.7-Table 
6.12, respectively. 
m/z 1063.632-m/z 1005.092-





























































































































































































































































































Figure 6.13 Base peak chromatogram MS
1
 and corresponding CID spectra for species 
detected in A. baumannii 1205 LOS at the following chromatographic  
retention times in seconds: a) 16.94, b) 17.72, c) 20.70, d) 21.61, e) 22.09, f) 
18.93, and g) 22.81. 
6.5 CONCLUSION 
The present method couples impressive chromatographic separations with MS
3
 
analysis to achieve structural characterization of intact LOS structures from complex 
mixtures. CID/HCD and CID/UVPD provided complementary information, thus 
facilitating confident structure assignment and localization of non-stoichiometric 
modifications. In particular, CID/HCD afforded more non-reducing end saccharide 
























































































































fragments, including cross-ring cleavages, that enabled modification localization. The 
results obtained for E. coli R3 and A. baumannii 19606 are consistent with previously 
determined structures pieced together based on analysis of separate lipid A and core OS 
substructures and showcase the level of detail that is possible using top-down analysis of 
intact LOS. In addition, MS
3
 analysis of A. baumannii 5075 and A. baumannii 1205 allow 
core OS structures to be derived. The present workflow addresses a number of the 
challenges associated with structural characterization of complex mixtures of LOS and is 
broadly applicable to any LOS-producing Gram-negative bacteria. In light of the global 
health threat that antibiotic-resistant Gram-negative bacteria pose, this method provides 
an unparalleled strategy to investigate LOS structures and has the potential to aide 
vaccine and therapeutic development. 
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6.6 SUPPORTING INFORMATION 
 
 
Figure 6.14 a) Targeted MS
3
 CID/HCD and b) targeted MS
3
 CID/UVPD (10 pulses, 2 
mJ) spectra of m/z 987.06
2- 
from A. baumannii 1205 corresponding to a 
hexa-acylated phosphoethanolamine-modified lipid A substructure. 
Fragment ion lists appear in Table 6.7. 
















































































Figure 6.15 a) Targeted MS
3
 CID/HCD and b) targeted MS
3
 CID/UVPD (10 pulses, 2 
mJ) spectra of m/z 1005.59
2- 
from A. baumannii 1205 corresponding to a 
hexa-acylated phosphoethanolamine and hexosamine-modified lipid A 
substructure. Fragment ion lists appear in Table 6.8. 
 





















































































Figure 6.16 a) Targeted MS
3
 CID/HCD and b) targeted MS
3
 CID/UVPD (10 pulses, 2 
mJ) spectra of m/z 1063.63
2- 
from A. baumannii 1205 corresponding to a 
hepta-acylated phosphoethanolamine-modified lipid A substructure. 
Fragment ion lists appear in Table 6.9. 












































































Figure 6.17 a) Targeted MS
3
 CID/HCD and b) targeted MS
3
 CID (NCE 25)/UVPD (10 
pulses, 2 mJ) spectra of m/z 1077.64
2- 
from A. baumannii 1205 
corresponding to a hepta-acylated phosphoethanolamine-modified lipid A 
substructure. Fragment ion lists appear in Table 6.10. 
















































































Figure 6.18 a) Targeted MS
3
 CID/HCD and b) targeted MS
3
 CID/UVPD (10 pulses, 2 
mJ) spectra of m/z 1096.67
2- 
from A. baumannii 1205 corresponding to a 
hepta-acylated phosphoethanolamine and hexosamine-modified lipid A 
substructure. Fragment ion lists appear in Table 6.11. 




















































































Figure 6.19 a) Targeted MS
3
 CID/HCD and b) targeted MS
3
 CID/UVPD (10 pulses, 2 
mJ) data of m/z 1088.67
2- 
from A. baumannii 1205 corresponding to a hepta-
acylated phosphoethanolamine and hexosamine-modified lipid A 
substructure. Fragment ion lists appear in Table 6.12. 
 
  






















































































Table 6.1 List of identified fragment ions for a) targeted MS
3
 CID/HCD of m/z 1053.31
2-
, b) targeted MS
3
 CID/UVPD (10 pulses, 4 mJ) of 1053.31
2-
, c) targeted 
MS
3
 CID/HCD of m/z 1359.81 and d) targeted MS
3
 CID/UVPD (10 pulses, 

































































































































































Table 6.2 E. coli R3 LOS fragment ion lists. List of identified fragment ions for a) 
targeted MS
3
 CID/HCD of m/z 1012.76
2-
, b) targeted MS
3
 CID/UVPD (10 
pulses, 4 mJ) of m/z 1012.76
2-
, c) targeted MS
3
 CID/HCD (NCE 30) of m/z 
1796.21 and d) targeted MS
3










































































































































































Table 6.3 A. baumannii 19606 LOS fragment ion lists. List of identified fragment ions 
for a) targeted MS
3
 CID/HCD of m/z 922.78
2-
, b) targeted MS
3
 CID/UVPD 
(10 pulses, 4 mJ) of m/z 92278.
2-
, c) targeted MS
3
 CID/HCD of m/z 1728.11 
and d) targeted MS
3


























































































































































Table 6.4 A. baumannii 19606 LOS fragment ion lists. List of identified fragment ions 
for a) targeted MS
3
 CID/HCD of m/z 619.69
2-
, b) targeted MS
3
 CID/UVPD 
(10 pulses, 2 mJ) of m/z 619.69
2-
, c) targeted MS
3
 CID/HCD (NCE 30) of 
m/z 1910.29 and d) targeted MS
3
























































1511.9342 [M-4]-, [M-1-10]-, [M-1-11]-, [M-6-10]-, [M-6-11]-















1529.9437 [M-5]-, [M-10-12]-, [M-10-13]-, [M-11-12]-, [M-11-13]-

























Table 6.5 A. baumannii 5075 LOS fragment ion lists Lists of identified fragment ions 
for a) targeted MS
3
 CID/HCD and  targeted MS
3
 CID/UVPD (10 pulses, 2 






































































Table 6.6 A. baumannii 1205 LOS fragment ion lists. Lists of identified fragment ions 
for a) targeted MS
3
 CID/HCD and b) targeted MS
3
 CID/UVPD (10 pulses, 2 



















































Table 6.7 A. baumannii 1205 LOS fragment ion lists. List of identified fragment ions for 
a) targeted MS
3
 CID/HCD and targeted MS
3









1710.0942 [M-10-21]-, [M-11-20]-, [M-14-17]-, [M-15-16]-
1648.1363 [M-11-19]-, [M-13-17]-
1570.9738 [M-1-11]-, [M-1-17]-
1554.9796 [M-2-11]-, [M-3-11]-, [M-2-17]-, [M-3-17]-
1552.9676 [M-1-10]-, [M-1-16]-









































Table 6.8 A. baumannii 1205 LOS fragment ion lists. List of identified fragment ions 
for a) targeted MS
3
 CID/HCD and targeted MS
3
 CID/UVPD (10 pulses, 2 






















































Table 6.9 A. baumannii 1205 LOS fragment ion lists. List of identified fragment ions 
for a) targeted MS
3
 CID/HCD and targeted MS
3
 CID/UVPD (10 pulses, 2 








1864.2403 [M-10-21]-, [M-11-20]-, [M-14-17]-, [M-14-17]-





































Table 6.10 A. baumannii 1205 LOS fragment ion lists. List of identified fragment ions 
for a) targeted MS
3
 CID/HCD and targeted MS
3
 CID/UVPD (10 pulses, 2 










1753.1415 [M-1-11]-, [M-1-17]-, [M-6-11]-, [M-6-17]-
1737.1436 [M-2-11]-, [M-2-17]-, [M-3-11]-, [M-3-17]-






































Table 6.11 A. baumannii 1205 LOS fragment ion lists. List of identified fragment ions 
for a) targeted MS
3
 CID/HCD and targeted MS
3
 CID/UVPD (10 pulses, 2 








1791.2101 [M-1-15]- , [M-8-15]-
















































Table 6.12 A. baumannii 1205 LOS fragment ion lists. List of identified fragment ions 
for a) targeted MS
3
 CID/HCD and targeted MS
3
 CID/UVPD (10 pulses, 2 







1817.1126 [M-1-13]-, [M-3-13]-, [M-8-13]-
1801.1220 [M-2-13]-





988.58282- [M-1]2-, [M-3]2-, [M-8]2-
958.06062- [M-1-18]2-, [M-3-18]2-, [M-8-18]2-
927.08292- [M-1-17]2-, [M-3-17]2-, [M-8-17]2-
918.07752- [M-1-16]2-, [M-3-16]2-, [M-8-16]2-
908.05172- [M-1-13]2-, [M-3-13]2-, [M-8-13]2-
898.50782- [M-5]2-
889.50022- [M-4]2-, [M-1-9]2-, [M-3-9]2-, [M-8-9]2-
888.49162- [M-1-3]2-, [M-1-8]2-, [M-3-8]2-






199.1697 1, 3, 8
m/z Fragment
1995.1771 [M-20]-, [M-21]-, [M-22]-
1978.1810 [M-1]-, [M-3]-, [M-8]-
1962.1783 [M-2]-
1817.1140 [M-1-13]-, [M-3-13]-, [M-8-13]-
1797.0097 [M-5]-





997.58812- [M-20]2-, [M-21]2-, [M-22]2-
989.59442- [M-9]2-
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Chapter 7: Structural Characterization of Glycosaminoglycan 
Carbohydrates Using Ultraviolet Photodissociation* 
7.1 OVERVIEW 
Structural characterization of sulfated glycosaminoglycans (GAGs) by mass 
spectrometry has long been a formidable analytical challenge owing to their high 
structural variability and the propensity for sulfate decomposition upon activation with 
low-energy ion activation methods. While derivatization and complexation workflows 
have aimed to generate informative spectra using low-energy ion activation methods, 
alternative ion activation methods present the opportunity to obtain informative spectra 
from native GAG structures. Both electron- and photon-based activation methods, 
including electron detachment dissociation (EDD), negative electron transfer dissociation 
(NETD) and extreme ultraviolet photon activation, have been explored previously to 
overcome the limitations associated with low-energy activation methods for GAGs and 
other sulfated oligosaccharides. Further, implementation of such methods on high 
resolution mass spectrometers has aided the interpretation of the complex spectra 
generated. Here, we explore ultraviolet photodissociation (UVPD) implemented on an 
Orbitrap mass spectrometer as another option for structural characterization of GAGs. 
UVPD spectra for both dermatan and heparan sulfate structures display extensive 
fragmentation including both glycosidic and cross-ring cleavages with the extent of 
sulfate retention comparable to that observed by EDD and NETD. In addition, the 
                                                 
*Klein. D. R.; Leach III, F. E..; Amster, I. J.; Brodbelt, J. S. Structural Characterization of 
Glycosaminoglycans using Ultraviolet Photodissocation. Anal. Chem. 2019, ASAP. 
 




relatively short activation time of UVPD makes it promising for higher throughput 
analysis of GAGs in complex mixtures. 
7.2 INTRODUCTION 
Glycosaminoglycans (GAGs), linear polysaccharides composed of repeating 
hexosamine and uronic acid disaccharides, are complex molecules that participate in a 
number of biological processes ranging from tissue development to inflammation.
1–3
 
GAG structural complexity arises from variations in their degree of polymerization, the 
extent of saccharide sulfation, and uronic acid stereochemistry. Such modifications are 
responsible for the specific interactions GAGs have with proteins, with misregulation of 
modifications implicated in a number of genetic diseases, including Alzheimer’s and 
cancer.
4–7
 Development and quality control of GAG therapeutics also relies on a detailed 
knowledge of GAG structures.
1,8
 In 2008, heparin, an anticoagulant drug, contaminated 
with oversulfated chondroitin sulfate resulted in 81 deaths.
8
 Detailed structural 
characterization of GAGs is therefore essential yet still impeded by a number of technical 
challenges. Advances in modern mass spectrometry, including the development of high 
resolution/high mass accuracy mass analyzers and hybrid instrumentation, have made it 
an indispensable tool for the structural characterization of GAGs.
9–13
 Owing to their 
acidic nature, GAGs are most frequently analyzed in the negative ion mode, and 
deprotonation of the sulfate half-ester leads to stabilization of this labile modification. If 
these moieties remain protonated, sequencing attempts with low-energy tandem mass 
spectrometry methods, including collision-induced dissociation (CID) and infrared 
multiphoton dissociation (IRMPD), or by using improper tuning conditions in high 
pressure regions of the mass spectrometer can result in preferential sulfate 
decomposition, especially for highly modified heparin and heparan sulfate. The 
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prevalence of sulfate decomposition impedes complete saccharide sequencing and sulfate 
localization.
14,15
 Previous studies have shown that informative CID spectra can be 
obtained after deprotonation of all sites of sulfation.
16,17
 Metal adduction using sodium or 
calcium ions effectively allows deprotonation of acidic sites that would otherwise lead to 
SO3 loss and enables informative spectra to be obtained from low-energy collisional 
activated dissociation.
14,18–20
 Derivatization strategies, while requiring more sample 
preparation, have similarly been beneficial for obtaining information spectra upon low-
energy collisional activated dissociation.
21,22
 High-energy collisional activation has also 




As a result of the limitations of low-energy activation methods a number of 
alternative ion activation methods have successfully been applied to analyze GAGs. 
Electron-based activation methods include electron detachment dissociation (EDD)
24–33
, 
negative electron transfer dissociation (NETD)
33–37
 and electron-induced dissociation 
(EID)
38
. EDD produces an extensive array of fragment ions, including sulfate-retaining 
glycosidic and cross-ring cleavage products for both free acid and sodium-proton 
exchanged species with observed fragments resulting from both direct dissociation and 
electron detachment.
24–27
 Both EDD and NETD has also shown promise for 
distinguishing hexuronic acid epimers based on both the presence of unique fragments 
and fragment ion abundances.
28–31
 While long activation times and low abundance 
product ions have prevented coupling of EDD with online separations, successful 
interfacing of field asymmetric-waveform ion mobility spectrometry (FAIMS) with an 
EDD-equipped FTICR instrument has enabled gas-phase separation and detection of 
GAG epimers.
32
 NETD has also shown great promise as an alternative activation method 
for negative ions, exhibiting similar fragmentation to EDD and the potential to be 
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performed on any mass spectrometer capable of gas phase ion-ion reactions.
33,35,36
 The 
recent application of NETD to GAG analysis on an Orbitrap platform confirmed that 
NETD can produce highly informative spectra with activation times amenable to a 
chromatographic or electrophoretic timescale.
36
  
Ultraviolet photon-based activation methods have also been considered as 
alternatives to low energy methods for the analysis of GAGs anions.
39–46
 The use of UV 
photons for oligosaccharide fragmentation was first reported by Reilly.
47
 In their work, 
both underivatized and derivatized oligosaccharides were fragmented on a home-build 
MALDI TOF/TOF equipped with a 157 nm excimer laser.
47–49
 Since then, others have 
investigated a range of wavelengths to activate oligosaccharides on a number of 
platforms. Racaud et al. performed ultraviolet photodissociation (UVPD) in the 220-290 
nm range in an ion trap mass spectrometer on a set of heparin-derived disaccharides and 
observed informative cross-ring cleavage fragments.
40
 UVPD favored a large number of 
cross ring cleavages in addition to unique electron-photodetachment ions with 
corresponding charge-reduced neutral loss products. Racaud et al. also investigated the 
influence of charge on the preference for fragmentation versus electron-photodetachment 
using UVPD.
41
 Similar to low-energy and electron-based activation methods, 
deprotonation of sulfate modification greatly influenced the fragmentation patterns with 
full deprotonation achieved through sodium adduction.
40,41
 Extreme UVPD (X-UVPD) at 
a photon energy of 18 eV was performed with synchrotron radiation on an ion trap mass 
spectrometer and provided detailed structure characterization of highly sulfated 
oligosaccharides.
43–45
 While synchrotrons provide a high-energy and tunable source of 
radiation, their limited accessibility make them less feasible for routine usage and broad 
applications. Moreover, while UVPD produces rich fragmentation patterns, it is apparent 
with increasingly large and complex biomolecules that interpretation of UVPD spectra 
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becomes challenging, if not impossible, when using low resolution ion trap mass 
spectrometers. 
Excimer lasers have been successfully interfaced to a number of mass 
spectrometers and likewise provide access to high energy photons.
50
 Integration of 193 
nm excimer lasers with high accuracy Orbitrap mass analyzers has greatly expanded the 
utility of UVPD as an activation method for larger biomolecules, enabling successful 
interpretation of complex fragmentation patterns.
50–52
 The successful structural 
characterization of acidic saccharides
53
 and localization of sulfate modifications on 
peptides
54
 using 193 nm UVPD, suggest it as a viable tool for GAG analysis. 
Additionally, the recent commercialization of UVPD with a 213 nm Nd:YAG laser has 
further increased its accessibility.
55,56
 The present study evaluates the use of UVPD for 
the structural characterization of GAGs. UVPD was found to perform comparably to 
collision-based activation methods for heparan and dermatan sulfate GAGs with low 
degrees of sulfation. More significantly, UVPD produced an extensive array of cross-ring 
cleavage fragments for fondaparinux, a highly sulfated heparin-like anticoagulant drug, 
enabling more detailed characterization than collision-based methods and comparable 
fragmentation to electron-based methods such as NETD. 
7.3 EXPERIMENTAL 
7.3.1 Materials and Reagents 
HPLC grade methanol (MeOH) and water (H2O) were acquired from EMD 
Millipore (Billerica, MA). Fondaparinux sodium was purchased from Sigma (St. Louis, 
MO). For data collection of fondaparinux with salt adduction, fondaparinux sodium was 
desalted on a PD MiniTrap G-10 column (GE Healthcare, Buckinghamshire, UK). 




 Dermatan sulfate oligosaccharides were prepared by partial 
enzymatic depolymerization of porcine intestinal mucosa dermatan sulfate (Celsus 
Laboratories, Cincinnati, OH, USA). A detailed protocol can be found in prior reports.
30
 
The structures of all the GAGs analyzed in the present study are shown in Table 7.1. 
Table 7.1 Structure and molecular weights of all GAGs analyzed 
 
7.3.2 Mass Spectrometry 
Higher-energy collisional dissociation (HCD) and UVPD spectra for all samples 
were collected on a Thermo Fisher Orbitrap Fusion Lumos mass spectrometer (San Jose, 
CA) equipped with a Coherent Excistar 193 nm excimer laser (Santa Clara, CA).
52
 
Samples were diluted in 50:50 MeOH:H2O to 50 µg/mL and sprayed from a nano- 
electrospray ionization (nanoESI) static source with a spray voltage of 0.8-1.2kV. The 
spray voltage and distance between the nanoESI source and the mass spectrometer inlet 
were adjusted to manipulate the observed charge state distribution. Spectra were collected 
in the negative ion mode at a resolving power of 120,000 at m/z 200 with the instrument 
in full-profile mode. The ion funnel RF was set to 10% to minimize sulfate 
decomposition in MS
1
 spectra. Precursor ions were isolated in the ion trap with an 





Dermatan sulfate dp4 (DS dp4) 918.14 
 






isolation width of 3 m/z. HCD was performed with a normalized collision energy (NCE) 
of 15-25, and UVPD was performed with 8 pulses at 4 mJ per pulse resulting in a 16 ms 
activation time. All presented HCD and UVPD spectra are an average of 50 transients.  
EDD and NETD spectra of IdoA-GlcNAc6S-GlcA-GlcNAc6S-(CH2)5NH2 were collected 
on a 9.4 T Bruker Apex Ultra Qe FTMS mass spectrometer (Billerica, MA) and a 
Thermo Scientific Instruments Orbitrap Elite mass spectrometer (Bremen, Germany), 
respectively.  EDD was performed on quadrupole mass selected precursor ions by 
irradiation with 19 eV electrons for a pulse duration of 1 s.  Twenty-four spectra were 
averaged and internally calibrated.  NETD was enabled by software modifications and 
performed on mass-selected precursors by ion-ion reaction with radical fluoranthene 
cations for 150 ms.  Thirty-six spectra were summed with a specified resolution of 
120,000. Fragment ions are labeled using Domon and Costello nomenclature (Figure 
7.1).
58
 Spectra were interpreted in a semi-automated fashion through the use of 
GlycoWorkbench.
59
 Fragment ions maps are depicted using dashed lines drawn through 
chemical structures with hash marks at the ends of dashed lines to indicate the presence 
of a fragment ion. An open circle at the end of a hash mark indicates a fragment ion with 
loss of a single SO3. A filled circle at the end of a hash mark indicates a fragment ion 
with loss of more than one SO3. Donut plots represent percentages of the summed ion 
abundances for each ion type (glycosidic, cross-ring, glycosidic-SO3, cross-ring-SO3) 
relative to summed abundances of all ion types.  Precursor neutral losses and ions 






Figure 7.1 Domon and Costello nomenclature with key indicating the symbols used to 
denote sulfate retention and decomposition.
58
 
7.4 RESULTS AND DISCUSSION 
Both synthetic and enzymatically-depolymerized GAG standards were analyzed 
to evaluate the capabilities of 193 nm UVPD for structural characterization, along with 
comparisons to HCD, EDD, and NETD spectra. Figure 7.2 shows the UVPD and HCD 
spectra of the [M-2H]
2-
 precursor ion of the unsulfated tetrasaccharide GlcA-GlcNAc-
GlcA-GlcNAc-(CH2)5NH2. The UVPD spectrum displays cleavage of every glycosidic 














Figure 7.2 a) UVPD (8 pulses, 4 mJ) and b) HCD (NCE 20) spectrum of [M-2H]
2-
 (m/z 
429) of GlcA-GlcNAc-GlcA-GlcNAc-(CH2)5NH2 and c) 193 nm UVPD 
fragment ion map. The UVPD spectrum contains an inset donut plot 
depicting the fragment ion composition (based on summed abundances of 
products from glycosidic versus cross-ring cleavages). Table 7.2 and Table 
7.3 contain lists of identified fragment ions for UVPD and HCD, 
























































































The UVPD spectrum also contains a characteristic charge-reduced, electron-
photodetachment product at m/z 859.31, which accounts for 2.6% of the total ion current, 
in addition the loss of CO2 from that species (m/z 815.32) which accounts for 7.6% of the 
total ion current. HCD of the same tetrasaccharide primarily yielded glycosidic cleavages 
in addition to a few low abundance cross-ring cleavages. The distribution of glycosidic 
and cross-ring fragments between HCD (glycosidic = 86.7%; cross-ring = 13.2%) and 
UVPD (glycosidic = 83.5%; cross-ring = 16.5%), as depicted in the donut plots of Figure 
7.2, is quite similar owing to the lack of labile sulfate modifications and ionization of 
both carboxylates. Comparison of fragment ions that are observed in both the UVPD and 
HCD spectra reveals that although B/Y and C/Z are prominent in both spectra, additional 
odd-electron species are generated exclusively upon UVPD. For example, in the HCD 
spectrum the even-electron B3 ion of m/z 554.14 is observed, while both even- and odd-
electron B3 and B3
•
 ions appear (m/z 554.14 and m/z 553.13) in the UVPD spectrum 
(Figure 7.3, Table 7.2, Table 7.3). These results are analogous to prior findings reported 
for the electron-based activation method EDD and suggest radical-based fragmentation as 
one of the contributing pathways of UVPD.
24,25
 Moreover, the broad array of cross-ring 
cleavages observed upon UVPD, including fragmentation across residues without 
ionizable sites, suggests that radical migration may play an active role in the 





Figure 7.3 Expanded a) UVPD (8 pulses, 4 mJ) and b) HCD (NCE 20) spectra [M-2H]
2-
(m/z 429) of GlcA-GlcNAc-GlcA-GlcNAc-(CH2)5NH2. 
Figure 7.4 shows the UVPD and HCD spectra of the [M-2H]
2-
 precursor ion of 
the tetrasaccharide IdoA-GlcNAc6S-GlcA-GlcNAc6S-(CH2)5NH2, a synthetic heparan 
sulfate with a low degree of sulfation. While the HCD spectrum does contain informative 
glycosidic fragments (primarily B, C, Y and Z ions), sulfate decomposition is a 
predominant fragmentation pathway. Sulfate decomposition is possible when these sites 
are protonated, a process that can result from either protonation during ionization or 
possible proton migration in the gas phase.
24,60
 With increasingly sulfated heparan sulfate 
species that have more than more than one sulfate per disaccharide, complete 
deprotonation is unlikely owing to charge repulsion, and incomplete deprotonation 














































Figure 7.4 a) UVPD and b) HCD (NCE 25) spectra of [M-2H]
2- 
(m/z 509) of IdoA-
GlcNAc6S-GlcA-GlcNAc6S-(CH2)5NH2. c) Fragment ion map contain 
fragment ions for both UVPD and HCD. Fragment ions only produced 
exclusively by UVPD are in red. Table 7.4 and Table 7.5 contain lists of 
identified fragment ions for UVPD and HCD, respectively (Chapter 7, 
Supporting Information). 
In contrast, the UVPD spectrum exhibits cleavage of every glycosidic bond in 



































































































allow determination of the saccharide linkage pattern and enable localization of 6-O 
sulfation to the glucosamine residues. Similar to GlcA-GlcNAc-GlcA-GlcNAc-
(CH2)5NH2, UVPD of IdoA-GlcNAc6S-GlcA-GlcNAc6S-(CH2)5NH2 (2-) generates an 
electron-photodetachment fragment of m/z 1019.22, in addition to a series of secondary 
electron-photodetachment products (m/z 975.23 and m/z 939.26) originating from neutral 
losses of CO2 and SO3, respectively. A comparative summary of fragmentation pathways 
for this compound in EDD, NETD, and UVPD is visualized in the donut plots in Figure 
7.5. The predominant ion of m/z 469.63 corresponding to sulfate decomposition from the 
precursor (Figure 7.4b) accounts for 18.1% of the total ion current.  Based on the 
summed abundances of glycosidic and cross-ring fragments in the HCD spectrum, 28.2% 
and 2.7% of the glycosidic and cross-ring fragments, respectively, undergo sulfate 
decomposition. For EDD, NETD, and UVPD, 5.4%, 0.0% and 10.3% of glycosidic, and 
1.3%, 4.7% and 5.2% of cross-ring fragments, respectively, undergo sulfate 
decomposition relative to the total summed abundances of glycosidic and cross-ring 
fragments. EDD, NETD, and UVPD all exhibit less sulfate decomposition than HCD and 
generally produce spectra that are more structurally informative.  While the distribution 
of glycosidic and cross-ring cleavages is quite comparable between NETD and UVPD, 
EDD appears to favor production of glycosidic cleavages.  Based on the summed 
abundances of all cross-ring fragment ions, 33.2% and 38.6% are sulfate-retaining cross-
ring fragments for NETD and UVPD, respectively, while only 4.9% are sulfate-retaining 




Figure 7.5 Donut plots depicting fragment ion compositions for HCD, EDD, NETD and 
UVPD for [M-2H]
2-
 of IdoA-GlcNAc6S-GlcA-GlcNAc6S-(CH2)5NH2 based 
on summed abundances of fragment types. Table 7.6 and Table 7.7 contain 
lists of identified fragment ions for EDD and NETD, respectively (Chapter 
7, Supporting Information). 
Dermatan sulfate (DS) is a sulfated GAG composed of repeating β-1,4 linked 
disaccharide units each comprised of β1,3-linked iduronic acid and 4-O-sulfated N-acetyl 
galactosamine (GalNAc) residues. Figure 7.6 shows the UVPD spectrum for a doubly 
sulfated DS tetrasaccharide. Although similar in length and sulfation extent, it contains a 
different linkage pattern and therefore different sulfate positions, and differing uronic 









Figure 7.6 a) UVPD spectrum of [M-2H]
2-
 (m/z 458) of DS dp4, b) UVPD fragment ion 
map, and c) UVPD donut plot depicting the fragment ion composition based 
on summed abundances of fragment types. Table 7.8 contains a list of 
identified fragment ions (Chapter 7, Supporting Information). 
These subtle structural differences have resulted in challenges to determine sequence and 
epimer content of chondroitin sulfate (CS)/DS GAGs de novo.
25,30
 The UVPD spectrum 
of [M-2H]
2-
 contains a complete series of glycosidic cleavages in addition to cross-ring 
cleavages that again enable localization of sulfate modifications. For example, pairs of 
fragment ions, Z3 and 
2,4
X2, and C3 and 
1,4
A4, confirm 4-O sulfation of each GalNAc. 
These cross-ring cleavages do not arise during EDD or NETD of the same precursor ion.  
1,5X2




























































The symmetry of this GAG precludes differentiation of C2/Z2 ions as these fragment ions 
are isobaric with the precursor ion.  UVPD again causes a relatively low degree of sulfate 
decomposition, thus minimizing the congestion of the spectrum with uninformative ions. 
In general, a larger number of cross-ring fragments were identified for UVPD of DS dp4 
compared to EDD and NETD, which is perhaps related in part to the increased signal-to-
noise of the UVPD spectrum.
25,34
 We estimate that approximately 20-30% of ions in the 
UVPD spectra are currently unassigned, whereas this value is 10-20% in EDD/NETD 
spectra. Interestingly, there is a prominent fragment ion of m/z 715.05 (1-). Further 
interrogation of this ion via MS
3
 results in a predominant neutral loss of 80.96 Da 
(HSO3
•
) to form an abundant C3 ion of m/z 634.09 (Figure 7.7). We speculate that this 
product arises during MS
2
 from a gas-phase rearrangement that entails loss of GalNAc by 
glycosidic bond cleavage in conjunction with the transfer of the sulfate modification to 
the reducing end of the incipient product. This fragment ion occurs in the 1- charge state 
and contains all sites of ionization; therefore this fragment is likely an odd-electron ion 
resulting from electron-photodetachment. The MS
3 
spectrum also shows an ion of m/z 
272.99, corresponding to a sulfate-containing uronic acid, further suggesting retention of 
the reducing end 4-O GalNAc sulfate group on uronic acid. This unusual ion of m/z 
715.05 has also been observed in EDD and NETD spectra of [M-2H]
2- 
of DS dp4, but has 
not been previously assigned.
25,30
 UVPD of [M-3H]
3-
 does not generate the ion at m/z 
715.05, indicating that number and sites of deprotonation influence gas-phase 
rearrangement processes (Figure 7.8). As expected, [M-3H]
3-
 yields lower percentages of 
sulfate decomposition in relation to the summed abundances of the glycosidic and cross-
ring fragments; [M-3H]
3-
 has 0.7% and 0.02% sulfate decomposition for glycosidic and 
cross-ring fragments, respectively, whereas  [M-2H]
2-
 displays 2.6% and 4.7% sulfate 





 activation of the fragment ion m/z 715.05 from DS dp4 by a) UVPD (8 
pulses, 4 mJ)/HCD (NCE 20) and b) UVPD (8 pulses, 4 mJ)/UVPD (8 
pulses, 4 mJ). Tables 7.9 and 7.10 contain lists of identified fragment ions 
for UVPD/HCD and UVPD/UVPD, respectively (Chapter 7, Supporting 
Information). 
  





























































Figure 7.8 a) UVPD spectrum of [M-3H]
3- 
(m/z 305) of DS dp4 with donut plot depicting 
the fragment ion composition UVPD spectrum of [M-3H]
3- 
(m/z 305) of DS 
dp4. Table 7.11 contains a list of identified fragment ions (Chapter 7, 
Supporting Information). 
While many structural characterization studies have focused on relatively small 
GAGs (dp2-dp4), analysis of larger oligosaccharides offers the potential for correlation of 
modification motifs with biological activity, analogous to analysis of combinatorial post-
translation modifications of proteins. Typical GAG-protein binding epitopes range from 
dp4-10; the previous analytes represent the lower boundary for this regime.  DS dp10 
represents a GAG standard with a higher degree of polymerization. The UVPD spectrum 
of the 5- charge state of DS dp10 is shown in Figure 7.9. The rich spectrum contains a 
full set of glyosidic cleavages and a number of cross-ring cleavages with a relatively low 

























































degree of sulfate decomposition. In addition, ions originating from sequential 
photodetachment events, analogous to multiple electron transfer events that are possible 
with NETD, are observed.
61





, representing doubly and triply charge-reduced species. The 
observed UVPD fragmentation pattern for DS dp10 is quite similar to that of EDD, with 




Figure 7.9 a) UVPD spectrum of [M-5H]
5-
 (m/z 458) of DS dp10 with inset donut plot 
depicting the fragment ion composition based on summed abundances of 
fragment types, and b) UVPD fragment ion map. Table 7.12 contains a list 
of identified fragment ions (Chapter 7, Supporting Information). 
With increasingly large GAG structures like DS dp10, high resolution and high accuracy 
mass analysis for assignment of fragment ions is necessary. The fragmentation caused by 






































































































 including abundant uronic acid cross-ring 
cleavages, albeit production of more abundant fragment ions by UVPD than EDD with a 
significantly shorter ion activation period. 
The prior examples have demonstrated the utility of UVPD in analytes with 
varied sulfation density (0-1 per dp2) and oligomer length yet were all homopolymers.  
Fondaparinux (trade name Arixtra) is a synthetic, highly-sulfated pentasaccharide with 
anticoagulant activity.
62
 The sulfation pattern of fondaparinux is based on a naturally 
occurring pentasaccharide motif in heparin that binds antithrombin III, and is therefore 
representative of the complex GAG structures that occur naturally in heteropolymers. 
Fondaparinux has therefore served as a benchmark for appraisal of new GAG ion 
activation methods. As stated previously, with increasingly sulfated GAGs, charge 
repulsion limits the number of ionized sites during ESI and promotes sulfate 
decomposition via residual protons. Assessing the impact of precursor charge state in 
conjunction with the use of sodium adduction to achieve a higher degree of deprotonation 
is a key milestone in the evaluation of performance metrics of MS/MS methods. While 
deprotonation of highly-sulfated GAGs via sodium adduction increases the effectiveness 
of collisional activation, benefits are only observed when all sites of ionization are 
deprotonated.
14
 The limited utility of collisional activation for highly-sulfated GAGs has 
led to exploration of other ion activation methods, including NETD. For comparison to 
previously reported collisional activation and NETD data, UVPD was used to 







 Figure 7.10 shows the UVPD mass spectrum acquired for the [M-
8H+3Na]
5-
. This charge state represents one in which the number of ionized sites matches 
the number of sulfate groups in an attempt to minimize sulfate decomposition. The 
fragment ion map in Figure 7.10b reflects cleavage between all saccharides while the 
 220 
donut plot in Figure 7.10a confirms a relatively low degree of SO3 loss (glycosidic-SO3 
= 7.3%; cross-ring-SO3 = 0.3%). 
 
Figure 7.10 a) UVPD spectrum of [M-8H+3Na]
5-
 (m/z 313) of fondaparinux with donut 
plot depicting the fragment ion composition based on summed abundances 
of fragment types, and b) UVPD fragment ion map. Table 7.13 contains a 
list of identified fragment ions (Chapter 7, Supporting Information). 
Figure 7.11 shows the UVPD fragmentation spectrum for [M-10H+5Na]
5- 
and 
corresponding fragment ion map and donut plot. This charge state exhibits an even lower 




but overall produces fewer informative fragments. This observation is consistent with 
EDD results for GAGs in which SO3 loss is minimized when the number of ionized sites 
is greater than the number of sulfate groups.
26,36
 However, less overall fragmentation is 







































































































observed when all ionizable sites are deprotonated, as sites that remain protonated are 
hypothesized to facilitate radical-based reactions that provide informative fragment ions. 
 
Figure 7.11 a) UVPD spectrum of [M-10H-5Na]
5-
 (m/z 322) of fondaparinux, b) UVPD 
fragment ion map, and c) UVPD donut plot depicting the fragment ion 
composition based on summed abundances of fragment types. Table 7.14 
contains a list of identified fragment ions (Chapter 7, Supporting 
Information). 
While deprotonation via sodium adduction represents one strategy to sequence 
highly sulfated GAGs, sodium adduction increases the number of possible ion types 
through generation of ions both with and without sodium adducts, which has the potential 
to increase spectral complexity, convolute interpretation, and increase the likelihood of 
false identifications. In addition, fragment ion signals can be split across various 
a) x7 x7

































































































































adduction states and can lead to reduced ion intensities. Conversely, highly-sulfated GAG 
ions without salt adducts often contain protonated sulfate moieties, which are particularly 
problematic during collisional activation as they promote sulfate decomposition and 
preclude modification localization. NETD has previously shown success for activation of 
fondaparinux with protonated sulfate groups, generating spectra that contain informative 
fragment ions with minimal sulfate loss.
33
 The UVPD mass spectrum of the [M-4H]
4-
 ion 
of fondaparinux is displayed in Figure 7.12. In contrast to collisional activation (Table 
7.15 Supporting Information, Chapter 7), UVPD generates a complete series of 
glycosidic fragments that retain sulfate modifications to a much larger extent (glycosidic-
SO3 = 12.2%; cross-ring-SO3 = 9.2%). The informative spectrum re-confirms that sulfate 
decomposition is further minimized with UVPD even when sulfate groups are likely 
protonated, consistent with the prevailing understanding of the different mechanism of 






Figure 7.12 a) UVPD spectrum of [M-4H]
4-
 (m/z 375) of fondaparinux with donut plot 
depicting the fragment ion composition based on summed abundances of 
fragment types, and b) UVPD fragment ion map. Table 7.15 contains a list 
of identified fragment ions (Chapter 7, Supporting Information). 
While the advantages of alternative ion activation methods for GAG analysis are 
apparent, many methods have limited accessibility and require instrument hardware 
modifications. Addition of a 213 nm solid state laser to an Orbitrap mass spectrometer 
was commercialized in 2017, thus making UVPD a more widely available technique.
55,56
 
We assessed the capabilities of 213 nm UVPD for GAG structural characterization, and 
one example is illustrated in Figure 7.13 for DS dp4, [M-3H]
3-
. While the 213 nm 
Nd:YAG laser is considerably less powerful than the 193 nm excimer laser, comparison 
of the UVPD fragment ion maps in Figure 7.8b and Figure 7.13b suggests that 213 nm 
UVPD results in fragmentation that is similar to that obtained by 193 nm UVPD.  
x50 x50




























































Figure 7.13. a) 213 nm UVPD (500 pulses, 3 µJ/pulse; 200 ms activation time) spectrum 
of [M-3H]
3- 
(m/z 305) of DS dp4 with donut plot depicting the fragment ion 
composition based on summed abundances of fragment types, and b) 213 
nm UVPD fragment ion map. The 213 nm UVPD spectrum was collected on 
the same Thermo Fisher Orbitrap Fusion Lumos mass spectrometer used for 
193 nm UVPD with a 213 nm laser (2.5 kHz rep. rate) in place of the 193 
nm excimer laser. For 213 nm UVPD, photoirradiation occurred in the lower 
pressure linear ion trap. Table 7.17 contains a list of identified fragment 
ions for 213 nm UVPD. 
However, the activation period for 213 nm UVPD (200 ms) is substantially greater than 
that used for 193 nm UVPD (16 ms). Future improvements to 213 nm UVPD are 
anticipated to decrease the required activation period.  Variations between the 193 nm 
and 213 nm UVPD spectra in Figure S5 are attributed to differences in the laser powers 
(which influence the distribution of multiphoton absorption events and accumulation of 
























































energy) and the different wavelengths which may access different excited electronic 
states. The fast, high-energy deposition of UVPD enhances cleavage of C-C and C-O 
bonds while minimizing loss of labile modifications. Moreover, UV photoabsorption can 
cause electron detachment, particularly for multiply-charged negative ions, potentially 
leading to both radical and hydrogen migration in the course of fragmentation. 
Considering the informative spectra that can be generated with short activation times, 
UVPD appears to be a natural fit for coupling to online or gas-phase separations of 
GAGs.
64,65
 Recent coupling of NETD with trapped ion mobility spectrometry 
demonstrates the advantage of coupling alterative ion activation methods with separation 
techniques for GAG analysis.
65
 For GAGs with a higher degree of sulfation, it is 
worthwhile to investigate separation techniques that can accommodate sodium 
cationization of GAGs for increased sulfate retention with spectra collected on high 
resolution mass spectrometers to alleviate concerns regarding spectral interpretation. 
These spectra are also amenable to automatic spectral interpretation which further 




The work presented here confirms that 193 nm UVPD demonstrates great promise 
for sequencing of GAGs by tandem mass spectrometry. Similar to electron-based 
activation methods, UVPD produces sulfate-retaining glycosidic and cross-ring fragment 
ions, with activation times comparable to NETD and much shorter than EDD. In general, 
the high resolution capabilities of the Orbitrap mass analyzer enabled confident 
assignment of fragment ions and permitted interpretation of the complex tandem mass 
spectra typical of GAGs. While informative fragment ions were generated for all charge 
states, the degree of sulfate decomposition and extent of fragmentation showed some 
 226 
dependence on the ionization state, reiterating the important impact of both ionization 
conditions and precursor ion selection.  In addition, the ability to modulate fragmentation 
patterns based on the particular ionization state of the precursor provides another strategic 
option when developing a workflow for high throughput analysis of GAGs in mixtures.   
  
 227 
7.6 SUPPORTING INFORMATION 





Measured m/z Intensity Relative intensity Ion ppm error Theoretical m/z
174.0164 9.29E+05 4.81 B1
• 0.22 174.0164
193.0347 1.25E+06 6.49 C1 3.50 193.0354
202.0716 2.89E+05 1.50 [Z1-(CH2)5NH2]
- -0.26 202.0715
220.0820 3.17E+04 0.16 [Y1-(CH2)5NH2]
- 0.51 220.0821
235.0452 2.90E+04 0.15 2,4A2 3.15 235.0459
249.0610 1.18E+05 0.61 3,5A2 2.37 249.0616
285.5686 4.36E+04 0.23 C3
2- 4.13 285.5698
295.0662 1.43E+05 0.74 0,2A2 2.95 295.0671
305.1710 1.70E+05 0.88 Y1 2.82 305.1719
306.0824 6.93E+03 0.04 1,4A2 2.14 306.0831
349.1009 8.65E+04 0.45 1,5A2
• -0.01 349.1009
378.1038 1.16E+05 0.60 B2 1.02 378.1042
396.1138 1.06E+07 54.64 C2 2.40 396.1147
421.1826 2.13E+04 0.11 2,4X1 0.52 421.1828
429.6534 1.93E+07 100.00 [M-2H]2- 1.55 429.6541
438.1244 2.19E+05 1.13 2,4A3 2.08 438.1253
463.1924 1.23E+06 6.39 Z2 2.12 463.1934
466.1192 2.88E+05 1.49 3,5A3 2.21 466.1202
481.2028 1.54E+06 7.95 Y2 2.39 481.2039
482.1146 1.98E+04 0.10 0,3A3 1.13 482.1151
509.1977 3.31E+05 1.71 1,5X2 2.28 509.1989
512.1245 9.38E+05 4.86 0,2A3 2.36 512.1257
526.1403 1.34E+05 0.70 1,5A3 2.01 526.1414
553.1273 4.62E+05 2.39 B3
• 1.08 553.1279
564.2399 2.47E+04 0.13 0,2X2 2.06 564.2411
572.1457 4.31E+05 2.23 C3 1.99 572.1468
579.2271 2.09E+04 0.11 2,5X2
• 0.78 579.2276
623.2529 5.19E+04 0.27 2,4X2
• 1.39 623.2538
628.1722 2.64E+04 0.14 3,5A4 1.36 628.1731
666.2714 2.04E+06 10.57 Z3 2.04 666.2728
674.1777 5.45E+03 0.03 0,2A4 1.23 674.1785
684.2819 1.07E+06 5.56 Y3 2.08 684.2833
712.2769 1.03E+05 0.53 1,5X3 1.88 712.2782
725.2845 9.85E+04 0.51 0,2X3
• 1.33 725.2855
729.2202 1.56E+04 0.08 1,5A4 0.73 729.2207
742.2854 6.58E+03 0.03 2,5X3 4.58 742.2888
755.2939 2.41E+04 0.12 0,3X3
• 2.82 755.2960
770.2819 9.13E+03 0.05 1,4X3 2.36 770.2837
772.2978 1.24E+06 6.43 3,5X3 2.03 772.2994
800.2928 3.30E+04 0.17 2,4X3/
1,3X3 1.85 800.2943
815.3163 6.92E+06 35.86 [M-2H-CO2]
-• 1.05 815.3172
859.3059 2.38E+06 12.33 [M-2H]-• 1.26 859.3070
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Measured m/z Intensity Relative intensity Ion ppm error Theoretical m/z
133.0143 1.44E+04 0.01 0,2A1 -0.40 133.0142
175.0246 3.51E+05 0.32 B1 1.21 175.0248
193.0350 1.99E+07 18.31 C1 1.95 193.0354
218.5587 4.18E+04 0.04 2,4A3
2- 1.46 218.5590
235.0458 2.15E+05 0.20 2,4A2 0.60 235.0459
276.5641 3.91E+05 0.36 B3
2- 1.44 276.5645
285.5691 6.24E+04 0.06 C3
2- 2.38 285.5698
287.1610 7.38E+05 0.68 Z1 1.03 287.1613
295.0668 1.23E+07 11.36 0,2A2 0.92 295.0671
305.1716 1.93E+07 17.79 Y1 0.85 305.1719
341.6379 1.83E+05 0.17 Y3
2- 0.36 341.6380
347.1824 8.21E+05 0.76 0,2X1 0.07 347.1824
378.1042 3.08E+06 2.83 B2 -0.04 378.1042
396.1149 4.49E+07 41.30 C2 -0.38 396.1147
399.6442 3.49E+04 0.03 2,4X3/
1,3X3 -1.75 399.6435
429.6554 1.09E+08 100.00 [M-2H]2- -3.10 429.6541
438.1256 9.26E+04 0.09 2,4A3 -0.65 438.1253
463.1935 8.58E+05 0.79 Z2 -0.25 463.1934
468.1360 3.18E+05 0.29 1,4A3 -0.26 468.1359
481.2043 5.91E+04 0.05 Y2 -0.73 481.2039
510.1475 4.54E+04 0.04 [B3-CO2]
- -2.08 510.1464
554.1367 2.64E+05 0.24 B3 -0.77 554.1363
666.2747 9.48E+03 0.01 Z3 -2.92 666.2728
684.2840 4.80E+05 0.44 Y3 -0.99 684.2833
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Measured m/z Intensity Relative intensity Ion ppm error Theoretical m/z
138.9704 1.24E+04 0.06 0,4A2/
0,4A4 1.92 138.9707
175.0245 8.73E+03 0.04 B1 1.78 175.0248
193.0351 3.89E+04 0.18 C1 1.43 193.0354
282.0286 3.27E+04 0.15 [Z1-(CH2)5NH2]
- -0.84 282.0284
295.0667 2.89E+04 0.13 [0,2A2-SO3]
- 1.25 295.0671
300.0389 4.05E+04 0.18 [Y1-(CH2)5NH2]
- 0.09 300.0389
316.5423 4.76E+03 0.02 B3
2- 1.91 316.5429
325.1071 6.43E+04 0.29 2,4X0 1.06 325.1074
329.0179 9.38E+03 0.04 3,5A2 1.54 329.0184
367.1176 3.95E+04 0.18 Z1 1.12 367.1180
375.0234 3.63E+04 0.16 0,2A2 1.29 375.0239
378.1035 2.10E+04 0.09 [B2-SO3]
- 1.81 378.1042
385.1281 4.07E+05 1.84 Y1 1.23 385.1286
396.1141 5.86E+04 0.27 [C2-SO3]
- 1.64 396.1147
413.1229 5.18E+04 0.23 1,5X1 1.43 413.1235
421.5943 1.71E+04 0.08 Y3
2- 1.16 421.5948
426.1305 1.84E+04 0.08 0,2X1
• 0.74 426.1308
430.0657 2.96E+04 0.13 1,5A2 0.89 430.0661
435.5918 1.93E+04 0.09 1,5X3
2- 1.02 435.5922
458.0606 7.04E+04 0.32 B2 0.87 458.0610
466.1193 1.62E+04 0.07 [3,5A3-SO3]
- 1.99 466.1202
469.6316 5.50E+04 0.25 [M-2H-SO3]
2- 1.75 469.6324
476.0709 2.02E+05 0.91 C2 1.39 476.0716
481.2035 1.10E+04 0.05 [Y2-SO3]
- 0.72 481.2038
488.1010 2.21E+05 1.00 [M-2H-C2H2O•]
2- 0.23 488.1011
509.6099 2.21E+07 100.00 [M-2H]2- 1.83 509.6108
543.1494 1.80E+05 0.82 Z2 1.29 543.1501
546.0762 9.66E+04 0.44 3,5A3 1.54 546.0770
554.1358 6.17E+04 0.28 [B3-SO3]
- 0.85 554.1363
561.1597 4.83E+04 0.22 Y2 1.72 561.1607
572.1475 9.99E+03 0.05 [C3-SO3]
- -1.16 572.1468
589.1548 3.13E+05 1.42 1,5X2 1.32 589.1556
592.0818 3.88E+04 0.18 0,2A3 1.22 592.0825
606.0974 1.58E+04 0.07 1,5A3 1.27 606.0982
634.0923 4.01E+04 0.18 B3 1.24 634.0931
644.1971 1.51E+04 0.07 0,2X2 1.05 644.1978
652.1030 4.61E+04 0.21 C3 1.00 652.1037
704.2184 3.75E+04 0.17 [2,4X2-SO3]
- 0.72 704.2189
708.1288 6.28E+03 0.03 [3,5A4-SO3]
- 1.51 708.1299
713.1381 1.99E+04 0.09 1,4X2 0.71 713.1386
746.2288 1.57E+05 0.71 [Z3-SO3]
- 0.90 746.2295
754.1343 2.51E+04 0.11 [0,2A4-SO3]
- 1.39 754.1353
764.2393 7.61E+04 0.34 [Y3-SO3]
- 0.96 764.2400
784.1747 1.88E+05 0.85 2,4X2 1.30 784.1757
792.2341 3.70E+04 0.17 [1,5X3-SO3]
- 1.07 792.2350
806.2493 1.08E+04 0.05 [0,2X3-SO3]
- 1.61 806.2506
826.1853 3.46E+05 1.57 Z3 1.19 826.1863
844.1957 2.34E+05 1.06 Y3 1.36 844.1969
852.2548 4.07E+04 0.18 [3,5X3-SO3]
- 1.50 852.2561
866.2704 4.93E+03 0.02 [0,4X3-SO3]
- 1.54 866.2717
872.1906 1.67E+05 0.76 1,5X3 1.34 872.1918
879.2416 2.26E+04 0.10 [2,4X3-SO3]
-•/[1,3X3-SO3]
-• 1.22 879.2427
886.2062 4.73E+04 0.21 0,2X3 1.37 886.2074
916.2169 3.87E+04 0.18 0,3X3 1.18 916.2180
932.2115 2.35E+05 1.07 3,5X3 1.50 932.2129
939.2618 3.73E+04 0.17 [M-2H-SO3]
-• 2.13 939.2638
960.2062 3.48E+04 0.16 2,4X3/
1,3X3 1.68 960.2078
975.2291 1.47E+06 6.67 [M-2H-CO2]
-• 1.17 975.2302
1019.2188 2.33E+06 10.56 [M-2H]-• 1.24 1019.2201
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Measured m/z Intensity Relative Intensity Ion ppm error Theoretical m/z
138.9705 6.35E+03 0.03 0,4A2/
0,4A4 1.21 138.9707
175.0247 1.24E+05 0.50 B1 0.64 175.0248
187.0081 2.86E+04 0.12 0,2A2
2- 1.09 187.0083
193.0352 5.50E+05 2.22 C1 0.91 193.0354
228.5267 2.01E+04 0.08 B2
2- 0.70 228.5269
235.0458 4.36E+04 0.18 2,4A2 0.60 235.0459
237.532 2.14E+05 0.87 C2
2- 0.60 237.5321
271.0713 4.38E+03 0.02 Z2
2- 0.41 271.0714
276.5646 4.43E+03 0.02 [B3-SO3]
2- -0.37 276.5645
280.0767 1.17E+04 0.05 Y2
2- -0.02 280.0767
295.0669 1.23E+06 4.96 [0,2A2-SO3]
- 0.58 295.0671
305.1717 6.63E+04 0.27 [Y1-SO3]
- 0.20 305.1718
316.5427 5.31E+05 2.14 B3
2- 0.65 316.5429
378.1042 5.60E+05 2.26 [B2-SO3]
- -0.04 378.1042
381.6166 2.56E+05 1.03 [Y3-SO3]
2- -0.58 381.6164
385.1283 2.48E+07 100.00 Y1 0.71 385.1286
396.1144 2.67E+06 10.78 [C2-SO3]
- 0.88 396.1147
421.5946 2.74E+06 11.04 Y3
2- 0.44 421.5948
427.1392 3.53E+04 0.14 0,2X1 -0.14 427.1391
429.6537 2.92E+05 1.18 [M-2H-2SO3]
2- 0.74 429.6540
438.1248 3.49E+04 0.14 [2,4A3-SO3]
- 1.17 438.1253
442.5992 1.00E+04 0.04 0,2X3
2- 1.96 442.6001
458.0609 1.96E+06 7.91 B2 0.22 458.0610
463.1929 2.37E+04 0.10 [Z2-SO3]
- 0.83 463.1933
469.6321 1.88E+07 76.00 [M-2H-SO3]
2- 0.69 469.6324
476.0711 2.92E+05 1.18 C2 0.97 476.0716
481.2035 5.41E+04 0.22 [Y2-SO3]
- 0.72 481.2038
509.6107 3.62E+06 14.61 [M-2H]2- 0.26 509.6108
512.1244 8.93E+03 0.04 [0,2A3-SO3]
- 2.55 512.1257
543.1501 1.95E+05 0.79 Z2 0.00 543.1501
554.1358 9.79E+06 39.52 [B3-SO3]
- 0.85 554.1363
561.1605 7.94E+04 0.32 Y2 0.29 561.1607
634.0928 1.46E+06 5.88 B3 0.45 634.0931
684.2818 3.73E+03 0.02 [Y3-2SO3]
- 2.08 684.2832
764.2397 4.57E+04 0.18 [Y3-SO3]
- 0.44 764.2400
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Table 7.6 Fragment ion list for EDD of [M-2H]
2-





Measured m/z Intensity Relative Intensity Ion ppm error Theoretical m/z
175.0248 1.52E+05 0.02 B1 0.07 175.0248
193.0354 8.90E+05 0.10 C1 -0.12 193.0354
235.0457 6.80E+04 0.01 2,4A2 1.03 235.0459
255.5586 4.23E+04 0.00 [0,2A3-SO3]
2- 2.41 255.5592
295.0669 6.05E+05 0.07 [0,2A2-SO3]
- 0.58 295.0671
316.5427 1.61E+05 0.02 B3
2- 0.65 316.5429
325.1071 1.58E+05 0.02 2,4X0 1.06 325.1074
325.5481 3.23E+04 0.00 C3
2- 0.27 325.5482
329.0184 5.92E+04 0.01 3,5A2 0.02 329.0184
367.1181 5.05E+05 0.06 Z1 -0.24 367.1180
375.0238 1.50E+05 0.02 0,2A2 0.23 375.0239
378.1040 4.98E+05 0.05 [B2-SO3]
- 0.49 378.1042
385.1286 1.10E+07 1.22 Y1 -0.06 385.1286
396.1147 8.47E+05 0.09 [C2-SO3]
- 0.12 396.1147
413.1236 4.09E+05 0.05 1,5X1 -0.27 413.1235
421.5948 1.51E+06 0.17 Y3
2- -0.03 421.5948
427.1388 6.45E+04 0.01 0,2X1 0.80 427.1391
430.0660 3.96E+05 0.04 1,5A2 0.20 430.0661
435.5922 1.42E+05 0.02 1,5X3
2- 0.10 435.5922
458.0610 2.40E+06 0.27 B2 0.00 458.0610
466.1206 8.53E+04 0.01 [3,5A3-SO3]
- -0.80 466.1202
469.6325 2.90E+06 0.32 [M-2H-SO3]
2- -0.16 469.6324
476.0715 1.97E+06 0.22 C2 0.13 476.0716
509.1980 1.44E+05 0.02 [1,5X2-SO3]
- 1.50 509.1988
509.6094 9.05E+08 100.00 [M-2H]2- 2.81 509.6108
526.1417 8.83E+04 0.01 [1,5A3-SO3]
- -0.65 526.1414
543.1499 7.53E+05 0.08 Z2 0.37 543.1501
546.0769 1.44E+06 0.16 3,5A3 0.26 546.0770
548.0947 7.56E+04 0.01 1,4A3 -3.66 548.0927
554.1365 2.70E+06 0.30 [B3-SO3]
- -0.41 554.1363
561.1605 2.10E+05 0.02 Y2 0.29 561.1607
562.0722 3.36E+04 0.00 0,3A3 -0.43 562.0720
572.1483 3.87E+04 0.00 [C3-SO3]
- -2.56 572.1468
576.0917 3.13E+04 0.00 2,5A3 -7.10 576.0876
589.1556 1.38E+06 0.15 1,5X2 -0.04 589.1556
592.0821 4.63E+05 0.05 0,2A3 0.71 592.0825
606.0980 5.24E+05 0.06 1,5A3 0.28 606.0982
634.0933 4.09E+06 0.45 B3 -0.34 634.0931
652.1039 7.93E+05 0.09 C3 -0.38 652.1037
694.1122 3.30E+04 0.00 2,4A4 2.90 694.1142
708.1274 3.21E+04 0.00 [3,5A4-SO3]
- 3.48 708.1299
713.1380 3.65E+05 0.04 1,4X2 0.85 713.1386
729.2269 1.08E+05 0.01 [1,5A4-SO3]
- -8.46 729.2207
746.2295 4.23E+05 0.05 [Z3-SO3]
- -0.04 746.2295
754.1353 2.04E+05 0.02 [0,2A4-SO3]
- 0.06 754.1353
764.2403 1.43E+05 0.02 [Y3-SO3]
- -0.35 764.2400
784.1724 5.28E+05 0.06 2,4X3 4.24 784.1757
792.2370 1.26E+05 0.01 [1,5X3-SO3]
- -2.59 792.2350
809.1834 9.01E+05 0.10 [1,5A4-SO3]
- -7.24 809.1775
826.1866 6.06E+06 0.67 Z3 -0.38 826.1863
834.0937 8.31E+04 0.01 0,2A4 -1.85 834.0922
836.2620 8.21E+04 0.01 [0,3X3-SO3]
- -1.00 836.2612
844.1962 3.20E+06 0.35 Y3 0.77 844.1969
872.1925 1.74E+06 0.19 1,5X3 -0.84 872.1918
880.2466 4.88E+04 0.01 [2,4X3-SO3]
- 4.99 880.2510
880.2466 4.88E+04 0.01 [1,3X3-SO3]
- 4.99 880.2510
886.2080 6.31E+05 0.07 0,2X3 -0.66 886.2074
916.2186 6.41E+05 0.07 0,3X3 -0.68 916.2180
932.2078 6.91E+04 0.01 3,5X3 5.46 932.2129
940.2720 6.81E+04 0.01 [M-H-SO3]
- 0.13 940.2721
946.2298 5.58E+04 0.01 0,4X3 -1.33 946.2285
960.2074 5.63E+05 0.06 2,4X3 0.43 960.2078
960.2074 5.63E+05 0.06 1,3X3 0.43 960.2078
1020.2264 1.37E+06 0.15 [M-H]•- 2.49 1020.2289
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Table 7.7 Fragment ion list for NETD of [M-2H]
2-






Measured m/z Intensity Relative Intensity Ion ppm error Theoretical m/z
430.0662 1.96E+01 0.03 1,5A2 -0.27 430.0661
458.0611 3.54E+02 0.57 B2 -0.22 458.0610
476.0707 1.23E+03 1.98 C1 1.81 476.0716
509.6107 6.22E+04 100.00 [M-2H]2- 0.26 509.6108
546.0764 1.37E+02 0.22 3,5A3 1.18 546.0770
592.0824 3.77E+01 0.06 0,2A3 0.21 592.0825
606.0953 3.94E+01 0.06 1,5A3 4.74 606.0982
634.0881 1.04E+03 1.67 B3 7.86 634.0931
652.0997 1.52E+03 2.45 C3 6.06 652.1037
713.1360 3.97E+02 0.64 1,4X2 3.66 713.1386
784.1726 3.98E+02 0.64 2,4X2 3.98 784.1757
809.1797 1.50E+03 2.41 [1,5A4-SO3]
- -2.66 809.1775
826.1825 1.18E+04 19.01 Z3 4.58 826.1863
844.1909 3.76E+03 6.05 Y3 7.05 844.1969
872.1873 4.53E+03 7.28 1,5X3 5.12 872.1918
886.2027 2.69E+02 0.43 0,2X3 5.32 886.2074
916.2133 1.84E+03 2.95 0,3X3 5.11 916.2180
932.2052 3.26E+01 0.05 3,5X3 8.25 932.2129
940.2632 3.84E+01 0.06 [M-H-SO3]
- 9.49 940.2721
960.2031 1.44E+03 2.32 1,3X3 4.90 960.2078
960.2031 1.44E+03 2.32 2,4X3 4.90 960.2078
1020.2197 3.38E+04 54.34 [M-H]•- 9.06 1020.2289
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Table 7.8 Fragment ion list for UVPD (8 pulses, 4 mJ) of [M-2H]
2-
 of DS dp4. 
 
Measured m/z Intensity Relative intensity Ion ppm error Theoretical m/z
152.9863 2.38E+04 0.47 3,5A2/
3,5A4 0.11 152.9863
157.0141 1.18E+04 0.23 B1 0.94 157.0142
175.0248 3.47E+04 0.69 C1 0.07 175.0248
198.9917 2.20E+04 0.44 1,3X0/
1,3X2 0.49 198.9918
202.0720 1.76E+03 0.03 [Z1-SO3]
- 0.48 202.0721
237.5319 7.23E+02 0.01 Y2
2- 1.02 237.5321
282.0285 3.44E+05 6.82 Z1 1.46 282.0289
300.0392 2.57E+05 5.10 Y1 0.92 300.0395
328.0343 4.72E+04 0.94 1,5X1 0.27 328.0344
342.0501 4.34E+04 0.86 0,2X1 -0.18 342.0500
357.0371 5.27E+03 0.10 2,5X1
• -0.08 357.0371
360.0939 4.32E+03 0.09 [B2-SO3]
- -0.78 360.0936
372.0609 4.31E+03 0.09 0,3X1 -0.79 372.0606
378.1041 5.95E+03 0.12 [Z2-SO3]
-/[C2-SO3]
- 0.22 378.1042
379.0501 2.14E+04 0.43 Y3
2- 0.36 379.0502
396.1147 2.11E+04 0.42 [Y2-SO3]
- 0.12 396.1147
397.0319 1.96E+05 3.89 [B2-CH3CO
•]- -1.02 397.0315
412.0554 4.05E+03 0.08 1,5A2 0.29 412.0555
416.0503 2.13E+04 0.42 2,4X1 0.32 416.0504
440.0504 1.01E+05 2.00 B2 0.08 440.0504
458.0610 5.04E+06 100.00 Z2/C2/[M-2H]
2- 0.00 458.0610
476.0713 3.04E+05 6.03 Y2 0.55 476.0716
500.0717 1.46E+04 0.29 2,4A3 -0.27 500.0716
504.0662 4.33E+04 0.86 1,5X2 0.55 504.0665
528.0663 2.83E+04 0.56 3,5A3 0.34 528.0665
536.1262 3.49E+03 0.07 [B3-SO3]
- -0.92 536.1257
554.1360 1.78E+04 0.35 [C3-SO3]
- 0.49 554.1363
559.1078 3.54E+03 0.07 0,2X2 1.57 559.1087
574.0717 1.89E+04 0.38 0,2A3 0.45 574.0720
588.0869 4.51E+03 0.09 1,5A3 1.20 588.0876
616.0822 5.53E+04 1.10 B3 0.52 616.0825
619.1297 5.80E+03 0.12 2,4X2 0.17 619.1298
634.0928 7.12E+05 14.12 C3 0.45 634.0931
662.1478 2.27E+04 0.45 [Z3-SO3]
-• -0.23 662.1476
679.1503 4.70E+03 0.09 [Y3-SO3]
-• 0.94 679.1509
720.1534 1.26E+05 2.51 [0,2X3-SO3]
-• -0.38 720.1531
740.0887 5.62E+03 0.11 Z3
• 0.15 740.0888
747.1400 7.92E+03 0.16 [1,4A4-SO3]
- 1.02 747.1408
758.0990 5.74E+03 0.11 Y3
• 0.50 758.0994
777.1499 3.00E+03 0.06 [1,3X4-SO3]
- 1.84 777.1513
791.1669 1.31E+04 0.26 [1,5A4-SO3]
- 0.10 791.1670
800.1102 3.85E+05 7.63 0,2X3
• -0.32 800.1099
816.0816 4.42E+03 0.09 0,2A4 -0.01 816.0816
818.1538 2.19E+04 0.44 [M-2H-H2SO4]
-• -0.34 818.1535
828.1043 7.23E+03 0.14 1,4A4
• 0.67 828.1049
836.1641 4.14E+04 0.82 [M-2H-SO3]
-• -0.02 836.1641
857.1077 1.48E+04 0.29 1,3X3 0.52 857.1081
870.1158 2.12E+05 4.20 1,5A4 -1.07 870.1149
898.1108 1.06E+05 2.09 [M-2H-H2O]
-• -0.52 898.1103
916.1213 3.04E+05 6.03 [M-2H]-• -0.44 916.1209
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Table 7.9 Fragment ion list for MS
3
 activation of the fragment ion m/z 715.05 from DS 
dp4 by UVPD (8 pulses, 4 mJ)/HCD (NCE 20). 
 
Table 7.10 Fragment ion list for MS
3
 activation of the fragment ion m/z 715.05 from DS 
dp4 by UVPD (8 pulses, 4 mJ)/ UVPD (8 pulses, 4 mJ). 
 
  
Measured m/z Intensity Relative intensity Ion ppm error Theoretical m/z 
272.9922 2.19E+05 1.07 [Y2+SO3]
- 0.00 272.9922
440.0503 4.90E+05 2.40 B2 0.30 440.0504
476.0714 6.08E+04 0.30 Y3 0.34 476.0716
634.0930 2.04E+07 100.00 C3 0.14 634.0931
Measured m/z Intensity Relative intensity Ion ppm error Theoretical m/z 
272.9920 1.01E+05 1.73 [Y2+SO3]
- 0.73 272.9922
440.0499 3.23E+05 5.49 B2 1.21 440.0504
458.0603 3.11E+04 0.53 C2 1.53 458.0610
476.0710 4.56E+05 7.76 Y3 1.18 476.0716
518.0816 1.34E+05 2.28 0,2X3 0.97 518.0821
554.1356 1.58E+05 2.69 [C3-SO3]
- 1.21 554.1363
590.0663 4.59E+05 7.81 [C3-C2H4O]
- 1.02 590.0669
634.0924 5.88E+06 100.00 C3 1.08 634.0931
715.0571 5.78E+06 98.23 [C3+HSO3]
-• 0.84 715.0577
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Table 7.11 Fragment ion list for UVPD (8 pulses, 4 mJ) of [M-3H]
3-
 of DS dp4. 
 
  
Measured m/z Intensity Relative intensity Ion ppm error Theoretical m/z
152.9862 4.01E+05 0.43 3,5A2/
3,5A4 0.77 152.9863
157.0141 1.98E+05 0.21 B1 0.94 157.0142
175.0246 2.71E+05 0.29 C1 1.21 175.0248
198.9918 7.80E+05 0.85 1,3X0/
1,3X2 -0.02 198.9918
202.0719 1.67E+04 0.02 [Z1-SO3]
- -0.99 202.0721
237.5322 3.40E+05 0.37 Y2
2- -0.24 237.5321
282.0287 9.23E+07 100.00 Z1 0.75 282.0289
300.0392 4.66E+06 5.05 Y1 0.92 300.0395
305.0382 6.44E+07 69.81 [M-3H]3- 0.13 305.0382
316.5428 1.00E+05 0.11 C3
2- 0.33 316.5429
328.0345 2.64E+06 2.86 1,5X1 -0.34 328.0344
342.0502 3.18E+06 3.44 0,2X1 -0.47 342.0500
357.0374 1.95E+06 2.11 2,5X1
• 0.76 357.0371
370.0452 2.22E+05 0.24 Z3
2- -0.66 370.0450
378.1042 2.39E+04 0.03 [Z2-SO3]
-/[C2-SO3]
- -0.04 378.1042
379.0504 1.16E+06 1.25 Y3
2- -0.43 379.0502
393.0479 7.31E+04 0.08 1,5X3
2- -0.52 393.0477
396.1149 8.37E+04 0.09 [Y2-SO3]
- -0.38 396.1147
399.5516 3.50E+06 3.79 0,2X3
2-• -1.36 399.5511
407.5367 3.55E+04 0.04 0,2A4
2- 1.13 407.5372
414.0713 3.82E+07 41.45 [Z2-CO2]
- -1.64 414.0706
435.0583 2.75E+05 0.30 1,5A3
2- -0.09 435.0583
440.0507 1.50E+06 1.63 B2 -0.60 440.0504
457.5572 2.97E+06 3.22 [M-3H]2-• -1.45 457.5565
458.0609 6.82E+06 7.39 Z2/C2 0.22 458.0610
476.0717 9.98E+05 1.08 Y2 -0.29 476.0716
499.0638 5.61E+04 0.06 2,4A3
• -0.12 499.0637
504.0667 6.25E+05 0.68 1,5X2 -0.44 504.0665
528.0666 3.49E+05 0.38 3,5A3 -0.23 528.0665
574.0725 8.54E+04 0.09 0,2A3 -0.95 574.0720
588.0879 6.84E+05 0.74 1,5A3 -0.50 588.0876
615.0751 7.34E+04 0.08 B3
• -1.55 615.0741
619.1301 6.62E+04 0.07 2,4X2 -0.47 619.1298
634.0934 4.50E+05 0.49 C3 -0.49 634.0931
661.1409 1.70E+05 0.18 [Z3-SO3]
- -0.80 661.1404
677.1357 6.79E+05 0.74 [Y3-SO3]
-•• -1.42 677.1347
741.0975 3.33E+04 0.04 Z3 -0.42 741.0972
747.1414 2.81E+04 0.03 [1,4A4-SO3]
- -0.85 747.1408
758.1007 5.82E+04 0.06 Y3
• -1.74 758.0994
719.1464 8.05E+05 0.87 [0,2X3-SO3]
-•• 0.76 719.1459
791.1675 2.16E+06 2.34 [M-3H-CO2-SO3]
-•• -0.66 791.1670
800.1110 3.08E+05 0.33 0,2X3
-• -1.32 800.1099
835.1575 1.02E+06 1.11 [M-3H-SO3]
-•• -1.48 835.1563
871.1244 1.35E+05 0.15 [M-3H-CO2]
-•• -0.70 871.1238
915.1144 1.07E+05 0.12 [M-3H]-•• -1.45 915.1131
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Table 7.12 Fragment ion list for UVPD (8 pulses, 4 mJ) of [M-5H]
5-
 of DS dp10. 
 
  
Measured m/z Intensity Relative intensity Ion ppm error Theoretical m/z
152.9863 3.69E+03 1.22 3,5A2/
3,5A4 0.11 152.9863
157.0140 1.94E+03 0.64 B1 1.57 157.0142
175.0248 4.08E+03 1.35 C1 0.07 175.0248
198.9917 5.73E+03 1.89 1,3X0 0.49 198.9918
282.0285 2.78E+05 91.74 Z1 1.46 282.0289
300.0392 2.68E+04 8.84 Y1 0.92 300.0395
328.0342 5.38E+04 17.76 1,5X1 0.58 328.0344
341.0423 5.39E+03 1.78 0,2X1
• -1.86 341.0417
357.0372 3.68E+03 1.21 2,5X1
• 0.19 357.0371
360.0935 1.51E+03 0.50 [B2-SO3]
- 0.33 360.0936
370.0448 7.02E+03 2.32 Z3
2- 0.42 370.0450
378.1042 5.67E+03 1.87 [Z2-SO3]
-/[C2-SO3]
- -0.04 378.1042
379.0501 6.35E+03 2.10 Y3
2- 0.36 379.0502
386.0396 8.62E+02 0.28 1,4X1
2- 0.70 386.0399
393.0475 1.26E+04 4.15 1,5X3
2- 0.49 393.0477
396.1145 2.11E+03 0.70 [Y2-SO3]
- 0.63 396.1147
399.5514 2.97E+03 0.98 0,2X3
2-• -0.85 399.5511
407.5490 1.75E+03 0.58 2,5X3
2-• -1.19 407.5485
412.0555 2.38E+03 0.78 1,5A2 0.05 412.0555
414.7184 3.02E+03 1.00 1,5X5
3- 0.95 414.7188
416.0504 4.61E+03 1.52 2,4X1 0.08 416.0504
425.5539 2.06E+03 0.68 1,5X7
4- 1.05 425.5543
437.0551 1.13E+03 0.37 2,4X3
2- 1.41 437.0557
440.0503 2.87E+04 9.49 B2 0.30 440.0504
449.0554 7.08E+03 2.34 B4
2- 0.70 449.0557













464.0644 1.58E+03 0.52 Y6
3- 0.26 464.0645
467.0659 1.36E+04 4.50 Y4
2- 0.82 467.0663
476.0712 1.07E+05 35.28 Y2 0.76 476.0716
481.0634 9.93E+02 0.33 1,5X4
2- 0.70 481.0637
481.3963 1.11E+03 0.37 3,5A7
2- -0.29 481.3962
493.0632 4.63E+03 1.53 3,5A5
2- 1.09 493.0637
496.7307 2.28E+03 0.75 0,2A7
3- 1.24 496.7313
502.0687 1.24E+03 0.41 C9
4- 0.64 502.0690
504.0661 8.18E+03 2.70 1,5X2 0.75 504.0665
510.3982 1.77E+03 0.58 B7
3-• 0.29 510.3983
516.0661 3.77E+04 12.46 0,2A5
2- 0.73 516.0665
516.7382 8.12E+02 0.27 C7
3- 0.31 516.7384
523.5834 1.24E+03 0.41 [0,2X9-SO3]
4-• 0.42 523.5836
528.0660 5.73E+03 1.89 3,5A3 0.91 528.0665
530.0827 2.67E+03 0.88 1,4A3 -1.08 530.0821
531.7568 2.46E+03 0.81 [Y7-SO3]
3- 1.59 531.7576
533.3192 6.97E+02 0.23 Y9
4- 6.54 533.3227
536.5674 1.14E+04 3.78 B5
2-• -0.19 536.5673
541.0887 8.26E+02 0.27 1,5X7
3- 1.08 541.0893
543.5729 7.88E+03 2.60 0,2X9
4-• -0.14 543.5728
546.0768 1.35E+04 4.44 C5
2- 0.44 546.0770
552.4055 9.81E+02 0.32 Z7
3- 1.62 552.4064
552.8364 9.23E+02 0.30 [M-5H-SO3]
4-• 4.46 552.8389
558.4092 4.55E+03 1.50 Y7
3- 1.28 558.4099
559.6006 1.36E+03 0.45 [Z5-SO3]
2- 0.15 559.6007
567.7407 2.13E+03 0.70 1,5X7
3- 1.50 567.7416
568.6055 6.56E+03 2.16 [Y5-SO3]
2- 0.82 568.6060
572.0770 2.42E+03 0.80 0,2X7
3-• -0.09 572.0769
572.5754 1.28E+04 4.23 [M-5H]4-• 0.28 572.5756
574.0715 1.09E+04 3.60 0,2A3 0.80 574.0720
577.4086 4.40E+03 1.45 2,5X7
3-• -0.02 577.4086
578.4267 6.78E+02 0.22 [B8-SO3]
3- 2.19 578.4280
582.6032 2.20E+03 0.73 [1,5X5-SO3]
2- 0.39 582.6034
588.0863 1.47E+03 0.48 1,5A3 2.22 588.0876
Measured m/z Intensity Relative intensity Ion ppm error Theoretical m/z
589.1069 4.79E+03 1.58 [0,2X5-SO3]
2-• -0.19 589.1068
599.5781 1.53E+03 0.51 Z5
2- 1.65 599.5791
604.7438 6.28E+02 0.21 B8
3-• -0.09 604.7437
607.7653 9.92E+02 0.33 [3,5A9-SO3]
3- 2.21 607.7666
608.5839 5.02E+03 1.66 Y5
2- 0.78 608.5844
611.0811 3.68E+03 1.21 Z8
3-/C8
3- 4.35 611.0838
615.0743 1.16E+04 3.84 B3
• -0.25 615.0741
622.5813 1.43E+03 0.47 1,5X5
2- 0.85 622.5818
626.4183 6.84E+02 0.23 1,5X8
3- 0.98 626.4189
629.0856 6.15E+03 2.03 0,2X5
2-• -0.64 629.0852
634.0928 1.28E+04 4.23 C3 0.45 634.0931
634.4182 1.76E+03 0.58 3,5A9
3- 1.13 634.4189
638.6108 7.30E+03 2.41 [B6-SO3]
2- 1.01 638.6114
647.6162 2.25E+03 0.74 [Z6-SO3]
3-/[C6-SO3]
3- 0.82 647.6167
654.4242 1.03E+03 0.34 1,5A9
3- 2.69 654.4260
656.6216 2.04E+03 0.67 [Y6-SO3]
2- 0.63 656.6220
661.1401 6.13E+03 2.02 [Z3-SO3]
- 0.41 661.1404
663.4213 3.73E+03 1.23 B9
3-• -0.29 663.4211
666.5893 9.64E+02 0.32 2,4X5
2- 0.83 666.5899
669.7596 2.48E+03 0.82 C9
3- 2.27 669.7611
678.5893 1.47E+04 4.84 2,4X5
2- 0.82 678.5899
679.1507 4.00E+03 1.32 [Y3-SO3]
- 0.35 679.1509
687.5950 1.80E+03 0.59 Z6
2-/C6
2- 0.20 687.5951
696.5999 1.66E+03 0.55 Y6
2- 0.74 696.6004
698.4457 1.04E+03 0.34 [0,2X9-SO3]
3-• 2.48 698.4474
702.1425 3.29E+03 1.09 [0,2X3-H2SO4]
• 0.09 702.1426
707.1455 3.68E+03 1.21 [1,5X3-SO3-H2O]
- 0.50 707.1459
710.1289 1812.7 0.60 [M-5H-2SO3]
3-•• 0.90 710.1295
720.1530 2.17E+03 0.72 [0,2X3-SO3]
-• 0.18 720.1531
725.0984 4.30E+03 1.42 0,2X9
3-• 1.80 725.0997
726.6254 6.95E+02 0.23 [B7-SO3]
2- 2.88 726.6275
736.7816 2126.9 0.70 [M-5H-SO3]
3-•• 0.29 736.7818
741.0968 9.68E+03 3.19 Z3 0.52 741.0972
759.1074 5.28E+03 1.74 Y3 0.46 759.1078
763.4336 6.61E+03 2.18 [M-5H]3-•• 0.63 763.4341
766.6038 1.21E+03 0.40 B7 2.74 766.6059
775.6097 1.83E+03 0.60 C7
2- 1.91 775.6112
777.1511 1.24E+03 0.41 1,3A8
2- 0.30 777.1513
787.1021 4.69E+03 1.55 1,5X3 0.72 787.1027
795.1622 8.67E+02 0.29 [2,4X3-SO3]
- -0.38 795.1619
800.1104 5.34E+03 1.76 0,2X3
• -0.57 800.1099
819.1613 1.81E+04 5.96 [B4-SO3]
- 0.73 819.1619
837.1725 8.01E+03 2.64 [Z4-SO3]
-/[C4-SO3]
- -0.05 837.1725
855.1827 5.63E+03 1.86 [Y4-SO3]
- 0.38 855.1830
899.1183 2.69E+04 8.88 B4 0.45 899.1187
907.1780 9.66E+02 0.32 [3,5A5-SO3]
- -0.07 907.1779
908.1213 9.60E+02 0.32 B8
2- 2.96 908.1240
917.1287 1.03E+04 3.40 Z4/C4 0.63 917.1293
935.1396 5.89E+03 1.94 Y4 0.25 935.1398
953.1829 8.91E+02 0.29 [0,2A5-SO3]
- 0.54 953.1834
963.1348 7.12E+02 0.23 1,5X4 -0.05 963.1348
987.1334 7.31E+02 0.24 3,5A5 1.37 987.1348
995.1918 1.17E+03 0.39 [B5-SO3]
- 2.19 995.1940
1004.6394 1.26E+03 0.42 C9
2-• 1.45 1004.6409
1013.2045 2.10E+03 0.69 [C5-SO3]
- 0.05 1013.2045
1032.1318 3.46E+03 1.14 0,2A5
• 0.06 1032.1319
1073.1349 2.28E+03 0.75 B5
•• -0.28 1073.1346
1093.1608 1.74E+03 0.57 C5 0.51 1093.1614
1145.1505 4.56E+02 0.16 [M-5H]2-••• -1.27 1145.1520
1198.2717 7.01E+02 0.23 [B6-2SO3]
- 1.38 1198.2734
1216.2826 5.89E+02 0.19 [C6-2SO3]
-/[Z6-2SO3]
- 1.09 1216.2839
1278.2295 1.39E+03 0.46 [B6-SO3]
- 0.52 1278.2302
1296.2401 7.11E+02 0.23 [C6-SO3]
-/[Z6-SO3]
- 0.49 1296.2407
1358.1857 1.60E+03 0.53 B6 0.95 1358.1870
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Table 7.13 Fragment ion list for UVPD (8 pulses, 4 mJ) of [M-8H+3Na]
5-




Measured m/z Intensity Relative intensity Ion ppm error Theoretical m/z 




159.4835 2.23E+02 0.05 B1
2- 2.77 159.4839
168.4888 1.01E+03 0.23 C1
2- 2.52 168.4892
198.9913 3.40E+02 0.08 0,2A1 2.50 198.9918
203.4915 8.20E+02 0.19 3,5A2
2- 2.28 203.4920
240.0178 6.62E+02 0.15 [B1-SO3]
- 2.27 240.0183
297.5798 1.16E+03 0.27 [M-8H+3Na-SO3]
5- 3.34 297.5808
311.9709 4.61E+03 1.06 [Y4+3Na]
4- 1.62 311.9714
313.4745 1.32E+04 3.05 [1,5X4+2Na]
2-/[2,4A4+2Na]
2- 0.47 313.4746
313.5716 4.33E+05 100.00 [M-8H+3Na]5- 1.77 313.5722
333.9900 7.92E+02 0.18 Z1 2.43 333.9908
337.9848 5.74E+02 0.13 C1 2.74 337.9857
351.6160 2.12E+03 0.49 [Z3+3Na]
3- 2.13 351.6167
355.9719 5.29E+03 1.22 [Z1+Na]
- 2.40 355.9728
357.6198 4.14E+02 0.10 [Y3+3Na]
3- 1.31 357.6203
359.6236 3.88E+02 0.09 [1,5X3+2Na]
3- 2.76 359.6246
366.9511 2.39E+03 0.55 [1,5X3+3Na]
3- 2.20 366.9519
387.4616 5.80E+03 1.34 [M-8H+3Na-H2O]
4-• 1.10 387.4628
391.9642 3.77E+03 0.87 [M-8H+3Na]4-• 2.71 391.9655
398.2939 1.42E+03 0.33 [B4+2Na]
3- 2.54 398.2949
402.9660 7.43E+02 0.17 [Z4+2Na]
3- 1.98 402.9668
404.2978 4.77E+02 0.11 [C4+2Na]
3- 1.57 404.2984
405.6212 2.12E+02 0.05 [B4+3Na]
3- 2.53 405.6222
410.2932 2.76E+03 0.64 [Z4+3Na]
3- 2.22 410.2941
411.6252 5.99E+02 0.14 [C4+3Na]
3- 1.33 411.6257
416.2970 2.01E+03 0.46 [Y4+3Na]
3- 1.52 416.2976
418.3008 3.60E+02 0.08 [1,5X4+2Na]
3-/[2,4X4+2Na]
3- 2.76 418.3020
425.6284 5.59E+03 1.29 [1,5X4+3Na]
3-/[2,4A4+3Na]3- 2.05 425.6293
456.9524 5.76E+02 0.13 [3,5A5+3Na]
3- 2.25 456.9534
472.2874 6.58E+02 0.15 [0,2A5+3Na]
3- 2.51 472.2886
476.9580 4.03E+02 0.09 [Z3+2Na-SO3]
2- 2.90 476.9594
485.9631 1.85E+03 0.43 [Y3+2Na-SO3]
3- 3.22 485.9647
487.9492 1.15E+03 0.26 [Z3+3Na-SO3]
2- 2.36 487.9504
495.9667 7.77E+03 1.79 [M-8H+3Na-SO3]
3-•• 2.79 495.9682
499.9610 1.82E+02 0.04 [1,5X3+2Na-SO3]
2-/[2,4A4+2Na]
2- 2.24 499.9621
510.9518 2.37E+02 0.05 [1,5X3+3Na-SO3]
2-/[2,4A4+3Na]
2- 2.53 510.9531
513.9584 4.48E+02 0.10 [3,5A4+2Na]
2- 2.29 513.9596
516.6152 7.29E+02 0.17 [M-8H+3Na-H2O]
3-•• 2.60 516.6169
522.6187 1.19E+03 0.27 [M-8H+3Na]3-•• 0.89 522.6204
527.9277 8.91E+02 0.21 [Z3+3Na]
2- 2.01 527.9288
536.9330 2.88E+02 0.07 [Y3+3Na]
2- 1.94 536.9340
550.9305 1.25E+03 0.29 [1,5X3+3Na]
2- 1.82 550.9315
568.9586 3.01E+02 0.07 [B4+3Na-SO3]
2- -0.05 568.9586
608.9356 5.93E+02 0.14 [B4+3Na]
2- 2.27 608.9370
615.9433 1.54E+03 0.36 [Z4+3Na]
2- 2.44 615.9448
617.9420 4.57E+02 0.11 [C4+3Na]
2- 0.42 617.9423
624.9497 4.70E+02 0.11 [Y4+3Na]
2- 0.62 624.9501










Measured m/z Intensity Relative intensity Ion ppm error Theoretical m/z 
138.9704 7.46E+03 0.15 0,4A1/
0,4A3/
0,4A5 1.92 138.9707
203.4916 4.31E+03 0.08 3,5A2
2- 1.79 203.492
240.0179 3.34E+04 0.65 [B1-SO3]
- 1.86 240.0183
244.4931 8.69E+03 0.17 [1,5A2+Na]
2-/[2,4X1+Na-SO3]
2- 1.64 244.4935
322.3644 5.12E+06 100.00 [M-10H+5Na]5- 1.66 322.3649
341.9564 9.71E+03 0.19 [B1+Na]
- 2.06 341.9571
355.9721 2.13E+05 4.16 [Z1+Na]
- 1.84 355.9728
359.9671 1.46E+04 0.28 [C1+Na]
- 1.58 359.9677
374.2784 3.58E+04 0.70 [1,5X3+4Na]
3- 2.20 374.2792
402.9552 5.77E+04 1.13 [M-10H+5Na]4-• 0.70 402.9555
412.9485 2.06E+03 0.04 [B4+4Na]
3- 2.53 412.9495
418.9523 7.64E+03 0.15 [C4+4Na]
3- 1.82 418.9531
426.2796 5.72E+03 0.11 [C4+5Na]
3- 1.83 426.2804
471.6072 5.98E+03 0.12 [3,5A5+5Na]
3- 1.81 471.6081
495.9582 7.08E+03 0.14 [M-10H+5Na-SO3-CO2]
3- -1.57 495.9574
500.6178 1.03E+05 2.02 [M-10H+5Na-CH2O-SO3]
3-•• 0.77 500.6182
500.9378 1.04E+05 2.03 [C3+4Na]
2- 1.96 500.9388
510.6213 1.30E+05 2.54 [M-10H+5Na-SO3]
3-•• 0.79 510.6217
522.6103 5.27E+04 1.03 [M-10H+5Na-CO2]3-•• 0.77 522.6107
527.2700 7.17E+04 1.40 [M-10H+5Na-CH2O]
3-•• 2.76 527.2715
535.9402 3.54E+03 0.07 [3,5A4+4Na]
2- 2.47 535.9415
537.2736 7.48E+04 1.46 [M-10H+5Na]3-•• 0.70 537.274
538.9189 9.82E+03 0.19 [Z3+4Na]
2- 1.55 538.9197
547.9240 2.61E+03 0.05 [Y3+4Na]
2- 1.85 547.925
549.9097 8.40E+03 0.16 [Z3+5Na]
2- 1.83 549.9107
561.9214 4.21E+03 0.08 [1,5X3+4Na]
2- 1.91 561.9225
572.9124 1.38E+04 0.27 [1,5X3+5Na]
2- 1.82 572.9134
615.9307 3.91E+05 7.64 [Z4+5Na-CO2]
2- 0.95 615.9313
637.9256 6.10E+04 1.19 [Z4+5Na]
2- 1.80 637.9267
639.9232 7.26E+03 0.14 [C4+5Na]
2- 1.57 639.9242
660.9284 1.75E+04 0.34 [1,5X4+5Na]
2-/[2,4X5+5Na]
2- 1.65 660.9295
1024.8645 7.60E+03 0.15 [C3+5Na]- 2.23 1024.867
1159.8390 9.36E+03 0.18 [0,2X3+5Na]
-• 2.11 1159.841
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Table 7.15 Fragment ion list for UVPD (8 pulses, 4 mJ) of [M-4H]
4-
 of fondaparinux. 
 
  
Measured m/z Intensity Relative intensity Ion ppm error Theoretical m/z 
198.9916 2.41E+03 0.01 0,2A1 0.99 198.9918
240.0181 3.01E+04 0.16 [B1-SO3]
- 1.02 240.0183
258.0287 2.91E+03 0.02 [C1-SO3]
- 0.82 258.0289
315.7623 2.06E+03 0.01 [M-4H-3SO3]
4- 2.04 315.7629
319.9749 3.39E+04 0.18 B1 0.81 319.9752
335.6379 1.87E+04 0.10 Y3_3- 1.27 335.6383
335.7516 7.91E+03 0.04 [M-4H-2SO3]
4- 1.64 335.7521
337.9853 1.75E+04 0.09 C1 1.26 337.9857
341.0098 4.47E+03 0.02 [Y4-2SO3]
3- 3.94 341.0111
344.9692 1.37E+04 0.07 1,5X3
3- 2.21 344.9700
352.0018 7.86E+03 0.04 Y1 -1.21 352.0014
355.7409 4.67E+05 2.50 [M-4H-SO3]
4- 1.27 355.7414
367.6641 3.28E+03 0.02 [Y4-SO3]
3- -1.86 367.6634
375.7307 1.86E+07 100.00 [M-4H]4- -0.38 375.7306
376.9936 9.61E+03 0.05 [1,5X4-SO3]
3-/[2,4A5-SO3]
3- 3.86 376.9951
379.9969 6.94E+03 0.04 1,5X1/
2,4A2 -1.61 379.9963
388.3119 3.59E+03 0.02 Z4
3- 0.69 388.3122
394.3153 1.10E+05 0.59 Y4
3- 0.98 394.3157
407.9909 3.68E+04 0.20 3,5A2 0.75 407.9912
416.0510 6.59E+03 0.04 [B2-SO3]
- -1.36 416.0504
456.9747 7.86E+03 0.04 C3
2- 0.42 456.9749
463.9823 5.58E+03 0.03 [Y3-SO3]
2- 0.90 463.9827
474.3213 1.50E+04 0.08 [M-4H-SO3]
3-• 0.70 474.3216
477.9798 2.65E+04 0.14 [1,5X3-SO3]
2-/2,4A4
2- 0.79 477.9802
491.9771 9.70E+03 0.05 3,5A4
2- 1.08 491.9776
494.9561 1.26E+04 0.07 Z3
2- -0.52 494.9558
496.0070 9.65E+03 0.05 B2 0.50 496.0072
500.9736 1.25E+05 0.67 [M-4H]3-• 0.60 500.9739
503.9606 2.20E+04 0.12 Y3
2- 1.04 503.9611
510.0227 2.80E+03 0.02 [Z2-SO3]
- 0.39 510.0229
512.0197 3.35E+03 0.02 [Y4-SO3]
2- 1.28 512.0204
514.0178 7.49E+03 0.04 C2 0.03 514.0178
514.9797 1.34E+03 0.01 0,2A4 1.31 514.9804
517.9581 1.17E+05 0.63 1,5X3
2- 0.93 517.9586
526.0175 8.22E+03 0.04 [1,5X4-2SO3]
2-/[2,4A4-2SO3]
2- 0.60 526.0178
535.9843 3.44E+03 0.02 [B4-SO3]
2- 2.53 535.9857
542.9929 4.54E+03 0.02 [Z4-SO3]
2- 1.07 542.9935
544.9905 5.05E+03 0.03 [C4-SO3]
2- 0.80 544.9909
551.9984 2.41E+04 0.13 [Y4-SO3]
2- 0.66 551.9988
565.9957 3.18E+04 0.17 [1,5X4-SO3]
2-/[2,4A5-SO3]
2- 0.92 565.9962
575.9633 7.38E+03 0.04 B4
2- 1.32 575.9641
582.9707 1.43E+04 0.08 Z4
2- 2.04 582.9719
584.9691 1.96E+04 0.11 C4
2- 0.42 584.9693
591.9769 5.64E+04 0.30 Y4
2- 0.46 591.9772
605.9742 9.33E+04 0.50 1,5X4
2-/2,4A4
2- 0.71 605.9746
607.9895 6.19E+03 0.03 Y2 1.28 607.9903
635.9849 4.42E+03 0.02 1,5X2/
2,4A3 0.46 635.9852
660.4659 3.22E+03 0.02 2,5X4
2-/1,4A5
2- 0.62 660.4663
711.4818 2.72E+04 0.15 [M-4H-SO3]
2-•• 0.35 711.4822
816.9885 4.08E+03 0.02 [B3-SO3]
2- 1.45 816.9897
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Table 7.16 Fragment ion list for HCD (NCE 15) of [M-4H]
4-
 of fondaparinux. 
 
Measured m/z Intensity Relative intensity Ion ppm error Theoretical m/z 
159.4837 4.12E+03 0.12 B1
2- 1.52 159.4839
168.4890 2.51E+03 0.07 C1
2- 1.33 168.4892
175.4968 5.33E+04 1.51 Y1
2- 1.42 175.4970
207.5213 2.21E+03 0.06 [B2-SO3]
2- 1.34 207.5216
223.5344 2.98E+03 0.08 [Y2-2SO3]
2- 1.28 223.5347
240.0181 5.27E+05 14.97 [B1-SO3]
- 1.02 240.0183
245.0058 9.76E+03 0.28 [B3-2SO3]
3- 1.25 245.0061
247.4997 5.10E+04 1.45 B2
2- 1.16 247.5000
255.6812 7.38E+04 2.09 [Y3-3SO3]
3- 1.22 255.6815
256.5050 1.17E+04 0.33 C2
2- 1.05 256.5053
258.0286 5.77E+03 0.16 [C1-SO3]
- 1.20 258.0289
263.5128 4.79E+04 1.36 [Y2-SO3]
2- 1.11 263.5131
271.6581 1.78E+04 0.51 [B3-SO3]
3- 1.02 271.6584
272.0443 3.32E+04 0.94 [Y1-SO3]
- 0.96 272.0446
275.7841 1.83E+03 0.05 [M-4H-5SO3]
4- 1.59 275.7845
282.3335 1.96E+05 5.57 [Y3-2SO3]
3- 1.00 282.3338
287.4781 5.33E+03 0.15 B4
4- 1.02 287.4784
295.7734 1.39E+06 39.59 [M-4H-4SO3]
4- 1.16 295.7737
298.3102 3.85E+03 0.11 B3
3- 1.51 298.3106
303.4912 1.36E+04 0.39 Y2
2- 0.99 303.4915
303.6831 7.28E+04 2.07 [B4-3SO3]
3- 1.21 303.6835
308.9857 5.81E+04 1.65 [Y3-SO3]
3- 1.15 308.9861
309.6866 7.16E+04 2.03 [C4-3SO3]
3- 1.26 309.6870
314.3588 3.80E+05 10.80 [Y4-3SO3]
3- 0.23 314.3589
315.7627 3.52E+06 100.00 [M-4H-3SO3]
4- 0.78 315.7629
319.9747 3.63E+04 1.03 B1 1.44 319.9752
321.0038 6.38E+02 0.02 [2,4X3-2SO3]
3-/[1,5A4-2SO3]
3- 0.94 321.0041
323.6903 1.36E+03 0.04 [1,5X4-3SO3]
3-/[2,4A5-3SO3]
3- 0.65 323.6905
328.0340 3.52E+04 1.00 [B3-3SO3]
2- 1.19 328.0344
330.3353 1.09E+05 3.11 [B4-2SO3]
3- 1.33 330.3357
333.9906 1.47E+03 0.04 Z1 0.63 333.9908
335.0068 1.17E+03 0.03 [Z4-2SO3]
3- 2.46 335.0076
335.0419 1.18E+04 0.33 [Z3-4SO3]
2- 0.94 335.0422
335.7518 5.59E+05 15.88 [M-4H-2SO3]
4- 1.04 335.7521
336.0934 2.89E+03 0.08 [B2-2SO3]
- 0.65 336.0936
336.3389 5.17E+04 1.47 [C4-2SO3]
3- 1.08 336.3393
337.0393 4.32E+03 0.12 [C3-3SO3]
2- 1.10 337.0397
341.0107 8.25E+05 23.44 [Y4-2SO3]
3- 1.31 341.0111
342.9839 2.15E+03 0.06 0,2A4
3- 1.72 342.9845
344.0470 1.78E+04 0.51 [Y3-4SO3]
2- 1.45 344.0475
347.6559 1.60E+03 0.05 [2,4X3-SO3]
3-/[1,5A5-SO3]
3- 1.36 347.6564
352.0009 6.84E+03 0.19 Y1 1.35 352.0014
355.7410 5.87E+03 0.17 [M-4H-SO3]
4- 0.99 355.7414
356.9876 9.97E+03 0.28 [B4-SO3]
3- 1.15 356.9880
362.9910 3.37E+03 0.10 [C4-SO3]
3- 1.47 362.9915
367.6630 1.09E+05 3.11 [Y4-SO3]
3- 1.13 367.6634
368.0123 2.12E+04 0.60 [B3-2SO3]
2- 1.35 368.0128
368.1193 1.53E+03 0.04 [Y2-3SO3]
- 1.45 368.1198
375.0203 8.80E+04 2.50 [Z3-3SO3]
2- 0.86 375.0206
376.0717 1.17E+04 0.33 [B4-5SO3]
2- 0.87 376.0720
377.0176 1.95E+03 0.06 [C3-2SO3]
2- 1.27 377.0181
392.0849 1.37E+03 0.04 [Y4-5SO3]
2- 0.60 392.0851
407.9908 2.21E+03 0.06 [B3-SO3]
2- 0.99 407.9912
414.9987 1.81E+04 0.51 [Z3-2SO3]
2- 0.79 414.9990
416.0500 2.88E+05 8.17 [B2-SO3]
-/[B4-4SO3]
2- 1.04 416.0504
423.0579 2.94E+03 0.08 [Z4-4SO3]
2- 0.85 423.0583
424.0040 3.03E+03 0.09 [Y3-2SO3]
2- 0.74 424.0043
425.0553 1.69E+04 0.48 [C4-4SO3]
2- 0.98 425.0557
430.0658 1.47E+03 0.04 [Z2-2SO3]
- 0.66 430.0661
432.0631 1.52E+04 0.43 [Y4-4SO3]
2- 1.02 432.0635
434.0605 1.20E+04 0.34 [C2-SO3]
- 1.15 434.0610
442.0309 7.59E+02 0.02 [2,4X3-3SO3]
2-/[1,5A4-3SO3]
2- 1.09 442.0314
448.0763 1.19E+04 0.34 [Y2-2SO3]
- 0.78 448.0766
456.0284 4.50E+04 1.28 [B4-3SO3]
2- 0.97 456.0288
463.0362 4.64E+04 1.32 [Z4-3SO3]
2- 1.01 463.0367
465.0336 2.20E+04 0.63 [C4-3SO3]
2- 1.13 465.0341
472.0416 6.48E+03 0.18 [Y4-3SO3]
2- 0.74 472.0419
496.0069 1.20E+04 0.34 B2/[B4-2SO3]
2- 0.70 496.0072
503.0147 1.05E+04 0.30 [Z4-2SO3]
2- 0.74 503.0151
505.0122 1.80E+03 0.05 [C4-2SO3]
2- 0.66 505.0125
510.0227 1.46E+03 0.04 [Z2-SO3]
- 0.39 510.0229
514.0174 3.60E+03 0.10 C2 0.80 514.0178
577.1193 1.39E+03 0.04 [B3-4SO3]
- -0.10 577.1192
671.0916 2.25E+03 0.06 [Z3-4SO3]
- 0.16 671.0917
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Table 17. Fragment ion list for 213 nm UVPD of [M-3H]
3-
 of DS dp4. 
 
  
Measured m/z Intensity Relative intensity Ion ppm error Theoretical m/z 
152.9863 1.82E+04 0.08 3,5A2/
3,5A4 0.11 152.9863
157.0143 2.39E+04 0.10 B1 -0.34 157.0142
175.0249 1.18E+04 0.05 C1 -0.51 175.0248
198.9919 4.76E+04 0.21 1,3X0/
1,3X2 -0.52 198.9918
228.5270 1.04E+04 0.04 Z2
2-/C2
2- -0.61 228.5269
237.5322 2.00E+05 0.87 Y2
2- -0.24 237.5321
252.3645 1.06E+04 0.05 Y3
3- -0.40 252.3644
282.0290 3.59E+06 15.49 Z1 -0.32 282.0289
300.0397 1.90E+05 0.82 Y1 -0.75 300.0395
305.0384 2.31E+07 100.00 [M-3H]3- -0.52 305.0382
316.5429 5.14E+04 0.22 C3
2- 0.02 316.5429
328.0345 1.38E+05 0.59 1,5X1 -0.34 328.0344
342.0501 8.79E+04 0.38 0,2X1 -0.18 342.0500
357.0372 1.70E+05 0.73 2,5X1
• 0.19 357.0371
370.0453 1.79E+04 0.08 Z3
2- -0.93 370.0450
378.1046 1.48E+03 0.01 [Z2-SO3]
-/[C2-SO3]
- -1.10 378.1042
379.0503 5.67E+05 2.45 Y3
2- -0.17 379.0502
393.0478 3.59E+04 0.16 1,5X3
2- -0.27 393.0477
399.5517 1.24E+06 5.35 0,2X3
2-• -1.61 399.5511
407.5372 1.19E+04 0.05 0,2A4
2- -0.10 407.5372
435.0584 1.59E+04 0.07 1,5A3
2- -0.32 435.0583
440.0507 1.62E+05 0.70 B2 -0.60 440.0504
457.5572 6.77E+05 2.92 [M-3H]2-• -1.45 457.5565
458.0607 7.17E+05 3.10 Z2/C2 0.65 458.0610
476.0717 1.34E+05 0.58 Y2 -0.29 476.0716
499.0642 5.67E+03 0.02 2,4A3
• -0.92 499.0637
504.0667 4.70E+04 0.20 1,5X2 -0.44 504.0665
528.0667 1.10E+04 0.05 3,5A3 -0.42 528.0665
558.1009 6.90E+03 0.03 0,2X2
• -0.09 558.1009
574.0725 4.50E+03 0.02 0,2A3 -0.95 574.0720
588.0879 3.94E+04 0.17 1,5A3 -0.50 588.0876
615.0751 1.27E+04 0.05 B3
• -1.55 615.0741
634.0936 3.72E+04 0.16 C3 -0.81 634.0931
661.1403 8.17E+03 0.04 Z3-SO3 0.11 661.1404
677.1357 1.92E+05 0.83 [Y3-SO3]
-•• -1.42 677.1347
719.1464 3.98E+04 0.17 [0,2X3-SO3]
-•• 0.69 719.1459
741.0974 2.68E+03 0.01 Z3 -0.29 741.0972
747.1422 1.96E+03 0.01 [1,4A4-SO3]
- -1.92 747.1408
759.1083 7.67E+03 0.03 Y3 -0.72 759.1078
791.1675 7.29E+04 0.31 [M-3H-CO2-SO3]
-•• -0.66 791.1670
800.1110 2.82E+05 1.22 0,2X3
-• -1.32 800.1099
835.1575 2.52E+04 0.11 [M-3H-SO3]
-•• -1.48 835.1563
871.1234 2.99E+03 0.01 [M-3H-CO2]
-•• 0.45 871.1238
915.1133 1.17E+04 0.05 [M-3H]-•• -0.25 915.1131
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Chapter 8:  Conclusions 
8.1 SUMMARY OF CHAPTERS 
 The rapid growth of the field of lipidomics can largely be attributed to 
innovations in mass spectrometry instrumentation. However, conventional tandem mass 
spectrometry methods often prevent determination of subtle structural features and 
provide limited information on targets that are structurally complex. Implementation of 
alternative ion activation methods, in particular UVPD, on high resolution mass 
spectrometers has significantly contributed to the ultimate goal of obtaining complete 
lipid structural characterization.
1
 The work presented in the dissertation both reaffirms 
193 nm UVPD as an effective means to obtain additional structural information and 
confirms that it can be successfully coupled to shotgun, chromatographic and imaging 
workflows. 
193 nm UVPD of phosphatidylcholine cations produced diagnostic pairs of ions 
that permitted localization of unsaturations within acyl chains. The number of double 
bonds appears to both influence the extent of fragmentation and the production of even- 
and odd- electron fragment ions. This result is not surprising considering the UV 
absorption properties of unsaturations in which molar attenuation coefficient increases 
with the number of double bonds.
2
 Application of 193 nm UVPD to a shotgun lipidomic 
workflow confirmed that double bond positional isomers could be detected in a complex 
lipid extract and that relative quantitation could be performed based on diagnostic ion 
intensities. Coupling of the developed UVPD method with DESI allowed double bond 
positional isomers to be detected in situ. Further, changes in the relative abundance of 
double bond positional isomers were localized to specific tissue features. 
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 Lipopolysaccharides (LOS) represent an even more structurally complex lipid 
target than phospholipids. In Chapter 5, a shotgun electrospray infusion method was 
developed in which collisional activation was used to bisect intact LOS ions to produce 
lipid A and oligosaccharide substructures. Subsequent activation of lipid A and 
oligosaccharide fragment ions by UVPD generated rich spectra that provided an 
unprecedented level of structural characterization for intact LOS. The developed MS
3
 
method was then coupled, in a targeted fashion, with online chromatographic separations 
in Chapter 6. The chromatographic method revealed the true heterogeneity of LOS 
samples and facilitated detection subtle structural features that of otherwise may have 
gone unnoticed during a shotgun infusion method. For example, intact LOS structures 
that differed only by the presence of a single unsaturation in one acyl chain were baseline 
separated; the isotope pattern of these species would have overlapped during shotgun 
infusion. Using the developed LC-MS
3
 method, the structures of LOS from strains of 
Acinetobacter baumannii, for which the structures were unknown, where determined.  
8.2 FUTURE DIRECTIONS 
The work presented in this dissertation establishes a versatile framework for 
characterization of phospholipids and lipopolysaccharides.  There remain many avenues 
for continuation of the methods development aspects and new applications that exploit 
the UVPD strategies.   
8.2.1 Glycerophospholipids 
To date, all methods utilizing UVPD for localization of double bonds within lipid 
acyl chains, including the work presented in Chapters 3 and 4, have been performed in 
positive mode.
3,4
 Positive mode analysis was the natural choice for PC and 
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sphingomyelin characterization, owing to the fixed positive charge on the head groups.
4
 
Williams et al. showed that sodium adduction using infusion of a sodium salt via a tee 
can be used to determine acyl chain and double bond positions in positive mode for a 
variety of glycerophospholipids via UVPD.
3
 However, introduction of a non-volatile salt 
is not practical for all workflows. Extension of the UVPD method to negative mode 
would allow a higher level of structural characterization for glycerophospholipids that 
preferentially ionize in negative mode.
5,6
 Preliminary data for a phosphatidylglycerol 
anion in Figure 8.1 confirm that UVPD can be used in the negative mode to determine 
the glyercophospholipids subclass, acyl chain composition and double bond positions in a 
single MS/MS event. This data further establishes UVPD as a promising method that can 




Figure 8.1 a) HCD (NCE 25) and b) UVPD (20 pulses, 4mJ) spectra of deprotonated 
phosphatidylglyercol 16:0/18:1 ([M-H]
-
, m/z 747.51) 
8.2.2 LPS/LOS 
For the work presented in Chapters 5 and 6, LOS served as good starting point for 
top-down structural characterization. However, LOS represents a relatively simple 
structure compared to LPS structures that contain O-antigen. Bacterial serotyping, which 
allows classification beyond the species level, is done based on bacterial surface antigens, 
including O-antigen.  Classification by serotype not only assists in identifying the source 
of the bacteria but also allows the potential severity of disease to be determined.
7,8
 O-









































































agglutination-based serotyping methods require a large number of O-antigen specific 
antibodies be maintained and can lead to false-positives as results are based on visual 
detection of agglutination.
10
 The development of mass spectrometry-based serotyping 
methods built on O-antigen characterization would allow accurate classification of 
bacteria, and allow more subtle structural features, including non-stoichiometric 
modifications, to be investigated. The next natural step with this work is to evaluate the 
compatibility of the developed methods with intact analysis of LPS. 
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